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ABSTRACT 
 
In this thesis, aspects of metabolism of lipids in dairy cows were studied, particularly 
18:1 trans fatty acid (tFA) concentrations in plasma and lipoprotein fractions, and 
transportation of FA in epithelial mammary gland cell cultures.  
 
Two in vivo studies were conducted to elucidate which lipoprotein fractions were 
involved in bovine plasma transport of tFA by infusing oils that induced different 
plasma tFA profiles. Fatty acid profiles of plasma and lipoprotein fractions [high 
(HDL), low (LDL), and very low density (VLDL) lipoprotein fractions] were analysed. 
Results showed that VLDL fraction was the main transport mechanism of tFA in 
plasma and was more responsive to supply of tFA.  
 
MAC-T cell cultures were used to study specific aspects of lipid uptake without 
interference from the cow’s digestive system and general metabolism. Treatments 
consisted of adding long-chain FA solutions to lactogenic medium at varying 
concentrations. After incubation, cystosolic triacylglycerol (TAG), protein and DNA 
contents were determined. Results demonstrated that cytosolic TAG accumulation is 
stimulated by addition of long-chain FA, which affects FA profile of cytosolic free FA.  
 
Overall, results from this thesis enhance knowledge on plasma transport and 
mammary uptake of 18:1 tFA in dairy cows. The information strengthens 
understanding of some aspects of milk fat synthesis and metabolism of FA in dairy 
cows fed with different sources of tFA. Findings from this thesis are important 
because saturated FA and tFA in milk fat have caused concern among human health 
researchers and more recently milk fat has gained appreciation as a functional food 
due to the health-promoting potential of some FA (vaccenic and conjugated linoleic 
acids) found specifically in ruminant-derived products.  
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CHAPTER 1 
1. Literature review 
1.1 Introduction 
Lipids obtained from dairy products are an important part of the human diet in many 
countries; roughly 75% of the total consumption of fat from ruminant animals comes 
from bovine milk fat (O’Donnell et al., 1993; Demeyer et al., 1999; Chilliard et al., 
2000). Milk fatty acid (FA) composition has numerous effects on milk quality, 
including its physical properties (e.g. melting point and hardness of butter, 
crystallization and fractionation of milk fat) and nutritional value (e.g. effects on 
human health). Different FA (short- and medium-chain saturated, branched, mono- 
and polyunsaturated, cis and trans, conjugated FA) present in ruminant milk fat are 
potentially positive or negative factors for the health of consumers (Williams, 2000; 
Jensen, 2002; Parodi, 2004; Chilliard et al., 2007). Dairy products provide 25–60% of 
the overall saturated fat consumption in Europe, which, for decades has made them, a 
target of concern due to the negative effects of excessive consumption of saturated FA 
on human health (Givens and Shingfield, 2006; Chilliard et al., 2007). Recently 
(Elwood et al., 2010) a review from different meta analyses showed that milk intake 
reduces risk factors  for ischemic heart disease, stroke and incident diabetes. However, 
this does not necessarily apply to full fat dairy products such as butter and cream. 
By altering the nutrition of the cow, farmers can markedly and rapidly modulate milk 
FA composition. The largest changes can be obtained either by altering forages in 
diets, particularly pasture, or by adding plant or marine lipid supplements to the diet 
(Chilliard and Ferlay, 2004; Chilliard et al., 2001, 2003, 2007; Lock and Shingfield, 
2004; Loor et al., 2005; Dewhurst et al., 2006). Modifying milk fat content by dietary 
manipulation is not a recent concept (Palmquist and Beaulieu, 1993). In the early 
1970s the concern for reducing saturated fat content in the human diet initiated an 
intense research era (Grummer, 1991). In recent years the interest in reducing fat from 
dairy products is mainly due to concern about the hypercholesteraemic effects of 
medium-chain saturated FA (Dewhurst and Lee, 2004). Conversely, in recent decades 
the dairy industry has increased the fat content of milk by making genetic 
modifications, principally in the British Friesian breed, with the aim of improving 
yields of cheese and butter, and milk fat as an energy source in the human diet 
(Palmquist and Jenkins, 1980; Wu et al., 1991; Dewhurst and Lee, 2004). Given that 
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economic factors define the future profits for farmers, dietary manipulation of fat 
content may be the most practical and appropriate approach to change milk FA 
composition.  
 
Lipids from ruminant milk have been estimated to contain over 400 different FA and 
this number is mainly due to events that take place within the rumen (Jensen, 2002; 
Bauman and Griinari, 2003). Diet has major effects on ruminal bacteria population 
and processes within the rumen. For this reason, diet and nutrition have an important 
role in determining the fat content and FA composition of milk (Bauman and Griinari, 
2003). 
Some FA, such as butyric acid, oleic acid, polyunsaturated FA (PUFA) and 
conjugated linoleic acid (CLA) have potential anticarcinogenic and antiatherogenic 
effects on human health. Other FA, such as some saturated (lauric, myristic and 
palmitic acids) and some trans FA (tFA), have potential negative effects on human 
health (Willet et al., 1993; Kinsella et al., 1990; Molkentin, 1999; Parodi, 1999;   
Chilliard et al., 2000). 
Trans fatty acids are produced during biohydrogenation of PUFA in the rumen. They 
are mixtures of positional and geometric isomers (Griinari and Bauman, 1999; 
Piperova et al., 2004), which are incorporated into milk fat (Parodi, 1977; Griinari and 
Bauman, 1999; Loor and Herbein, 2001; Piperova et al., 2002, 2004; Precht et al., 
2002).  There has been intensive research on tFA, mainly on the negative effect of 
specific isomers of 18:1 trans that can be found in either dairy products or chemically 
produced partially hydrogenated vegetable oils (PHVOs) (Willet et al., 1993; Wolff, 
1995; Chilliard et al., 2000). There is also interest in the role of trans isomers of 18:1 
mediating the milk fat depression associated with some specific dairy diets (Griinari et 
al., 1998, 1999; Chilliard et al., 2000). 
A number of researchers have highlighted the negative effect of tFA on milk fat 
concentration. However, the exact mechanisms of this phenomenon remain unclear. 
Milk fat depression has a great impact on economics, causing important losses to dairy 
producers. Therefore, more research is needed to understand the exact mechanisms by 
which tFA cause milk fat depression. Additionally, the influence of tFA on milk 
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composition is of interest due to their biological effects and potential role in human 
diseases.  
1.2 Lipids 
Lipids are a group of heterogeneous chemically substances that are insoluble in water, 
but soluble in non-polar solvents such as chloroform, hydrocarbons and alcohols 
(Christie, 1981). Lipids include a wide range of compounds including neutral fats 
(triacylglycerols), waxes, terpenes and more complex lipids such as glycolipids and 
phospholipids. Lipids play important biological roles as structural cell membrane 
components, storage forms of energy, metabolic fuels, emulsifying and insulating 
agents, steroid hormones, vitamins, prostaglandins and roles in signal transduction 
(Hajri and Abumrad, 2002; Doege and Stahl, 2006). 
1.2.1 Fatty acid nomenclature 
The number, geometry, and position of double bonds in FA affect their melting point. 
Triglycerides high in long-chain saturated FA will easily conglomerate in a crystal 
lattice and are therefore solid at room temperature (Katan and Zock, 1995). On the 
other hand, cis unsaturated double bonds introduce bends in the molecule that hinders 
crystal formation, which explains why oils are liquid. The spatial structure of tFA is in 
between that of saturated FA and cis unsaturated FA. As a result, oleic acid melts at 
13°C; its trans isomer elaidic acid (18:1 trans 9) melts at 44°C; and stearic acid 
(18:0), which is straight and saturated, melts at 72°C (Katan and Zock, 1995). 
Different conventions are used to name unsaturated FA according to the number of 
carbons in the molecule, the position of the centres of unsaturation (double bonds) and 
the geometrical configuration of the double bonds. The carbon atoms of an acid can be 
numbered (or lettered) HLWKHUIURPWKHFDUER[\OJURXSǻQXPEHULQJV\VWHPRUIURP
the carbon atom furthest from the FDUER[\OJURXSQRUȦQXPEHULQJV\VWHP (Katan 
and Zock, 1995) )$ QDPHV DUH DEEUHYLDWHG LQ WKH ǻ QRPHQFODWXUH E\ OLVWLQJ WKH
number of carbon atoms followed by the number of double bonds: i.e. ǻ9. The 
QXPEHUDIWHUǻLQWKLVFODVVLILFDWLRQV\VWHPLVWKHSRVLWLRQRIWKHGRXEOHERQGUHODWLYH
WRFDUER[\OHQG)RUH[DPSOHLQǻ9, the single double bond is nine carbon atoms 
away from the carboxyl group; meaning that it is between carbon atoms 9 and 10, 
FRXQWLQJ WKH FDUER[\O FDUERQ DWRP DV FDUERQ DWRP QXPEHU  ,Q WKH Ȧ QXPEHULQJ
system, palmitoleic would be referred as 16:1 (n-7). This indicates seven carbon atoms 
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DZD\IURPWKHȦ-carbon atom (Katan and Zock, 1995). This system is currently most 
widely used. Most unsaturated FA are found in the cis configuration where the 
hydrogen atoms are on the same side of the double carbon bond, whereas tFA have 
hydrogen atoms on opposite sides of the double bond (Figure 1.1) (Food Safety, 
Authority of Ireland, 2008). 
 
     
Figure 1.1 Cis (left) and trans (right) configurations of carbon double bonds in fatty acids (Food Safety, 
Authority of Ireland, 2008). 
 
1.2.2 Essential fatty acids 
Mammals cannot synthesize two PUFA, linoleic and linolenic acids, which, as they 
and products of their metabolism play essential physiological roles, are therefore 
essential dietary requirements. Linoleic acid consists of a chain of 18 carbon atoms 
containing two double bonds separated by one methylene group. In the “n” notation, 
linoleic is designated n-6 and can be represented as 18:2 (n-6) (AbuGhazaleh et al., 
2007). The hydrogen atoms on each side of the double bonds are in the cis 
configuration. LinolenLFDFLGRIWHQGHQRWHGDVĮ-linolenic acid to distinguish it from 
isomeric forms) has three bonds 18:3 (n-3). Linoleic acid has two double bonds at 
ǻ9,12 DQG Į-linolenLF KDV WKUHH ǻ9,12,15. These FA cannot be synthesized because 
DQLPDOV ODFN ǻ12 DQG ǻ15 desaturases which prevents introduction of double bonds 
beyond carbon atom 9 in the chain (Christie, 1982). 
The richest sources of linoleic acid are seed oils (i.e. safflower, sunflower, maize and 
soya bean oils) (AbuGhazaleh et al., 2007). Alpha linolenic acid is found in high 
amounts in flax (linseed) oil, and in lesser amounts in rapeseed oil, soya bean oil and 
oats in even lower quantities in cottonseed, corn, palm, safflower and sunflower oils 
(Shingfield et al., 2010). 
1.2.3Conjugated linoleic acid (CLA) 
Conjugated linoleic acid refers to the group of isomers of linoleic acid with 
conjugated double bonds (Bauman et al., 1999; Chichlowski et al., 2005). CLA is 
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produced during the biohydrogenation of PUFA in the rumen (Figure 1.2) (Griinari 
and Bauman, 1999; Piperova et al., 2004).  CLA is an intermediate in the rumen 
hydrogenation of linoleic acid, whereas vaccenic acid (18:1 trans 11) is a common 
intermediate in the biohydrRJHQDWLRQRIOLQROHLFDQGĮ- DQGȖ-linoleic acids (Chilliard 
et al., 2000). Griinari et al. (2000) demonstrated that endogenous synthesis of CLA cis 
9, trans 11 from vaccenic acid represents the primary source of CLA in milk fat (Shen 
et al., 2007). 
 
Dairy products and meat from ruminants represent the only significant natural source 
of CLA (Lawson et al., 2001; Burdge et al., 2005). CLA has been suggested to have 
numerous beneficial physiological effects such as changes in body composition 
(Gaullier et al., 2004; Chichlowski et al., 2005) and lower insulin resistance associated 
with CHD (Aminot-Gilchrist and Anderson, 2004; Chichlowski et al., 2005). Other 
health effects, such as anti-carcinogenic, anti-atherogenic, anti-obesity, anti-
diabetic
 
and immune system enhancement, have been investigated in different animal 
models, and to a lesser extent in humans (McGuire and McGuire, 2000;
 
 
Belury, 2002). 
An increase in milk CLA, particularly rumenic acid content is associated with an 
increase in other tFA, particularly 18:1 trans-11, which acts as a precursor of rumenic 
DFLGYLD WKHHQ]\PDWLFDFWLRQRIǻ9
 
-desaturase,  and to a lesser extent 18:1 trans-10 
(Williams, 2000; Lock and Garnsworthy, 2002; Lock et al., 2004; Hurtaud and 
Peyraud, 2007). This was also reported by Chilliard et al. (2000), who found a linear 
relationship between the content of CLA in milk and 18:1 trans. Similarly, Hurtaud 
and Peyraud (2007) showed strong correlations between milk CLA and 18:1 trans. 
Dietary starch and fibre levels affects biohydrogenation of FA by ruminal microflora 
and hence, on the equilibrium of CLA isomers passing to the duodenum (Chilliard et 
al., 2000; Offer et al., 2001).  Supplementation of dairy cow diets with plant oils (soya 
bean, sunflower, linseed, rapeseed and maize) results in significant increases in milk 
fat CLA concentrations. Moreover, plant oils high in linoleic acid give the greatest 
response in cattle. Feeding pasture to dairy cows has been also shown to increase milk 
fat content of CLA (Stanton et al., 1997; Kelly et al., 1998; Lawless et al., 1998; 
Chilliard et al., 2000; Boken et al., 2005; Hurtaud and Peyraud, 2007). However, other 
studies have shown that milk CLA increases with diets low in 18:2, such as those 
which include fish oil supplements; because of those observations it has been 
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suggested that CLA could be synthesized by tissues (i.e. adipose tissue) (Chilliard et 
al., 2000).  
Lock and Garnsworthy (2002) demonstrated that dietary lipid manipulation can alter 
CLA cis-9, trans-11 content in milk fat when linoleic or linolenic acids are fed to 
cows. They found similar increases in milk CLA cis-9, trans-11 content when either 
dietary linoleic or linolenic acids were increased and higher concentrations were 
observed when both oils were increased together. They also found that there was 
considerably more CLA cis-9, trans-11 (approximately 80%) in milk than that 
produced in the rumen in agreement with the concept of endogenous synthesis of CLA 
cis-9, trans-11 in the mammary gland via the enzymatic action RIǻ9-desaturase. 
The concentration of CLA can be increased in pasture grazing cows when their feed is 
supplemented with oils (Boken et al., 2005; AbuGhazaleh et al., 2007). Other studies 
(Lawless et al., 1998) have concentrated on supplementation of grazing cows with 
full-fat soyabeans or full-fat rapeseed to increase milk CLA concentration. 
Alternatively, fish oil (FO) has been used as an effective means to increase 
concentration of CLA in milk (AbuGhazaleh et al., 2007). However, there is low 
efficiency of transfer of dietary (n-3) long-chain PUFA (LCPUFA) to milk (Offer et 
al., 2001) mainly due to three factors occurring in the rumen: 
1. Biohydrogention of these dietary lipids in the rumen  (Figure 1.2) 
2. Their selective incorporation into certain plasma lipoprotein fractions which 
are ineffective in delivering FA into the mammary gland 
3. A low specificity of the relevant enzymatic systems of the mammary gland for 
these FA 
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C18 PUFA 
Ļ 
Conjugated C18 PUFA 
     ĻRQHRUPRUHUHGXFWLYHVWHSV 
  C18:1 trans 
    Ļ 
  C18:0 
Figure 1.2 General pathway for rumen biohydrogenation of PUFA 18-carbon FA (from 
Harfoot and Hazlewood, 1988; Bauman and Griinari, 2003) 
 
1.3 Milk fat composition 
Lipids in milk normally comprise 60 to 70% saturated fatty acids (SFA; e.g. myristic, 
palmitic and 18:0 acids) (Yu et al., 1995; Dewhurst and Lee, 2004), 25 to 35% 
monounsaturated fatty acids (MUFA; e.g. oleic acid) and up to 5% PUFA (e.g. 
OLQROHLF &/$ Į-linoleic acids) (Jensen, 2002; Corl et al., 2003; Lock et al., 2004; 
Dewhurst and Lee, 2004). Normally, milk contains low levels of longer-chain PUFA 
such as eicosapentaenoic acid (EPA; C20:5) and docosaheaenoic acid (DHA; C22:6) 
(Jacobs et al., 2004; Dewhurst and Lee, 2004). Milk fat contains significantly higher 
concentrations of short-chain FA and medium-chain FA and relatively lower 
concentrations of UFA compared with other dietary sources of vegetable and animal 
fat (Berner, 1993; Kennelly, 1996). Milk fat has been criticized because it contains a 
less desirable balance of FA than many vegetable or fish oils. Two principal medium-
chains FA in butterfat, myristic acid and palmitic acid, have been identified as major 
dietary factors responsible for raising plasma low density lipoprotein cholesterol 
(Keys et al., 1965; Hegsted et al., 1965; Grande, et al., 1970; Denke and Grundy, 
1992; Nestel et al., 1994). In particular, myristic acid, of which dairy products are a 
major source, is reputedly more potent than palmitic acid in cholesterol-raising effects 
(Zock et al., 1994) (Tables 1.1 and 1.2). 
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Table 1.1 Lipids in milk 
Lipid class % of total lipid 
Phospholipid 1.11 
Cholesterol 0.46 (15 mg/dl) 
Triacylgycerol 95.80 
1, 2- Diacylglycerol 2.25 
Free fatty acids 0.28 
Monoacylglycerol 0.08 
Cholesteryl ester 0.02 
Fat g/dl 3.25 
 
Adaptated from Jensen, 2002; data was obtained by densitometric analysis of separate milk 
lipids on TLC plates 
 
Table 1.2 Fat composition of milk in the United Kingdom
1
 and composition of the 
major fatty acids in milk fat
2 
Type of milk Per 100 g Fatty acid
 
Common name 
    
 Whole milk   
Fat (g) 3.9 4:0 Butyric 
          SFA 2.5 6:0 Caproic 
          MUFA 1.0 8:0 Caprylic 
          PUFA 0.1 10:0 Capric 
          tFA 0.1 12:0 Lauric 
 Semi-skimmed milk 14:0 Myristic 
Fat (g) 1.7 15:0 Pentadecanoic 
          SFA 1.1 16:0 Palmitic 
          MUFA 0.4 16:1 Palmitoleic 
          PUFA Trace 17:0 Margaric 
          tFA 0.1 18:0 Stearic 
 Skimmed milk 18:1 Oleic 
Fat (g) 0.3 18:2 Linoleic 
          SFA 0.1 18:3 Linolenic 
          MUFA 0.1   
          PUFA Trace   
          tFA Trace   
    
1
From The Dairy Council, 2010. Data was taken from the 2002 summary edition of The Composition of 
Foods (Food Standards Agency (2002) McCance and Widdowson’s The Composition of Foods, Sixth 
summary edition. Cambridge: Royal Society of Chemistry); 
2
 Adaptated from Jensen, 2002 
 
1.3.1 Factors affecting milk fat composition 
Ruminant milk FA composition is linked to intrinsic (animal species, breed, genotype, 
pregnancy and lactation stages) or extrinsic (environmental) factors (Palmquist et al., 
1993; Chilliard and Ferlay, 2004; Chilliard et al., 2007). In a given animal species, the 
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effects linked to breed or genotypes are significant but restricted and they can only be 
altered over long terms. The effect of lactation stage on milk fat content and FA 
composition is associated to body fat mobilization in early lactation (Chilliard et al., 
1991, 2007), but it only lasts a few weeks each year. Garnsworthy et al. (2006) 
investigated the variation in citrate with stage of lactation and de novo FA synthesis, 
without confounding dietary effects. They found that cows in late lactation produced 
milk with a FA profile similar to that of cows in mid lactation. Differences between 
mid and late lactation in yield of FA were due to differences in milk fat yield, 
concluding that stage of lactation does not affect the relative incorporation of FA from 
de novo synthesis vs. preformed sources when diet composition is constant. 
 
1.4 Dietary fat in dairy cow diets 
Supplementation with lipids has been used to increase the energy concentration of the 
diet and to avoid negative associative effects on dry matter intake, digestibility, and 
milk production and composition sometimes experienced with cereal grains (Coppock 
and Wilks, 1991; Staples et al., 1998; Garnsworthy, 1997). Many sources of 
supplemental fat have been fed to beef and dairy cattle under experimental conditions. 
These include blends of animal and vegetable fat, tallow, yellow grease, fishmeal, 
cottonseeds, soyabeans, rapeseeds, canola seeds, peanut hearts, safflower seeds, 
sunflower seeds, flaked fat, prilled fat, hydrogenated fat, calcium soaps of fat, 
medium-chain triglycerides, and free FA (Staples et al., 1998; Funston, 2004). The FA 
profile of these fat sources varies widely. Coppock and Wilks (1991) reported the FA 
profile of many of the commonly used fats. The major FA in most feed lipids is 
linoleic acid whereas linolenic acid predominates in most forage lipids (Staples et al., 
1998). Tallow (40.9%) and yellow grease (46.8%) contain different contents of oleic 
acid (Coppock and Wilks, 1991). Granular fats, such as calcium soaps of palm oil, and 
prilled fats contain mainly saturated palmitic and stearic acids (Staples et al., 1998).  
The fat content of ordinary diets for ruminants is less than 50 g/kg and digestive 
problems can occur by increasing total fat content of the diet to more than 100 g/kg 
(Garnsworthy, 1997). Rumen microorganisms cannot utilise large quantities of fat, 
although limited quantities of FA can be incorporated into microorganisms during cell 
synthesis. More important than the quantity of FA in the diet is their form, since long-
chain UFA have a detergent effect on bacterial cell walls. Under normal 
circumstances, the ester linkages of tryglycerides are rapidly hydrolysed by bacterial 
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lipases in the rumen. Once released from the ester combination, unsaturated fatty acids 
are subsequently hydrogenated to detoxify them (Garnsworthy, 1997). Fibre particles 
in the rumen can be physically coated by fat and be inaccessible for microbial attack. 
The magnitude of these effects depends on level, source and type of fat, dietary 
carbohydrate source and feed intake. Similarly, another problem is that long-chain 
free FA can form soaps with calcium and magnesium in the rumen. This will detoxify 
FA, but it can also reduce the availability of minerals (Garnsworthy, 1997). 
Theoretically, supplementation of fat could have some of the following advantages: 
a. Increase the energy concentration of the diet because fat contains three times 
more net energy for lactation than protein- and carbohydrate-rich feeds 
(Palmquist, 1984)  
 
b. Improve the energetic efficiency because reduced loss of energy as heat, 
methane, and urine may be expected (Palmquist and Jenkins, 1980), and 
because the dietary fatty FA are incorporated directly into milk fat by the 
mammary gland (Wu and Huber, 1994; Garnsworthy, 1997) 
 
c. Reduce the risk of rumen acidosis and a decrease in milk fat percent induced 
by feeding high levels of cereal grains in the diet (Palmquist and Conrad, 
1978; Palmquist, 1984) 
 
Lipids can be manipulated by several means in order to avoid adverse effects in the 
rumen and to retain availability in the small intestine (Palmquist, 1984). These 
modified fat products are known as “by-pass fats” or “rumen inert fats”, and their 
protection against rumen microbial action can be natural (i.e., encapsulation in 
formaldehyde-treated casein or formation of calcium soaps) or physical (i.e., selection 
of fatty acids with a high melting point and small particle size) (Garnsworthy, 1997). 
Development of commercial products based on calcium soaps of long-chain fatty 
acids offers dairy cattle producers a method of increasing energy concentration of 
rations without disturbing rumen fermentation (Palmquist, 1984; Chalupa et al., 1986; 
Espinoza et al., 1995). 
Fat supplementation has been associated with positive and negative effects on 
reproduction although (Grummer and Carroll, 1991; Fahey et al., 2002) the amount of 
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supplemental fat needed to elicit an effect on reproductive function is largely 
unknown. Some studies indicate that the amount of added plant oil necessary to 
maximize positive ovarian effects is not less than 4% (Stanko et al., 1997; Thomas, 
Bao and Williams, 1997). Staples et al. (1998) found that 3% added dietary fat (DM 
basis) has often positively influenced the reproductive status of the dairy cow. Lower 
levels of added fat (2%) have also been shown to affect positively reproductive 
performance (Bellows et al., 1978). 
Lipids are rich sources of energy and have important roles in the structure and 
function of different biological membranes (Cribier et al., 1993; Fouladi-Nashta et al., 
2007). Dietary FA are crucial in the reproductive performance of dairy cows due to 
their influence on the energy balance and other reproductive processes that are not 
related to energy (Thatcher et al., 2002; Fouladi-Nashta et al., 2007). 
Feeding fat to cattle generally improved establishment and maintenance of pregnancy. 
Potential improvements in fertility of cows caused by fat feeding have generally been 
associated with enhanced follicle development postpartum, increased diameter of the 
ovulatory follicle, increased progesterone (PG) concentrations during the luteal phase 
of the cycle, altered uterine/embryo cross-talk by modulating PG synthesis, and 
improved oocyte and embryo quality. Some of these effects have been more 
influenced by the type of FA than by fat feeding per se. Differential responses in vivo 
to FA feeding suggest that UFA of the n-6 and n-3 families were most beneficial 
(Santos et al., 2008). 
1.4.1 Saturated fatty acids and oleic acid 
There is a huge potential to alter medium-chain SFA (10:0 to 16:0). For example, it 
has been reported (Roy et al., 2006; Chilliard et al., 2007) that cows fed with hay-
based diets can increase these four FA to 56% of milk fat whereas supplementation 
with linseed oil can decrease them to 29%. Lipid supplements rich in medium-chain 
FA, can increase these FA; for example, calcium salts of palm oil increased palmitic 
acid concentration (Chilliard et al., 2007). 
On the other hand, it has been shown (Collomb et al., 2004; Loor et al., 2005; 
Gonthier et al., 2005) that stearic acid in milk can be increased either by dietary 18:0 
intake or by supplementation of 18-carbon unsaturated FA, because they are 
hydrogenated to 18:0 in the rumen (Loor et al., 2004, 2005; Chilliard et al., 2007). 
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Similarly, secretion of oleic acid can be increased through its direct gut absorption and 
mammary gland secretion or, perhaps more importantly, from its ruminal 
biohydrogenation followed by mammary desaturation of 18:0. Also its concentration 
can be increased by manipulating the distribution of oleamides (amides of oleic acid 
that resists ruminal biohydrogenation and elevate milk oleic acid concentration when 
fed to lactating cows) (Jenkins, 1998, 2006; Loor et al., 2002; Chilliard et al., 2007). 
1.4.2 Lipid metabolism in the rumen 
Unlike monogastrics, in which lipid digestion and absorption take place primarily in 
the stomach and small intestine, in ruminants the rumen plays an important role. 
Dietary lipids also affect ruminal fermentation, and ruminal fermentation in turn 
affects the digestion and utilization of other nutrients. Hence, dietary lipids can have 
profound effects on ruminant nutrition and animal performance. Grummer (1991) and 
Mansbridge and Blake (1997) studied ruminal lipids metabolism focusing on 
manipulation of physicochemical events in the rumen with two purposes:  
 
1) To control the adverse effect of fatty acids on ruminal bacterial growth so 
that supplementary lipids do not adversely affect ruminal fermentation and 
nutrient digestion and  
 
2) To regulate ruminal biohydrogenation to alter profiles of fatty acids 
reaching the small intestine and those secreted in milk. 
  
There are three major factors that influence the transfer of dietary fat to milk fat (Wu 
et al., 1991; Palmquist et al., 1993):  
1) Ruminal biohydrogenation 
2) Absorption (digestibility)  
3) Deposition in adipose tissue  
For decades farmers have fed lipid supplements to modify and improve dairy 
performance and energy metabolism (Chilliard et al., 1993; Lock and Shingfield, 2004; 
Chilliard et al., 2007) and milk FA composition (Palmquist et al., 1993; Givens and 
Shingfield, 2006; Chilliard et al., 2000, 2006, 2007). Both source and presentation 
form of the lipids influence their effects. Changing the proportion of one category of 
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FA often has consequences for other FA. Thus, feeding a diet that increases PUFA 
and/or CLA and decreases in milk SFA results in higher 18:1 trans concentration 
(Lock et al., 2005; Roy et al., 2007; Bauchart et al., 2007; Chilliard et al., 2007). 
Dietary lipids are mainly in the form of triacylglycerols, with small amounts in the 
form of monoacylglycerols, free FA, galactolipids and phospholipids (Mansbridge and 
Blake, 1997). Most common lipid supplements comprise predominantly of FA (90-
95%) with a chain length greater than 14 carbons and typically contain greater than 
75% C18 FA. The degree of unsaturation varies considerably (Grummer, 1991). 
Ingested lipids are subjected to two important microbial transformations in the rumen, 
lipolysis and biohydrogenation. 
1.4.3 Lipolysis  
Dietary lipids, if not protected, are rapidly and almost completely hydrolyzed to 
glycerol and free FA by lipases from different strains of bacteria. This process is 
referred to as lipolysis. Protozoa are not involved to any great extent in hydrolysis, 
except for that of phospholipids (Doreau and Ferlay, 1994). According to Bauchart et 
al. (1990), the extent of ruminal hydrolysis of lipids is high for most unprotected lipids 
(85-95%). Anaerovibrio lipolytica, which is best known for its lipase activity, 
produces a cell-bound esterase and a lipase (Harfoot, 1978). These lipases hydrolyze 
acylglycerols completely to free FA and glycerol with little accumulation of mono- or 
diglycerides (Jenkins, 1993). Glycerol is fermented to volatile or short chain fatty 
acids, mainly propionate and butyrate (Doreau and Ferlay, 1994), which are absorbed 
through the ruminal wall, and may eventually be used as precursors for de novo 
synthesis of short- and medium chain FA in the mammary gland (Mansbridge and 
Blake, 1997). Released FA are subjected to subsequent biohydrogenation and /or used 
for synthesis of microbial lipids. The dietary short-chain SFA released by microbial 
lipolysis are also absorbed through the ruminal wall into the blood stream (Doreau and 
Ferlay, 1994). Fatty acids also are released from plant galactolipids and phospholipids; 
hydrolysis of those esterified lipids is attributed to a variety of galactosidases and 
phospholipases produced by ruminal microbes (Jenkins, 1993).  
1.4.4 Biohydrogenation 
Released UFA are subjected to rapid and extensive biohydrogenation of double bonds 
by ruminal microbes to saturated products. This process may have evolved to protect 
microbes from toxic effects of UFA, because UFA are more toxic to ruminal microbes 
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than SFA (Palmquist and Jenkins, 1980). Biohydrogenation occurs only on free fatty 
acids with a free carboxyl group adsorbed on feed particles or microbial cells 
(Harfoot, 1978). The first step in biohydrogenation is an isomerization reaction that 
converts the cis-12 double bond to a trans-11 isomer, catalyzed by isomerase. The 
isomerase is not functional unless the FA has a free carboxyl group. This requirement 
establishes lipolysis as a prerequisite for biohydrogenation (Kepler et al., 1970; 
Jenkins, 1993). The extent to which UFA are biohydrogenated depends on several 
factors, such as forage:concentrate ratio (Kucuk et al., 2001) and type of protective 
treatment of the dietary fat (Tymchuk, 1998; Whitlock et al., 2002). 
 
Lipolysis and biohydrogenation by rumen bacteria can be reduced by treating lipids 
chemically (e.g. formaldehyde treatment or calcium salts) or physically (e.g. heat) to 
resist microbial lipolysis and saturation in the rumen. Intact oilseeds also provide a 
degree of protection from biohydrogenation by microbial enzymes (Kennelly, 1996; 
Petit, 2001).  
 
It has been reported (Doreau and Ferlay, 1994; Loor et al., 2005) that the process of 
biohydrogenation of PUFA in the rumen can be reduced with high concentrate diets 
causing low conversion of 18:1 trans isomers to 18:0. This phenomenon may be 
provoked by shifts in bacterial populations (Loor et al., 2005) and decreases in pH 
(Kalscheur et al., 1997; Loor et al., 2005).  Loor et al. (2004, 2005) proposed other 
factors (e.g. dietary starch amount and degradation rate, buffering capacity) that 
contribute to accumulation of biohydrogenation intermediates in the rumen with high 
concentrate diets. A shift in biohydrogenation pathways due to diet can have a huge 
impact if the shift enhances ruminal production of 18:1 trans 10 and 18:2 trans 10, cis 
12; which are associated with milk fat depression (Bauman and Griinari, 2003; Loor et 
al., 2005). 
 
1.4.4.1 Biohydrogenation intermediates 
The major tFA intermediates produced from the ruminal metabolism of linoleic acid 
are 18:1 trans 11 and cis 9, CLA trans 11. However, the dynamics of the ruminal 
biohydrogenation pathways allow production of a wide range of positional and 
geometrical FA isomers as well as modified FA such as hydroxyl and keto derivates 
(Jenkins et al., 2008; Harvatine et al., 2008). These compounds are absorbed and 
incorporated into milk fat at varying concentrations. However, production of high 
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concentrations of these FA can be induced only under experimental conditions 
involving atypical diets (Lock and Bauman, 2004; Shingfield and Griinari, 2007; 
Harvatine et al., 2008).  
 
1.4.5 Effects of dietary lipids on rumen fermentation 
Lipids added to ruminant diets can disrupt ruminal fermentation, causing reduced 
digestibility of other nutrients, especially those of non-lipid energy sources. It has 
been shown that ruminal digestion of structural carbohydrate can be reduced 50% or 
more by less than 10% added fat (Knight et al., 1978). This is accompanied by the 
reduced production of methane, hydrogen and volatile FA, which are the products of 
ruminal fermentation. Moreover, decreased ratio of acetate to propionate was 
observed (Ikwuegbu and Sutton, 1982). This negative effect of added fat on 
fermentation of structural carbohydrate can be alleviated to some extent by hindgut 
fermentation, but increased fibre excretion in faeces often still occurs (Palmquist and 
Jenkins 1980).  Several mechanisms have been proposed to explain how dietary lipids 
interfere with ruminal fermentation. The generally accepted theories are:  
 
x Close physical attachment of microbial matter to feed particles is necessary for 
cellular digestion in rumen, and physical coating of the fibre with dietary fat 
prevents microbial attack.  
x Direct antimicrobial effects of lipids on certain microorganisms (Jenkins, 
1993).  
 
A depression in milk protein content is frequently observed with dietary lipid 
supplementation (Doreau and Chilliard, 1997). Wu and Hubert (1994) showed that the 
decrease of milk protein was attributed to a lack of increase in amino acids available 
to the mammary gland for protein synthesis as milk yield increased during fat 
supplementation. However, daily protein production may be unchanged as 
supplemental fat has a positive effect on milk production (Kennelly, 1996). In some 
cases, high dietary fat can cause decreases in both milk protein percentage and yield. 
This is possible because dietary fat adversely affects microbial fermentation and 
microbial protein yield, thereby decreasing the supply of amino acids available for 
absorption by the animal (Palmquist and Jenkins, 1980). However, previously Wu and 
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Hubert (1994) proposed four possible mechanisms to explain how dietary fat reduces 
milk protein concentration: 
1. Glucose deficiency 
2. Insulin resistance 
3. Increased energetic efficiency of milk production 
4. Somatothrophin deficiency 
 
Glucose deficiency appears to be the explanation for milk protein depression observed 
with dietary fat supplementation. In order to maintain adequate protein supplies when 
fats are included in a diet, dietary protein content should be increased and 
consideration given to increasing the supply of fermentable carbohydrates. Even 
where protein supply is sufficient, glucose status may be marginal with high fat diets, 
due to insulin resistance and absorption requirements (Garnsworthy, 1997). 
 
Compared with fibre and protein, ruminal digestibility of non-structure carbohydrate 
is less affected by dietary fat. Several studies showed normal starch digestion in the 
rumen of cattle that were fed additional fat even though dry matter or fibre 
digestibility was depressed (Jenkins, 1993).  Similarly, feeding high fat diets often 
depresses feed and energy intakes. When cows are fed large amounts of fats which 
cannot be metabolized, feedback satiety signals may be generated to prevent further 
intake of food (Choi and Palmquist, 1996). 
 
Detrimental effects of supplemental lipids on ruminal fermentation are affected by 
several factors, including the degree of unsaturation, amount and type of fat fed. 
Studies have demonstrated that UFA inhibit fermentation more than SFA (Jenkins, 
1993; Doreau and Chilliard, 1997). The mechanism behind this phenomenon is not 
clear. Unsaturated free fatty acids (FFA) concentration in the rumen is affected by the 
amount and type of lipid fed and also by the rates of lipolysis, biohydrogenation, and 
formation of carboxylate salts. A free carboxyl group seems important for inhibition 
of ruminal fermentation. This is because FA derivatives, such as Ca salts of LCFA 
(Enjalbert, 1994), fatty alcohols, fatty acyl amides and triglycerides inhibit 
fermentation less than do FFA. Relevant knowledge has been used to produce ruminal 
inert FA products for energy supply without adversely affecting ruminal fermentation 
and nutrients utilization.  
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Compared with single fat sources, blended fat sources may have less or even no 
adverse effects on ruminal fermentation and utilization of nutrients. Commercial 
blends of animal fat and vegetable oil sometimes have little effect on fermentation, 
and more resemble ruminally inert fats, despite their relatively high degree of 
unsaturation (Jenkins, 1993).  
 
Inclusion of FO, in the diet of ruminants, enhances the concentrations of 20:5n-3 and 
22:6n-3 in milk (Offer et al., 1999; Shingfield et al., 2003; Loor et al., 2005a) and 
muscle (Scollan et al., 2001; Kook et al., 2002). FO is also known to inhibit the 
complete biohydrogenation of C18 PUFA to C18:0 resulting in an accumulation of 
18:1 trans 11 (Shingfield et al., 2003, Lee et al., 2005, Loor et al., 2005b). This 
particular FA is consequently available for endogenous conversion to CLA cis 9, trans 
11 via the action of stearoyl-CoA desaturase in the mammary gland (Griinari et al., 
2000; Palmquist et al., 2005) and explains FO’s effect in enhancing CLA cis-9, trans-
11 concentration in milk (Offer et al., 1999; Chilliard et al., 2000; Shingfield et al., 
2003). Enhancement of CLA in ruminant products (meat and dairy) through dietary 
manipulation is an important contributor towards the recommended CLA intake of 
0.31 g/100 FA (Roche et al., 2001) as part of a complete diet approach (Lee et al., 
2008). 
 
1.5 Milk fat synthesis 
Fatty acids incorporated into milk triglycerides are derived from two sources, uptake 
of preformed FA from peripheral circulation and FA synthesis in mammary secretory 
cells. Depending on breed, stage of lactation and diet, FA synthesis de novo in the 
bovine contributes to proportionately 0.60 on a molar basis or 0.40 by weight to total 
FA secretion in milk (Shingfield et al., 2010). 
 
Mammary epithelial cells synthesize short- and medium chain FA using acetate and 3-
hydroxy-butyrate as substrates. Fatty acid synthesis de novo accounts for all 4:0 to 
12:0, most of the 14:0 (ca. 95%) and about 50% of 16:0 secreted in milk, whereas all 
18 carbon and longer chain FA are thought to be derived from circulating plasma 
lipids (Chilliard et al., 2000). De novo FA synthesis has an absolute requirement for 
acetyl-CoA, the presence of two key enzymes, acetyl-CoA carboxylase and FA 
synthase and a supply of NADPH reducing equivalents (Barber et al., 1997). Both 3-
hydroxy-butyrate and acetate contribute equally to the initial four carbon unit. Acetate 
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is converted to acetyl CoA in the cytosol and used to extend the chain length of 
synthesized FA via the malonyl-CoA pathway, whereas 3-hydroxy-butyrate is 
incorporated directly following activation to butyryl CoA. Conversion of acetate to 
malonyl-CoA, catalyzed by ACC, is considered to be the rate limiting step (Bauman 
and Davis, 1974). 
 
1.5.1 Milk fat depression (MFD) 
Decreases in milk fat synthesis are common in cows fed diets containing: high 
proportions of concentrates, FO and marine algal lipids or ionophores (Bauman and 
Griinari, 2001 and 2003). Even though certain attributes of a diet are important in the 
establishment of MFD, there is considerable interaction between the composition of 
the basal diet, amount and source of dietary lipid supplement and feeding frequency 
(Chilliard et al., 2007; Shingfield and Griinari, 2007). 
 
A number of theories have been proposed to explain diet induced MFD. The major 
theories have attributed the decreases in milk fat synthesis during diet-induced MFD 
to: 
 
1. Reductions in the supply of acetate and 3-hydroxy-butyrate for de novo FA 
synthesis in the mammary gland 
2. Elevated insulin secretion stimulating the preferential partitioning of FA 
towards adipose tissue at the expense of the mammary gland  
3. Direct inhibition of mammary lipogenesis by tFA formed during the 
biohydrogenation of dietary UFA in the rumen (Shingfield et al., 2010). 
 
Of all the hypotheses developed to explain diet-induced MFD, the biohydrogenation 
theory appears to be the most robust and offers a more convincing explanation for 
MFD over a wider range of diets (Shingfield et al., 2010). However, increases in 
ruminal outflow of CLA trans-10, cis-12, do not explain the decreases in milk fat 
synthesis in all cases of diet-induced MFD, with the implication that additional 
biohydrogenation intermediates and/or mechanisms must be involved (Shingfield and 
Griinari, 2007). Milk fat depressing diets (high concentrate, high starch, PUFA, and 
pasture sometimes) also alter ruminal environment (decrease in pH with high 
concentrate) and fermentation products (increased propionate production). MFD diets, 
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thus, lead to a simultaneous increase of numerous FA isomers and other energetic 
nutrients, complicating the elucidation of related mechanisms (Glasser et al., 2010). 
1.6 Lipid transport 
1.6.1 Plasma lipoproteins 
The plasma lipoproteins are soluble complexes of lipids (triacylglycerols-TAG, 
phospholipids, cholesterol esters and cholesterol) with specialized proteins 
(apolipoproteins) (Vance and Vance, 1991). The main function of these lipoproteins is 
to transport water insoluble lipids throughout the body. Lipoproteins deliver lipid to 
cells efficiently. This efficiency is due to the fact that dispersion of lipid by exchange 
or diffusion is very low. The delivery of lipid by lipoproteins is also very specific 
when required (Vance and Vance, 1991). The main fluid space through which the 
lipoproteins circulate is the blood plasma, but many lipoproteins can filter through the 
vascular wall to interact with parenchymal cells. Liver and intestine are the major sites 
of lipoprotein synthesis and the major flow of lipids is from tissues capable of lipid 
synthesis to tissues which make little of their own lipid. There are also important 
reverse transport systems in which lipid from peripheral tissues is returned to the liver 
for catabolism and recirculation. 
 
1.6.2 Lipoprotein structure 
The major lipoprotein particles are (Small and Shipley, 1974). The composition of 
these lipoprotein types are summarized in Table 1.3: 
 
x Chylomicrons 
x Very low density lipoprotein (VLDL) 
x Intermediate density lipoprotein (IDL) 
x Low density lipoprotein (LDL) 
x High density lipoprotein (HDL) 
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Table 1.3 Composition of blood lipoproteins 
Lipoprotein 
class
Density 
(g/ml) 
a
 
Composition (%) 
  Protein Triglyceride Phospholipid Cholesterol 
      
Chylomicrons  <0.94 1-2 85-95 3-6 3-7 
VLDL  
ȕ-lipoprotein) 0.94-1.006 6-10 50-65 15-20 20-30 
LDL  
ȕ-lipoprotein) 1.006-1.063 18-22 4-8 18-24 51-58 
HDL  
Į-lipoprotein) 1.063-1.21 45-55 2-7 26-32 18-25 
      
a
VLDL denotes very-low-density lipoprotein, LDL low-density lipoprotein, and HDL high-density 
lipoprotein (From: Church and Pond, 1988). 
 
1.6.3 Chylomicrons 
Dietary lipid, consisting mainly of TAG and phospholipids, are hydrolysed in the 
intestinal lumen, absorbed by the intestinal enterocyte, re-esterified into TAG and 
package into TAG-rich chylomicron particles. Chylomicrons principally, transport 
exogenous FA from the intestine to peripheral tissues and the liver but they also 
transport both dietary and biliary cholesterol (Colowick and Kaplan, 1986). 
 
1.6.4 Very low density lipoprotein 
VLDL primarily transports endogenous TAG. The liver produces and secretes TAG-
rich VLDL particles that contain apoB100, apoCI, CII and CIII, and apoE. Plasma VLDL 
particles also receive additional cholesterol esters from HDL by the action of 
cholesterol ester transfer proteins which acts to transfer cholesterol esters to LDL. 
VLDL-TAG can also undergo hydrolysis by endothelial cell lipoprotein lipase to 
produce a VLDL remnant. This remnant particle, termed IDL, can undergo further 
loss of TAG and apolipoproteins to form LDL which can be taken up via its apoB100 
fraction (Fielding and Fielding, 1991). 
 
1.6.5 Low density lipoprotein 
Lipolysis of VLDL by lipoprotein lipase produces a range of particles of intermediate 
density (IDL) with different amounts of TAG. These particles are rich in apoE and act 
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at an important point in lipoprotein metabolism because they may be cleared from the 
circulation by the liver or they may be further processed to become LDL (Jackson et 
al., 1976). 
 
1.6.6 High density lipoprotein 
HDL is formed in the circulation from apolipoproteins produced by the liver and 
intestine. apoAI combines with unesterified cholesterol and phospholipid to form disk 
shaped particles before undergoing modification to become HDL3 and the HDL2 as 
they acquire cholesterol ester and other apolipoproteins including apoAII, apoE and 
apoCs (Tall, 1990). The hydrolysis of chylomicrons and VLDL by lipoprotein lipases 
results in a further net transfer of phospholipids and unesterified cholesterol to HDL 
(Tall, 1990). 
 
1.6.7 Lipoprotein isolation 
Different methods can be used for lipoprotein isolation including; gel filtration, 
precipitation or antibody affinity columns. The most frequent technique used is the 
sequential flotation ultracentrifugation because plasma lipoproteins have lower 
hydrated densities relative to the other plasma proteins (Ray et al., 1954). Sequential 
centrifugation permits the process of large volumes or many small samples. However, 
during lipoprotein separation by this method, centrifugation times are often 18 h and 
greater, and consequently exchanges or transfers including losses of apolipoproteins 
from the lipoprotein surface may occur (Ray et al., 1954). 
 
1.7 Fatty acids and human health effects 
 
1.7.1 Saturated fatty acids (SFA) in human foodstuffs 
A SFA is an aliphatic carboxylic acid with no double bonds between any of its carbon 
atoms. Table 1.4, provides systemic names, shorthand notations, trivial names and 
dietary sources of most common and nutritionally important SFA. According to the 
Food Standards Agency (FSA, 2010) SFA can be found in dairy products, meat, 
pastries, coconut and palm oils and most British people consume 20% more than the 
recommended maximum amount (20-30 g/d) of SFA. 
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Table 1.4 Typical saturated fatty acids in foods 
Systemic name 
Shorthand 
notation 
Trivial 
name 
Major sources 
    
Tetranoic 4:0 Butyric Butter 
Hexanoic 6:0 Caproic Butter 
Octanoic 8:0 Caprylic Coconut 
Decanoic 10:0 Capric Most milk fats 
Dodecanoic 12:0 Lauric Palm kernel, coconut 
Tetradecanoic 14:0 Myristic Palm kernel, coconut 
Hexadecanoic 16:0 Palmitic Palm 
Octadecanoic 18:0 Stearic Most animal fats, cocoa 
Eicosanoic 20:0 Arachidic Peanut 
Docosanoic 22:0 Behenic Seeds 
Tetracosanoic 24:0 Lignoceric Peanut 
    
From: Perkins, 1991; Food and Drug Administration, US, 2009; Food Standards Agency, UK, 2010. 
 
1.7.2 Unsaturated fatty acids (UFA) in human foodstuffs 
Naturally occurring UFA are mostly in the cis configuration. Table 1.5, provides 
information for common UFA available in food sources. According to the FSA (2010) 
foods rich in UFA include fish oil (e.g., from mackerel, salmon and trout), sardines, 
avocados, nuts and seeds, and sunflower, rapeseed, and olive oils. 
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Table 1.5 Unsaturated fatty acids in foods 
Systemic name Shorthand 
notation 
Trivial name Major sources 
    
 Monounsaturated   
Cis    
9-Tetradecanoic 14:1n5 Myristoleic Butter 
9-Hexadecanoic 16:1n7 Palmitoleic Seafood, beef 
9-Octadecanoic 18:1n9 Oleic Olive, Canola 
11-Octadecanoic 18:1n7 Cis-Vaccenic Seafood 
13-Docosenoic 22:1n9 Eruic Rapeseed 
Trans    
9-Octadecanoic Trans-
18:1n9 
Elaidic Hydrogenated 
fats 
11-Octadecanoic Trans-
18:1n7 
Vaccenic Hydrogenated 
fats, 
Butter 
 Polyunsaturated   
All Cis    
9,12-Octadienoic 18:2n6 Linoleic Sunflower, 
safflower 
6,9,12-Octadecatrienoic 18:3n6 J-Linolenic Primrose 
8,11,14-Eicosatrienoic 20:3n6 dihomo-J-
linoleic 
Shark liver 
5,8,11,14-Eicosatetraenoic 20:4n6 Arachidonic Eggs, most 
animal fats 
9,12,15-Octatrienoic 18:3n3 Linolenic Soybean, canola 
5,8,11,14,17-
Eicosapentaenoic 
20:5n3 Timnodonic Seafood 
7,10,13,16,19-
Docosapentaenoic 
22:5n3 Clupadonic Seafood 
4,7,10,13,16,19-
Docosahexaenoic 
22:6n3 Cervonic Seafood 
    
From: Perkins, 1991; Food and Drug Administration, US, 2009; Food Standards Agency, UK, 2010. 
 
1.7.3 Trans fatty acids in human foodstuffs 
The most important sources of tFA in the human diet are PHVO, and ruminant milk 
and meat products (Salter et al., 2006). Trans fats can be found in many of the same 
foods as saturated fat, such as vegetable shortenings, some margarines, crackers, 
candies, cookies, snack foods, fried foods, baked goods, and other processed foods 
made with partially hydrogenated vegetable oils (FDA, 2006). According to Hulshof 
et al., 1999, in many European countries about 50% of tFA come from dairy fat. 
Ruminant derived lipids often contain 1 to 8% of total FA as tFA (Craig-Schmidt 
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1998; Salter et al., 2006), and those are predominantly 18:1 trans (Emken, 1995; 
Salter et al., 2006). The most common 18:1 trans in ruminant fat is vaccenic acid, 
accounting for 60% to 80% of total tFA (Emken, 1995; Craig-Schmidt 1998; Salter et 
al., 2006). tFA from ruminant tFA (vaccenic acid) can be converted to CLA cis 9, 
trans 11 (rumenic acid; RA), through the action of stearoyl coenzymeA desaturase. In 
European countries such as Denmark and Switzerland, legislation limited the use of 
industrially-produced oils to no more than 2% of fat in human food products (Salter et 
al., 2006). In 2007, the Food Standards Agency (2010), along with the Scientific 
Advisory Committee on Nutrition (SACN) recommended that average tFA intake 
should not exceed 2% of food energy. However, average intakes of tFA in the UK are 
half the recommended maximum of 2 of total food energy and therefore are not a 
cause for concern (FSA, 2010). 
1.7.4 Dietary fatty acids and blood lipoprotein and cholesterol levels 
Absorption of fat after a meal is associated with a large increase in lipid concentration 
of the blood, referred to as lipidaemia (Helfant and Banka, 1978). Blood lipids consist 
of dietary lipids absorbed from the intestine, as well as lipids mobilized from depot 
stores and from synthesis in body tissues, especially the liver and adipose tissues. Diet 
is the primary source of cholesterol to the body. Cholesterol is also synthesized in 
many tissues of the body including the liver (Helfant and Banka, 1978). According to 
the National Health Service (NHS) in England, two out of three adults have a total 
cholesterol level of 5mmol/l or above. On average, men have a cholesterol level of 5.5 
mmol/l and women have a level of 5.6 mmol/l. The UK Government recommends that 
cholesterol levels should not exceed 5 mmol/l (NHS, 2009).  
 
Diets rich in SFA are believed to increase plasma cholesterol levels (Spady et al., 
1993) by increasing blood concentration of LDL which contains about 51 to 58% 
cholesterol (Church and Pond, 1988). This condition is known as 
hypercholesterolemia. For example, a meta-analysis of human dietary studies 
(Mensink et al., 2003) suggested that lauric (12:0), myristic (14:0) and palmitic (16:0) 
acids each increased HDL fraction more than UFA did but the effect on the LDL 
fraction was greater.  Numerous controlled feeding studies of the effects of different 
dietary FA on serum cholesterol levels have been summarized in meta-analyses from 
which predictive equations have been developed (Keys et al., 1966; Yu et al., 1995). 
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Those studies confirmed that SFA increase and PUFA decrease in the LDL fraction. 
All three classes of FA (SFA, MUFA and PUFA) elevate HDL fraction when they 
replace carbohydrates in the diet, and this effect is slightly greater with SFA (Hu and 
Willet, 2002). Also, TAG levels increase when dietary FA are replaced by 
carbohydrates. Replacement of saturated fat with carbohydrates proportionally 
reduces both LDL and HDL fractions; this change in diet would be expected to have 
minimal benefit on coronary heart disease risk. When MUFA or PUFA replace 
saturated fat, LDL fraction decreases and HDL fraction changes only slightly (Hu and 
Willet, 2002). 
 
1.7.4.1 Effects of individual fatty acids on blood cholesterol level 
There is agreement that certain, but not all, SFA raise plasma levels of LDL-
cholesterol. Short chain fatty acids (butyric acid, caproic acid, caprylic acid, and 
capric acid), present in a small number of food sources, do not appear to raise LDL-
cholesterol levels (Berner, 1993). Medium-chain SFA, (lauric acid, myristic acid, and 
palmitic acid) are generally considered to raise serum total and LDL-cholesterol (Keys 
et al., 1965; Hegsted et al., 1965). These three FA account for approximately 41% of 
milk fat (Berner, 1993). It has been suggested that 14:0 is more hypercholesterolemic 
than 16:0 (Zock et. al., 1994). The other 59% of milk FA are not hypercholesterolemic 
compared with medium-chain FA. These FA are short-chain FA, stearic acid (18:0), 
MUFA, PUFA, and traces of others (Berner, 1993). 
1.7.5 Health effects related to milk trans fatty acids  
Although different studies have reported negative effects of tFA on human health, it is 
important to take into account that the main sources (PHVOs and milk/meat products 
from ruminant animals) of dietary tFA differ substantially in the isomer distribution of 
18:1 trans. Also, there is reasonable evidence that tFA associated with PHVO increase 
LDL-cholesterol, possibly decrease HDL-cholesterol and increase risk of 
cardiovascular disease (Salter et al., 2006).    The impact of ruminant tFA is much less 
certain and it may actually be beneficial as it is mainly vaccenic acid (18:1 trans-11) 
that can be converted to CLA (Salter et al., 2006).   
In the early 1990s the adverse effects of consuming tFA on blood lipid levels 
(Mensink and Katan, 1990; Ascherio et al., 1999) and coronary heart disease (Willet 
and Ascherio, 1994; Ascherio et al., 1999) were identified. There is also evidence that 
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tFA are also implicated in increasing risk of cardiovascular disease to an extent equal 
to or greater than the hypercholesterolemic saturated FA (Judd et al., 2002; Baer et al., 
2004). In 1994, the UK Department of Health recommended to reduce total fat 
consumption to 30% of total energy intake, with 10% of energy intake coming from 
saturated FA (Wood et al., 2003). At the same time it was also advised to increase the 
intake of PUFA. Besides the health benefits from PUFA for human health, CLA 
isomers have received much attention due to their health promoting effects (Jahreis et 
al., 2000; Connor, 2000; Pariza et al., 2000, 2001; Roche et al., 2001; Williams, 2000; 
Raes et al., 2004).  
Despite the fact that tFA have been regarded and implicated as a causal factor of heart 
diseases, Ackman (2000) questioned this theory and explained that humans have 
consumed tFA in milk fat throughout history since ruminants were domesticated and 
their products consumed, and hence human metabolism may have adapted positively 
to their presence (Ackman, 2000; Jensen, 2002). Nevertheless, potential negative 
effects on animal health have been observed (Teter et al., 1990; Jensen, 2002). 
Consumption of tFA by humans (Table 1.6) was estimated by Craig-Schmidt (1998) 
and Allison et al. (1999); however, Jensen (2002) observed that in both investigations 
consumption was underestimated when based on data obtained only with capillary 
GLC columns. Additionally, Jensen (2002) criticized the research conducted by Katan 
(2000) in which tFA were implicated as a cause of cardiovascular disease; Jensen 
(2002) mentioned that milk fat is a minor source of tFA and hence it should not be 
excluded from human diets for this reason. 
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Table 1.6 Quantities of trans-18:1 in butter and milk fat samples determined by GLC 
with capillary columns and corrected by analyses with the argentation (Ag)-TLC/GLC 
method 
 Method of analysis    
Source of 
lipids 
n Capillary only Ag- 
TLC/GLC 
Correction 
factors 
Reference 
      
France 60 
1
 2.00 3.30 1.65 Wolff et al. 
(1995) 
France 24 
2
 1.82 3.22 1.77 Wolff (1994) 
France 24 
3
 2.78 4.28 1.54 Wolff (1994) 
Germany 1756 
4
 2.47 3.83 1.55 Precht and 
Molkentin 
(1996) 
Germany 927 
5
 1.53 2.65 1.73 Precht and 
Molkentin 
(1997) 
Germany 236 
6
 2.42 3.80 1.57 Precht and 
Molkentin 
(1997) 
Germany 593 
7
 3.53 5.08 1.44 Precht and 
Molkentin 
(1997) 
Germany 58 
8
 2.92 4.35 1.49 Precht and 
Molkentin 
(1997) 
      
Adaptated from Jensen, 2002 
1
Butter samples obtained throughout year, 
2
autumn butter, 
3
spring butter, 
4
milk from different 
seasons, 
5
milk from barn fed cows (winter), 
6
milk from winter to summer, 
7
milk from pasture fed cows 
(summer), 
8
 
slight energy deficit. 
1.7.6 Blood cholesterol level and atherosclerosis 
Atherosclerosis is a generalized, chronic, inflammatory vessel disorder and leading to 
cardiovascular diseases like myocardial infarction and stroke (Nordestgaard and 
Zacho, 2009). The inflammation is initiated by entrance of cholesterol-rich 
lipoproteins into in the vessel wall of arteries, and afterwards macrophages absorb 
these and are transformed into foam cells (Nordestgaard and Zacho, 2009). 
 
Atherosclerosis is the condition of thickening and losing elasticity of the arterial wall, 
and narrowing of the arterial lumen due to building up of cholesterol and other lipids 
on the arterial wall. Cholesterol released into blood in the form of LDL can infiltrate 
arterial walls. At the sites where LDL-cholesterol infiltrated the arterial wall, 
abnormal smooth muscle cells are multiplied and connective tissue components are 
increased (Cancel and Tarbell, 2010). Cholesterol accumulates in cells and in extra-
cellular spaces of the wall endothelial lining. Calcium salts are deposited on top of the 
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lipids, and a fibrous net is formed over the mass. This atherosclerotic plaque projects 
into the arterial lumen (Cancel and Tarbell, 2010). 
Dietary tFA have been linked to atherosclerosis but the mechanisms by which they 
cause the disease remains unclear. Chen et al. (2010) found that dietary tFA cause 
atherosclerosis by the increase deposition of cholesterol into cellular plasma 
membranes in vascular tissue as in hypercholesterolemia. This is in agreement with 
previous research (Lichtenstein et al., 2003; Vega-López et al., 2009) in which the 
major risk factor of cardiovascular disease caused by dietary tFA is LDL cholesterol 
levels and total cholesterol/HDL ratios in plasma. 
1.7.7 Blood cholesterol level and stroke development 
Increased blood cholesterol levels are related to an increased risk of coronary heart 
disease (CHD) (Imamura et al., 2009). In contrast, the relation between total 
cholesterol levels and the risk of stroke remains unclear because of conflicting results 
reported in the literature. The inconsistent results may be due to several reasons. First, 
because stroke is a heterogeneous syndrome of different etiologic origins, lipid levels 
may be important for some subtypes of stroke but not for others. An inverse 
association has been observed between total cholesterol and haemorrhagic stroke, and 
there is a positive association between total cholesterol and ischemic stroke (Imamura 
et al., 2009). Furthermore, the association may be different for ischemic stroke 
subtypes. Second, lipoprotein subfractions are considered to exert varying influence 
on stroke risk. It is possible that the protective effect of HDL cholesterol against 
stroke weakens the positive association between total cholesterol and stroke in 
instances where lipoprotein sub fractions are counted together (Imamura et al., 2009). 
 
The stroke-cholesterol relation is complex and contains several paradoxes. Whereas 
total cholesterol is a well-documented risk factor for CHD, evidence of a relation 
between cholesterol and risk of stroke is inconsistent (Olsen et al., 2007). In search of 
an explanation for this paradox, it has been noted that most large-scale studies on 
cholesterol and stroke risk have not differentiated between ischemic and hemorrhagic 
stroke, nor did they differentiate among various subtypes of ischemic stroke. It has 
been suggested that cholesterol may increase the risk of only certain types of infarcts 
and that LDL predisposes to hemorrhagic stroke, thus attenuating an association 
between cholesterol and all stroke (Olsen et al., 2007). 
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1.7.8 Blood cholesterol level and coronary heart disease 
Over the past decades, numerous population-based and intervention studies have 
identified LDL cholesterol as a key risk factor for CHD. However, although many 
trials have documented the benefits of lowering plasma LDL levels for primary and 
secondary prevention of CHD, studies have shown that individuals reaching their LDL 
target may still be at increased CHD risk if they have detrimental levels of other 
parameters of the lipoprotein-lipid profile. In this regard, it has been proposed 
(Kastelein et al., 2008) that other lipid parameters such as cholesterol levels in 
lipoproteins other than HDL (i.e., non–HDL cholesterol levels), TAG levels, or the 
total cholesterol (TC) to HDL- cholesterol ratio could better predict cardiovascular 
outcomes in patients on LDL- cholesterol lowering therapy. However, there is a lack 
of epidemiological data to suggest that the aforementioned parameters of the 
lipoprotein-lipid profile could better predict CHD risk than LDL- cholesterol in 
asymptomatic individuals (Arsenault et al., 2010). Death rates of CHD in both the 
United Kingdom and the Unites States have declined over the last 40 years, 
particularly in men. The reasons for these rates are not fully understood. However, 
they appear to be a consequence of a combination of improved treatment of 
individuals and changes in risk factor within the whole population. In England and 
Wales, it has been estimated that 42% of the decrease seen between 1981 and 2000 
was due to improved treatment whereas the 58% remaining was due to risk factor 
conditions within the population (Unal et al., 2004; Salter et al., 2007). Of the risk 
factors, by far the biggest impact (48% of overall deaths) was from reduction in 
smoking, with lesser effects of reduced blood pressure (9.5%) and reduced cholesterol 
(9.6%) (Salter et al., 2007). 
 
For prevention and treatment of CHD, vigorous dietary intervention is needed to 
lower serum cholesterol level by at least 6% (Temple, 1996). For this purpose, the 
foods of animal origin should be eaten sparingly, and more prominence should be 
given to the foods rich in carbohydrate and fibre, especially fruit and vegetables. If 
acceptability of the diet becomes a problem and people desire more fat in their diet, 
then the UFA rich oils such as olive or canola could be incorporated in the diet 
(Temple, 1996). Similarly, Connor and Connor (1997) suggested a prominent 
therapeutic role for FO in prevention and treatment of coronary artery disease. The n-3 
FA of fish and FO have great potential for prevention and treatment of patients with 
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coronary artery disease. That is because n-3 FA promote synthesis of beneficial nitric 
oxide in the endothelium (Connor and Connor, 1997). FO has a profound 
hypolipidemic effect in humans, especially lowering of plasma triacylglycerol. Both 
very-low-density lipoprotein production and apolipoprotein B synthesis are inhibited 
by FO. Finally, FO has a mild blood pressure-lowering effect in both normal and 
mildly hypertensive individuals.  
On the other hand, Hu and Willet (2002), reported that there is substantial evidence 
indicating that diets using non hydrogenated UFA as the predominant form of dietary 
fat, whole grains as the main form of carbohydrates, an abundance of fruits and 
vegetables, and adequate omega-3 fatty acids can offer significant protection against 
CHD.  
1.8 Using mammary gland cell lines to study fatty acid uptake 
Lipids in milk are present in fat globules; they are formed mainly by triacygycerols 
and are enclosed within a membrane derived from the secretory epithelial mammary 
cell (Jensen, 2002; Heid and Keenan, 2005). Although the general principles of lipid 
droplet formation, growth, movement, and secretion are known, practically few 
studies have been performed on lipid absorption and secretion by mammary gland 
cells (Ernens et al., 2007). 
 
Milk fat, normally produced, is assembled in the mammary alveolar cells from FA 
derived partly by de novo synthesis from acetate within these specialized cells, and 
partly by absorption from the blood. Fatty acids synthesised within alveolar cells are 
mostly saturated and contain from four to sixteen carbon atoms per molecule (Kinsella 
et al., 1968). Lipids produced by the lactating bovine mammary cell are distinctive, 
which facilitates the assessment of the biochemical fidelity of these cells when used in 
vitro (Kinsella et al., 1968). 
 
1.8.1 Immortalized bovine mammary epithelial cell line: MAC-T 
Mac-T cells are an established cloned cell line produced from primary bovine 
epithelial cells by transfection with SV-40 large-T-antigen designated (MAC-T). 
Differentiation was induced (Turner et al., 1993) by increasing cell to cell interactions 
on a floating extra cellular matrix in the presence of prolactin. MAC-T cells have 
normal physiological responses in that it produces milk constituents which comprises 
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Į- DQG ȕ- casein and lactose. These cells provide a method of studying in vitro 
lactation due to their normal physiological responses. They also provide a method of 
in vitro screening for gene expression in transgenic cows prior to gene transfer when 
the mammary gland is the target organ of expression and hence reduce the cost of 
genetic engineering (Zavizion et al., 1995). This cell line has been deposited at the 
American Type Culture Collection (ATTC) under the accession number CRL 10274. 
The MAC-T cells were reported to have >150 passages without senescence or 
replication problems (Turner et al., 1993), which represents continuous culture for 
more than one year. These cells have a “cobblestone” morphological characteristic 
when they reach 90-100% confluence. They are also heterogeneous in morphology, 
growth, and cytogenetic characteristics (Zavizion et al., 1995). 
 
MAC-T cells have been used for gene expression  studies (Keating et al., 2008; 
Kadegowda et al., 2009; Thering et al., 2009) that evaluated in vitro effects of certain 
FA on mammary epithelial cell growth, morphological changes and apoptosis, as well 
as effects of hormones (insulin and prolactin) on metabolic regulation of TAG 
biosynthesis (Morand et al., 1998). Johnson et al., (2010) reported changes in TAG, 
cholesterol and phospholipids distribution in MAC-T cells stimulated with 10 ng / ml 
of growth hormone. These cells have also been studied for their response to bacterial 
virulent factors produced by mastitis pathogens. Matthews et al. (1994) reported that 
MAC-T cells proliferation was inhibited by different concentrations of Escherichia 
coli endotoxin.   
 
Peterson et al. (2004) used this cell line to study the effects of CLA trans 10, cis 12 on 
milk fat depression and abundance of mRNA for lipogenic enzymes. The study 
reported that lipogenesis was inhibited by 56% when cells were incubated with 75 
ȝPRO  l of CLA trans 10, cis 12. Keating et al. (2008) reported that increasing 
concentrations of CLA isomers trans 10, cis 12 and cis 9, trans 11 have negative 
impacts on cell growth inducing apoptosis of the mammary cells. They observed that 
DWKLJKHUGRVHVRI&/$ȝ0DQGDERYHFHOOJURZWKZDVLQKLELWHGRULQVRPHFDVHV
cells were no longer available. Those findings are in agreement with the negative 
effects seen on milk yield and composition when cows are abomasally infused with 
high doses of CLA (Bell and Kennelly, 2003). Sorensen et al., (2008) treated MAC-T 
cells with CLA and other C18-UFA to study effects on lipogenic enzymes. They 
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concluded that MFD caused by CLA trans 10, cis 12 could affect a number of 
lipogenic enzymes including diacylglycerol acyltransferase. Jayan and Herbein (2000) 
studied the effects of oleic and vaccenic acids on the activity of acetyl-CoA 
carboxylase-ACC, fatty acid synthetase –FAS and stearoyl-CoA desaturase- SCD. 
Their data suggested that vaccenic acid inhibited activity of ACC and FAS, which are 
responsible for synthesis of SFA secreted into milk, and simultaneously enhanced 
SCD activity. 
 
Other studies used (Yonezawa et al., 2004a, 2004b 2009) cloned mammary gland 
epithelial cells (bMEC) and worked on the effects of FA on the expression of certain 
enzymes involved in lipid synthesis. Yonezawa et al., (2004a) measured the effect of 
LCFA on TAG accumulation on bMEC cells treated wiWKȝ0SDOPLWDWHVWHDUDWH
oleate and linolate for 24 h and TAG accumulation on bMEC cells treated with the 
same FA at different concentrations. Their results suggested that exogenous LCFA 
could enhance accumulation of cytosolic TAG and expression of CD 36 (a FA 
traslocase) which plays an important role in FA translocation in various cells and 
plays a positive role in uptake of LCFA in bMEC (Figure 1.3). Yonezawa et al. 
(2004b) evaluated the effect of 10 mM of acetate, butyrate and octanoate on bMEC 
for 1, 3, 5 and 7 d and various concentrations of octanoate for 7 d. Octanoate induced 
the accumulation of cytosolic TAG and formation of lipid droplets in bMEC (Figure 
1.4).  
Most of the studies using Mac-T cells focus on gene expression and enzymatic 
responses; hence few data are available on FA uptake and secretion.  
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Figure 1.3 A) The bMEC were treated with 400 ȝM palmitate, stearate, oleate, or linoleate for 24 h. 
Values with different letters are statistically different (P < 0.05). B) The bMEC were treated with 
various concentrations of palmitate, stearate, oleate, or linoleate complex for 24 h. The data are 
expressed as means ± SEM (n = 3) (From Yonezawa et al., 2004a). 
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Figure 1.4 A) The bMEC were treated with DMEM containing 10% FCS plus 10 mM-acetate, 
butyrate, or octanoate for 1, 3, 5 or 7 d, respectively. Values with different letters are statistically 
different among the columns on the same day (P < 0.05). B) bMEC were treated with various 
concentrations of octanoate for 7 d. Results are expressed as means ± SEM of triplicate dishes (From 
Yonezawa et al., 2004b). 
 
1.8.2 Fatty acid transport proteins 
Fatty acid transport proteins (FATP) are a family of proteins involved in fatty acid 
uptake and activation. They were identified through their ability to increase fatty acid 
uptake when over expressed, and all mammalian FATP have been reported to increase 
FA uptake upon overexpression (Stahl, 2004; Doege and Stahl, 2006; Gimeno, 2007). 
Studies in vitro showed that FATP have both FA uptake and enzymatic activity with 
distinct subcellular localization, substrate specificities and kinetic properties for 
individual FATP family members (Gimeno, 2007). 
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1.8.3 Fatty acid transport across cellular membranes 
The mechanism by which FA enter cells has been a matter of debate. Fatty acid must 
be extracted from the internal face of the plasma membrane and move into the interior 
of the cell; without extraction, FA would remain available in the membrane to move 
back to the outer face of the plasma membrane and be recaptured by albumin present 
in the interstitial fluid (Mashek and Coleman et al., 2006). There are different 
approaches (Abumrad et al., 1998; Kleinfeld, 2000) that provide evidence that there 
are two processes involved in LCFA uptake: 
 
1. Passive  diffusion through the lipid bilayer 
2. Protein facilitated transport 
 
The relative contribution of each component depends on concentrations and molar 
ratios of FA and albumin in the circulation (Hajri and Abumrad, 2002). 
 
1.8.4 Determinants of fatty acid transport 
In the extracellular medium and in the circulation, FA are carried bound to albumin. In 
the absence of albumin or other FA binding protein (FABP), the concentration of 
LCFA that can be used is very low and is depleted by cells automatically, meaning the 
linear portion of the uptake time course would be too short to measure (Hajri and 
Abumrad, 2002). When mixtures of FA and albumin are used, uptake follows the 
unbound FA, which is determined by the molar ratio of FA to albumin. Within the cell, 
one or more types of abundant cytosolic FABP buffer intracellular FA. There is an 
important role for cytosolic FABP in shuttling FA between plasma membrane and 
intracellular membranes or metabolic compartments (Hajri and Abumrad, 2002).  
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1.9 Conclusions 
This review has summarised the background of some aspects of lipid structure, milk 
fat composition and FA metabolism in dairy cows. The review has also studied the 
role of dietary FA on human health. 
 
However, we do not know how tFA are transported in the blood and partitioned into 
lipoprotein fractions of dairy cows. Moreover, we do not know how dietary lipids 
affect lipoprotein fractions in dairy cows and whether those fractions lead to 
differences in tFA concentrations. We also do not know how certain FA 
concentrations perform within the bovine mammary gland cells. 
 
All of these questions will help us to understand the regulation of milk fat synthesis 
that is central to the development of nutritional strategies to enhance the nutritional 
value of milk in ruminants. 
 
1.10 General objectives 
In summary, this thesis aims to: 
x Compare plasma cholesterol fractions and FA profiles from cows subjected to 
different treatments 
x Examine the effects of dietary lipids on the transportation of tFA among the 
plasma cholesterol fractions 
x Study LCFA uptake in epithelial mammary gland cell cultures on MAC-T 
cells line 
x Evaluate the effects of lipids on the transportation of FA in epithelial 
mammary gland cell cultures (MAC-T cells)  
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CHAPTER 2 
2. Ruminal pulses of fatty acids in dairy cows: 1. Soya oil and partially 
hydrogenated vegetable oil 
2.1 Introduction 
In ruminants, tFA are produced naturally during biohydrogenation of PUFA in the 
rumen and are incorporated into carcass fat or milk fat (Katz and Keeney, 1966; 
Griinari and Bauman, 1999; Piperova et al., 2004).  The predominant tFA in ruminant 
fat is vaccenic acid (VA; C18:1 trans-11), accounting for 60% to 80% of total tFA, 
although other tFA (e.g. C18:1 trans-10) occur when high-fat or high-concentrate 
diets are fed to ruminants. PHVO contains a mixture of C18:1 trans isomers, the most 
predominant being elaidic acid (EA; C18:1 trans-9) (Meijer et al., 2001). Vaccenic 
acid may not have the same deleterious health effects in humans as tFA from PHVO 
(Salter et al., 2006).  
 
Cholesterol is important for the transport and clearance of fatty acids in all mammals, 
and also plays vital roles in cell membrane structure and steroid hormone synthesis. 
Although proportions of low- and high- density lipoproteins (LDL and HDL) have 
been studied extensively in humans, they have received little attention in ruminants. 
The mammary gland appears to have differential uptake of lipids from lipoprotein 
fractions and affect the efficiency of transfer LCFA from diet to milk (Offer et al., 
2001). No in vivo study has been published in which effects of different tFA on 
lipoprotein fractions or their FA profile have been compared in ruminants. We were 
particularly interested to see if there are different effects of VA (naturally produced in 
the rumen) and EA (from PHVO).  
 
The main hypothesis being tested in this experiment was that FA profiles of plasma 
and lipoprotein fractions would be different depending on source of the dietary lipids, 
which would lead to differences in tFA concentrations. The objective of the present 
study was to elucidate which lipoprotein fractions are involved in tFA transport and 
whether there is a difference between 18:1 tFA isomers. This objective was achieved 
by comparing plasma lipoprotein fractions in cows subjected to ruminal pulses of soya 
oil (SO; to induce high VA production and absorption) or PHVO with high 
concentrations of a range of 18:1 tFA isomers. 
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2.2 Materials and methods 
2.2.1 Animals and treatments 
Three non-lactating Holstein nuliparous cows [BW 773 ± 63 kg (average ± SD)], each 
with a rumen cannula were utilized in a 3 x 3 Latin square design with 3 d treatment 
periods (adapted and modified from Kadegowda et al., 2008 and Castaneda-Gutierrez 
et al., 2007) followed by 4 d washout interval between treatments to minimize 
carryover effects (Loor et al., 2005) (Figure 2.1). Cows were treated with ruminal 
pulses of: 1) skim milk (SM; 500 ml/d) as control; 2) SO (250 g/d in 500 ml/d of SM) 
and 3) PHVO (250 g/d in 500 ml/d of SM). PHVO was supplied by the manufacturers 
(Aarhus Karlshamn, Ltd., Hull, UK) and was based on hydrogenated rapeseed oil. 
Quantities of fat and SM in ruminal pulses were calculated according to previous 
studies (Ferlay and Doreau, 1992). 
 
 
 
 
 
 
 
Figure 2.1: The experiment had three treatment periods, each followed by a 4-d washout interval. 
Cows were given each treatment in a 3 x 3 Latin square design. 
Emulsions were prepared the day before each pulse. To provide a homogenised 
release of pulses, skim milk was used (Loor and Herbein, 2003) (500 ml/d) to 
emulsify the oils (SO and PHVO) using a laboratory mixer emulsifier (L2R Silverson, 
Machines Ltd., Waterside, Chesham, Bucks). Before each pulse, emulsions were 
heated for 30 min at 60 ºC in water bath (Grant Y28, Cambridge Ltd., England) to 
provide easier diffusion of PHVO. During pulses and sampling periods, cows were 
housed in tie stalls and had free access to water. Cows were fed a maintenance diet 
which comprised meadow hay (ad libitum) and a concentrate based on barley (25-40 
g/kg), sugar beet pulp (8 g/kg) and wheat (8 g/kg) and cane molasses (<5 g/kg), 
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limestone flour (<5 g/kg), vitamins (<5 g/kg) and minerals (<5 g/kg) [1-2 kg/day at 
12:00; Manor Farm Feeds (Owston) Ltd., Oakham].  
2.2.2 Sampling, measurements and analyses 
Samples of ruminal fluid (50 ml) were collected from various parts of the rumen using 
a syringe screwed to a stainless tube. Ruminal fluid samples were collected prior to 
ruminal pulse (0 h) and at 1, 2, 3, and 6 h post pulsing during the 3 d collection 
periods. Immediately after fluid collection, 10 ml of ruminal fluid was used to 
determine pH by using a pH meter (Piccolo Plus, HI 1295, Hanna Instruments, 
Portugal). Following pH determination, ruminal fluid was centrifuged for 10 min at 
3,000 x g (Centaur 2 MSE, Milton Keynes); 10 ml of ruminal fluid was preserved by 
adding 1 ml of 25% metaphosphoric acid for VFA determination, and another 10 ml 
of untreated ruminal fluid was kept for NH3-N analysis. Samples were frozen (-20ºC) 
for later analysis. Samples of ruminal fluid were analyzed for VFA using a gas 
chromatograph (GC; Agilent, GC 6890 series) equipped with a CP-Sil 88 fused-silica 
capillary column (100 m x 0.25 mm i.d., with 0.2 µm film thickness; Varian Inc., 
Oxford).  A flame ionisation detector was used with an oven initial temperature of 
140ºC and maximum temperature of 250ºC with an equilibrium time of 0.50 min. The 
inlet temperature was 300°C, the split ratio was 15:1 and a 1 µl injection volume was 
used. The detector temperature was 250ºC, hydrogen carrier gas flow to the detector 
was 40.0 ml/min, airflow was 450 ml/min and the flow of nitrogen makeup gas was 
45.0 ml/min. A standard was included in the GC assay containing acetic, propionic, 
butyric, isobutyric, valeric and isovaleric acids (Table 2.1).  
Table 2.1 Volatile fatty acid concentrations of standard used in GC analysis 
 Volume (ml) Density Molecular 
weight 
Concentration 
(mM) 
     
Acetic 0.101 1.049 60.05 17.52 
Propionic 0.101 0.993 74.08 13.46 
Isobutyric 0.101 0.950 88.11 10.79 
n-butyric 0.101 0.959 88.11 10.89 
Isovaleric 0.101 0.931 102.14 9.10 
Valeric 0.101 0.939 102.14 9.20 
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Individual VFA concentrations for each sample were determined by comparing 
chromatogram peak areas (ChemStation for GC A.09.01; Agilent Technologies UK 
Ltd.) as follows: 
 
    Sample area 
Sample (mmol / l) =  _____________  x      concentration of standard 
 
   Standard area 
 
Molar concentrations for individual acids were then calculated by dividing the 
concentration of each VFA by the total concentration of all six VFA in the sample. 
Ruminal NH3-N was determined by a photometric test with a Clinical Chemistry 
Autoanalyzer using an enzymatic ultraviolet method (Rx Imola; Randox Laboratories 
Ltd., Cat. No. AM3979). Ruminal NH3-N samples were diluted with distilled water 
(1:10; 100µl of ruminal fluid + 900 µl distilled water) before analysis. 
Reagents used for Ruminal NH3-N: 
 
R1a. 5HDJHQW1$'+DQGĮ-oxoglutarate 
R1b. Buffer: Triethanolamine 
R2. Glutamate dehydrogenase (GLDH) 
CAL. Standard (Ammonia/Ethanol controls; Randox Laboratories Ltd. EA1366, 
EA1367) 
 
Calculation: 
ABLANK = Blank A1 – Blank A2 
ASAMPLE = Sample A1 – Sample A2 
 
 
Blank A1: Read initial absorbance of sample and blank 
Blank A2: Read final absorbance of sample and blank     
 
Asample - Ablank 
   
Concentration of ammonia (µmol/l) = ____________ x Standard concentration 
       
Astandard – Ablank  
 
Blood samples (10 ml) were obtained via jugular catheter prior to the pulse (0 h) and 1, 
2, 3 and 6 h after pulsing during each 3 d collection period for lipoprotein 
fractionation. Blood was transferred to tubes containing EDTA and immediately 
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centrifuged for 10 min at 3,000 x g (Centaur 2 MSE, Milton Keynes) for harvesting 
plasma.  
Based on their density, lipoprotein fractions were separated sequentially by 
preparative ultracentrifugation in a Beckman XL-70 Preparative centrifuge (Beckman 
Coulter UK Ltd., Buckinghamshire, UK). Potassium bromide (KBr) was added to the 
plasma to obtain the required density calculated by use of the Radding-Steinberg 
(1960) formula: 
     [(V (df – di)] 
  X= __________________ 
    [1 – (0.312 x df)] 
X= grams of KBr 
di= initial density 
df= final density 
V= volume of serum (ml) 
0.312= partial specific volume of KBr 
 
The density ranges selected for isolation of the major lipoprotein fractions of the 
bovine were those normally adopted for human lipoprotein separation, i.e., LDL, d< 
1.063 g/ml (this fraction also contains chylomicrons/VLDL fractions) and HDL, d> 
1.063 g/ml (Chapman, 1980).  The chylomicrons/VLDL fraction was not isolated due 
to its low concentration. KBr was added to the plasma and mixed until the salt was 
dissolved. Density was adjusted in order to obtain the LDL fraction. The plasma and 
salt solution were added to Beckman Quick-Seal tubes. Plasma was then separated 
into lipoprotein fractions (LDL and HDL fractions) by ultracentrifugation at 39,000 x 
g for 20 h at 12ºC. Tubes were carefully removed after ultracentrifugation and each 
tube was cut using a Kontron bench tube slicer to retrieve the top layer which was 
predominantly LDL fraction. Density of lipoprotein and KBr solution was re-adjusted 
to obtain the HDL fraction and tubes were ultracentrifuged at 39,000 x g for 40 h at 
12ºC. Tubes were carefully removed from the centrifuge and cut as previously. 
Another 10 ml blood sample was collected at each sampling time and stored at -20ºC 
for analysis of FA profile and quantification of lipoprotein fractions. Lipids from 
plasma, HDL and LDL fractions were extracted by adaptation of the method by Bligh 
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and Dyer (1959) and methylated according to the method of Christie (1982) with 
modifications by Chouinard et al. (1999). All chemicals and solvents used for this 
method were of analytical grade. For analysis of FA in plasma and lipoprotein 
fractions, a GC system (Agilent, GC 6890 series) equipped with a CP-Sil 88 fused-
silica capillary column (100 m x 0.25 mm i.d., with 0.2 µm film thickness; Varian Inc., 
Oxford) was used. The GC conditions were as follows: the oven temperature was 
initially set at 110°C for 4 min after injection, and then increased to 240°C with 
equilibration time of 2 min. The inlet and flame-ionization detector temperatures were 
260°C, the split ratio was 15:1 and a 2 µl injection volume was used. The hydrogen 
carrier gas flow to the detector was 25 ml/min, airflow was 400 ml/min, and the flow 
of nitrogen makeup gas was 40 ml/min. Fatty acid peaks were identified by using a 
fatty acid methyl ester standard (FAME; Supelco 37 Component FAME mix, 
Bellefonte, PA) and a tFA reference standard (trans 11- C18:1, methyl ester, Supelco, 
Bellefonte, PA).  
Concentrations of lipoprotein fractions in plasma (LDL and HDL fractions) were 
determined using a Clinical Chemistry Autoanalyzer (Rx Imola; Randox Laboratories, 
Ltd.).  
HDL/LDL Calibrator - Cat. No. CH2673 
Performance data for HDL cholesterol (Cat. No. CH3811): 
Range:   0.04 - 3.73 mmol (1.43 - 144 mg/dl) 
Sample type:   EDTA plasma 
Intra-assay precision:  1.20% at 0.96 mmol/l (37.07 mg/dl) 
1.53% at 1.5 mmol/l (57.93 mg/dl) 
Inter-assay precision: 0.93% at 0.97 mmol/l (37.7 mg/dl) 
0.88% at 1.5 mmol/l (58.1 mg/dl) 
Performance data for LDL cholesterol (Cat. No. CH3841): 
Range    0.19 - 22.2 mmol (7.35 - 860 mg/dl) 
Sample type   EDTA plasma 
Intra-assay precision 0.58% at 2.0 mmol/l (77.5 mg/dl) 
0.50% at 4.95 mmol/l (191.4 mg/dl) 
Inter-assay precision 1.61% at 1.27 mmol/l (49.0 mg/dl) 
1.78% at 2.78 mmol/l (107.5 mg/dl) 
Cholesteryl esters, triglycerides, and phospholipids were separated by thin layer 
chromatography using the solvent system light petroleum ether (b.p. 40-60):diethyl 
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ether:acetic acid  in ratios of 90:30:1ratio (by volume) (Brown et al., 1980). Lipid 
subgroup standards were included on each TLC plate to identify the position of the 
lipids of interest. The bands were then visualized with iodine vapour and scraped to 
re-extract the lipids (Hara and Radin, 1978; Brow et al., 1980). FA in each band were 
determined by capillary column GC described for plasma and lipoprotein fractions. 
The concentration of each FA (g/100g) was calculated for 16:0 to 22:6n3 FA with 
concentrations higher than 0.3 g/100g. 
2.2.3 Statistical analysis  
Data were analysed using the GenStat 12
th
 statistical package (VSN International Ltd.,  
Oxford) as a Latin square 3 x 3 design with fixed effects of treatments, periods and 
sampling times; cow was included as a random effect to account for repeated 
measures. Fatty acid composition of lipid subgroups within lipoproteins was analysed 
using a Factorial design based on treatments (3), fractions (2) and lipids (3). Diurnal 
variations were analysed as POLYANOVA based on days (3) and sampling times (5) 
factorial. Data are reported as least square means ± SED across all sampling times.  
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2.3 Results 
2.3.1 Composition of treatments 
PHVO+SM contained higher concentrations of saturated (18 g/100g), 
monounsaturated (57 g/100g) and trans (51 g/100g) fatty acids and lower 
concentrations of unsaturated (59 g/100gr) and polyunsaturated (2 g/100g) fatty acids 
than SO+SM. VA (8 g/100g) and EA (8 g/100g) concentrations were higher in the 
PHVO+SM mix (Table 2.2).  
2.3.2 Ruminal fermentation parameters 
Ruminal pH was not affected by treatment. Compared with control, SO and PHVO 
resulted in lower (P < 0.05) concentrations of ruminal NH3-N and total VFA 
concentrations. Individual molar concentrations of VFA were not affected by 
treatment (Table 2.3). 
 
2.3.3 Plasma samples and treatment effects 
There was no difference between treatments in concentrations of SFA and PUFA in 
plasma or lipoprotein fractions (Table 2.4). Compared with control, SO and PHVO 
resulted in higher (P < 0.05) concentrations of MUFA in plasma and the LDL+VLDL 
fraction, higher (P < 0.05) concentrations of trans fatty acids in plasma and both 
lipoprotein fractions, and  higher (P < 0.05) concentrations of UFA (MUFA+PUFA) 
and LCFA in the LDL+VLDL fraction (Table 2.4).  
Treatments influenced individual FA concentrations of some 18:1 trans isomers in 
plasma samples. SO resulted in higher concentrations of 18:1 trans 10, trans 11, and 
20:1, and lower concentrations of 12:0, 15:0, 18:1 trans 5, 20:3n6 and 23:0 compared 
with control and PHVO (Table 2.5). 
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Table 2.2 Fatty acid composition of oils and skimmed milk emulsions used for 
ruminal pulses 
 Control            Oils Treatments
4 
     
Fatty acid, g/100 g SM
1 
SO
2 
PHVO
3 
SO+SM
 
PHVO+SM
 
      
10:0  2.51 - - - - 
12:0 2.14 - 0.23 - 0.24 
14:0 7.89 0.07 0.18 0.08 0.30 
14:1  0.50 - - - - 
15:0 0.98 - - - - 
16:0 27.02 10.74 7.82 10.84 7.80 
16:1 1.54 - - - 0.13 
17:0 0.63 - - 0.08 0.07 
18:0 11.69 4.28 8.35 4.30 8.15 
18:1 trans-4 - - 0.59 - 0.48 
18:1 trans-5 - - 1.48 - 1.38 
18:1 trans-6-8 - - 17.60 - 16.67 
18:1 trans-9  - - 8.39 - 8.33 
18:1 trans-10 - - 9.28 - 8.96 
18:1 trans-11 1.70 - 7.67 - 7.54 
18:1 trans-12 - - 7.35 - 6.97 
18:1 cis-9 21.08 22.42 6.06 22.33 6.27 
18:2 n-trans 6 - - 1.13 - 0.84 
18:2 n-cis 6 3.39 53.03 0.42 52.90 0.46 
20:0 - 0.34 0.76 0.34 0.73 
18:3 n-6 - - 0.42 - 0.58 
20:1 - 0.20 - 0.18 0.15 
18:3 n-3 0.61 6.78 0.06 6.75 0.14 
18:2 cis-9, trans-11 1.03 - - - - 
20:2 - 0.05 0.05 - - 
22:0 - 0.38 0.44 0.37 0.42 
24:0 - 0.15 0.15 0.14 0.18 
Saturated 53.89 15.96 19.93 16.15 17.89 
Monounsaturated 24.82 22.62 58.42 22.51 56.88 
Polyunsaturated 4 59.86 2.08 59.65 2.02 
Unsaturated (Mono+PUFA) 28.82 82.48 60.50 82.16 58.90 
Trans 1.7 - 53.49 - 51.17 
Unidentified
5 
17.29 1.56 21.57 1.69 23.21 
      
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day, 
5
Fatty acids < 0.03 g / 100g. 
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Table 2.3 Effect of treatments on ruminal fermentation parameters  
 Control Treatments
4 
  
      
Parameters SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
      
pH 6.7 6.5 6.5 0.03 0.111 
NH3-N,  mM 15
a
 8
b
 13
a
 1.2 0.001 
Total VFA, mM 90
a
 72
b
 72
b
 5.6 0.003 
  Acetate 61.9 61.3 61.7 0.96 0.843 
  Propionate 23.3 23.6 23.5 0.31 0.652 
  Butyrate 11.2 11.7 11.2 0.58 0.637 
  Isobutyrate 1.1 1.0 1.1 0.04 0.065 
  Valerate 0.9 1.0 1.0 0.07 0.523 
  Isovalerate 1.2 1.1 1.2 0.09 0.131 
      
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences between means; 
6
P-value represents the 
probability of a treatment effect; 
a,b,c
 Means in the same row with different superscripts are different 
(P<0.05).  
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Table 2.4 Treatment effects on major fatty acid classes in plasma and lipoprotein 
fractions 
  Control Treatments
4 
  
       
Fatty acid, g/100 g Fraction SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
       
Saturated Plasma 41.5 40.9 41.1 0.61 0.643 
 HDL 35.9 34.6 35.4 0.63 0.113 
 LDL+VLDL 45.5 45.8 43.8 0.94 0.080 
Monounsaturated Plasma 20.3
a
 22.4
b
 22.6
b
 0.42 <0.001 
 HDL 21.2 22.3 22.1 0.52 0.067 
 LDL+VLDL 20.0
a
 22.9
b
 23.9
b
 0.74 <0.001 
Polyunsaturated Plasma 21.8 21.0 21.2 0.41 0.131 
 HDL 26.0 24.8 25.5 0.72 0.271 
 LDL+VLDL 14.1 12.9 13.9 0.73 0.197 
Unsaturated Plasma 42.2 43.4 43.9 0.71 0.050 
(Mono+PUFA) HDL 47.2 47.2 47.6 1.09 0.914 
 LDL+VLDL 34.1
a
 35.8
b
 37.8
b
 1.01 0.002 
Trans Plasma 2.3
c
 3.4
a
 3.1
b
 0.15 <0.001 
 HDL 1.8
b
 2.2
a
 2.1
a
 0.08 <0.001 
 LDL+VLDL 2.8
a
 5.7
b
 5.8
b
 0.66 <0.001 
Long chain fatty acids Plasma 10.5 9.7 10.2 0.65 0.441 
 HDL 12.9 13.0 12.6 0.86 0.872 
 LDL+VLDL 13.0
a
 11.6
b
 12.9
a
 0.57 0.026 
Unidentified
7 
Plasma 16.2 15.5 14.9 0.79 0.220 
 HDL 16.7 18.0 16.9 1.14 0.449 
 LDL+VLDL 20.2
a
 18.3
b
 18.2
b
 0.78 0.016 
       
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences of means; 
6
P-value represents the probability of 
a treatment effect;
 7
Fatty acids < 0.03 g / 100g; 
a,b,c
 Means in the same row with different superscripts 
are different (P<0.05).  
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Table 2.5 Fatty acid distribution in plasma  
 Control Treatments
 4 
  
      
Fatty acid, g/100 g SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
      
10:0 4.3 4.6 3.6 0.74 0.412 
12:0 0.1 0.1 0.1 0.01 0.018 
13:0 0.1 0.1 0.1 0.01 0.534 
14:0 0.5 0.4 0.4 0.02 0.298 
14:1 0.2 0.2 0.2 0.06 0.828 
15:0 1.2
a
 1.0
b
 1.1
a
 0.08 0.048 
15:1 0.1 0.1 0.1 0.01 0.818 
16:0 13.8 13.7 14.0 0.20 0.268 
16:1 1.5 1.4 1.5 0.06 0.072 
17:0 1.0
a
 0.9
b
 0.9
b
 0.02 <0.001 
17:1 0.3 0.2 0.3 0.09 0.124 
18:0 19.5 19.7 19.6 0.29 0.911 
18:1 trans-4 0.0
c
 0.1
b
 0.2
a
 0.02 <0.001 
18:1 trans-5 0.2
a
 0.1
b
 0.2
a
 0.02 0.008 
18:1 trans-9  0.0
c
 0.1
b
 0.2
a
 0.02 <0.001 
18:1 trans-10 0.1
b
 0.2
a
 0.1
b
 0.01 <0.001 
18:1 trans-11 0.8
b
 1.5
a
 0.9
b
 0.18 <0.001 
18:1 trans-12 0.2
b
 0.3
a
 0.3
a
 0.02 0.008 
18:1 cis-9 15.6
b
 16.3
a
 16.6
a
 0.30 0.002 
18:1 cis-13 0.1
c
 0.1
b
 0.1
a
 0.01 <0.001 
18:2n-trans 6 0.1 0.1 0.1 0.01 0.116 
18:2n-cis 6 12.0 11.9 11.9 0.25 0.893 
20:0 0.1 0.1 0.1 0.01 0.327 
18:3n6 0.2
a
 0.1
b
 0.1
b
 0.01 <0.001 
18:3n3 1.9 1.9 1.9 0.07 0.999 
18:2 cis-9, trans-11 0.2 0.3 0.2 0.02 0.302 
20:2 0.0 0.1 0.1 0.01 0.442 
22:0 0.1 0.1 0.1 0.01 0.331 
20:3n6 2.2
a
 1.8
b
 1.9
b 
0.04 <0.001 
20:4n6 4.3 4.1 4.1 0.10 0.110 
23:0 0.1
b
 - 0.2
a
 0.09 0.027 
22:2 0.3 0.3 0.2 0.04 0.099 
24:0 0.6 0.6 0.5 0.05 0.240 
20:5n3 0.2 0.2 0.3 0.05 0.379 
24:1 0.5 0.4 0.4 0.06 0.109 
22:6n3 0.3 0.4 0.4 0.07 0.485 
      
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences of means; 
6
P-value represents the probability of 
a treatment effect; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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2.3.4 Lipoprotein fractions and treatment effects 
There was no difference between treatments in plasma concentration of lipoprotein 
cholesterol fractions (Table 2.6). Compared with control and SO, PHVO resulted in 
higher concentrations of EA, but lower concentrations of 18:1 trans 10 in the HDL 
fraction (Table 2.7). Compared with control and SO, PHVO, resulted in higher 
concentrations of 18:1 trans 5, trans 6-8, and EA, and trans 10 in the LDL+VLDL 
fraction (Table 2.8). Compared with control and PHVO, SO resulted in higher 
concentrations of VA in both lipoprotein fractions. 
Significant interactions (P < 0.05) between lipoprotein fractions and treatments were 
observed. Compared with control and SO, PHVO resulted in higher concentration of 
18:1 trans 5, trans 9 and 18:2n-trans 6 in the HDL fraction. On the other hand, 
compared with control and SO, PHVO resulted in higher concentrations of 18:1 trans 
5, trans 9, trans 10 and trans 12 in the LDL+VLDL fraction (Table 2.9).  
Table 2.6 Concentrations of HDL and LDL+VLDL fractions in plasma 
 Control Treatments
4 
  
      
Parameters (mg/l) SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
      
HDL 0.4 0.5 0.4 0.05 0.261 
LDL+VLDL 0.1 0.1 0.1 0.02 0.519 
      
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences of means; 
6
P-value represents the probability of 
a treatment effect. 
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Table 2.7 Fatty acid distribution in the HDL fraction 
 Control Treatments
4 
  
      
Fatty acid, g/100 g SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
      
10:0 2.4 2.0 1.5 0.72 0.475 
12:0 0.1 0.1 0.1 0.02 0.207 
13:0 0.1 0.1 0.08 0.01 0.100 
14:0 0.1 0.1 0.1 0.02 0.722 
14:1 0.1 0.05 0.04 0.01 0.273 
15:0 0.8 0.9 0.8 0.12 0.688 
15:1 0.1 0.08 0.08 0.02 0.987 
16:0 12.1 11.8 12.3 0.63 0.758 
16:1 1.1 1.1 1.2 0.06 0.138 
17:0 0.9 0.8 0.9 0.07 0.716 
17:1 0.2 0.3 0.3 0.05 0.894 
18:0 19.2 18.4 18.6 0.61 0.430 
18:1 trans-4 0.1 0.1 0.1 0.02 0.483 
18:1 trans-5 - 0.03 0.04 0.01 0.058 
18:1 trans-9  0.02
a
 0.07
b
 0.09
b
 0.01 <0.001 
18:1 trans-10 - 0.02 - 0.01 0.059 
18:1 trans-11 0.5
a
 0.7
b
 0.5
a
 0.04 <0.001 
18:1 trans-12 0.1
a
 0.2
b
 0.1
a
 0.01 0.004 
18:1 cis-9 16.7 17.5 17.2 0.94 0.747 
18:2n-trans 6 0.02 0.03 0.05 0.01 0.051 
18:2n-cis 6 13.6 13.2 13.8 0.50 0.489 
18:3n6 0.1 0.1 0.1 0.02 0.855 
20:1 0.2 - 0.1 0.09 0.084 
18:3n3 1.8 1.9 1.9 0.17 0.776 
20:2 0.07 0.06 0.06 0.01 0.713 
20:3n6 2.6 2.2 2.3 0.19 0.105 
22:1n9 0.06 0.04 0.03 0.04 0.679 
20:4n6 5.9 5.6 5.5 0.43 0.636 
23:0 - - 0.07 0.03 0.172 
22:2 0.4 0.3 0.3 0.06 0.330 
20:5n3 0.9 0.8 0.8 0.06 0.079 
24:1 0.6 0.6 0.6 0.17 0.915 
22:6n3 0.4 0.3 0.3 0.04 0.083 
      
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences of means; 
6
P-value represents the probability of 
a treatment effect; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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Table 2.8 Fatty acid distribution in the LDL+VLDL fraction   
 Control Treatments
4 
  
      
Fatty acid, g/100 g SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
      
10:0 1.1 0.6 0.5 0.51 0.444 
12:0 0.08 0.08 0.08 0.01 0.711 
13:0 0.05 0.05 0.04 0.01 0.323 
14:0 1.0 1.0 1.0 0.08 0.865 
14:1 0.04 0.04 0.04 0.00 0.887 
15:0 1.8 1.4 1.4 0.22 0.137 
16:0 17.2 16.9 16.8 0.44 0.670 
16:1 2.0 1.8 1.9 0.09 0.256 
17:0 1.2
a
 1.1
b
 1.1
b
 0.03 <0.001 
17:1 0.3 0.3 0.3 0.08 0.879 
18:0 21.5
b
 23.1
a
 21.5
b
 0.49 0.002 
18:1 trans-4 0.08 0.1 0.1 0.03 0.188 
18:1 trans-5 0.04
a
 0.09
a
 0.2
b
 0.06 0.015 
18:1 trans-6-8 0.01
a
 0.2
a
 0.4
b
 0.12 0.001 
18:1 trans-9  0.09
a
 0.2
b
 0.5
c
 0.07 <0.001 
18:1 trans-10 0.08
a
 0.1
a
 0.3
b
 0.08 0.024 
18:1 trans-11 1.1
a
 2.6
b
 1.3
b
 0.17 <0.001 
18:1 trans-12 0.2
a
 0.40
a
 0.5
b
 0.07 <0.001 
18:1 cis-9 13.9 13.5 13.4 1.14 0.913 
18:2n-trans 6 0.06 0.04 0.05 0.01 0.308 
18:2n-cis 6 7.6 7.3 7.8 0.76 0.786 
20:0 0.4 0.4 0.4 0.04 0.580 
18:3n6 0.1 0.09 0.1 0.02 0.197 
20:1 0.06 0.03 0.02 0.03 0.332 
18:3n3 1.4 1.4 1.5 0.06 0.278 
18:2 cis-9, trans-11 0.1 0.1 0.09 0.02 0.170 
22:0 0.2 0.2 0.2 0.03 0.445 
20:3n6 1.3
a
 0.9
c
 1.1
b
 0.13 0.026 
20:4n6 2.3 1.9 2.2 0.28 0.466 
23:0 0.3 0.2 0.2 0.04 0.268 
22:2 0.2 0.1 0.3 0.16 0.402 
24:0 0.1 0.1 0.2 0.05 0.362 
20:5n3 0.6 0.5 0.4 0.06 0.053 
24:1 0.2 0.2 0.2 0.06 0.717 
22:6n3 0.2 0.2 0.2 0.02 0.225 
      
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences of means; 
6
P-value represents the probability of 
a treatment effect; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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Table 2.9 Interactions between fractions and treatments for concentrations of 18:1 
trans isomers 
  Control Treatments
4 
  
       
Fatty acid, g/100 g Fraction SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
       
18:1 trans-5 HDL - 0.03
a 
0.04
a 
0.035 0.043 
 LDL+VLDL 0.04
b 
0.10
a 
0.23
a 
  
18:1 trans-6-8 HDL - - - 0.030 <0.001 
 LDL+VLDL 0.49
a 
0.01
c 
0.20
b 
  
18:1 trans-9  HDL 0.03
c 
0.07
b 
0.09
a 
0.057 <0.001 
 LDL+VLDL 0.10
c 
0.27
b 
0.53
a 
  
18:1 trans-10 HDL - 0.02
a 
- 0.056 <0.001 
 LDL+VLDL 0.08
a 
0.15
a 
0.31
 
  
18:1 trans-11 HDL 0.53
a 
0.72
a 
0.57
a 
0.149 <0.001 
 LDL+VLDL 1.16
b 
2.70
a 
1.35
b 
  
18:1 trans-12 HDL 0.17
c 
0.23
a 
0.19
b 
0.039 <0.001 
 LDL+VLDL 0.21
c 
0.40
b 
0.52
a 
  
18:2n-trans 6 HDL 0.02
b 
0.03
b 
0.05
a 
0.010 0.042 
 LDL+VLDL 0.06
a 
0.05
a 
0.05
a 
  
       
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences of means; 
6
P-value represents the probability of 
a fraction-treatment effect; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05). 
 
2.3.5 Total amount of trans fatty acids in lipoprotein fractions 
There was no difference between treatments in total amount of tFA of lipoprotein 
fractions (Table 2.10). 
Table 2.10 Treatment effects on trans fatty acids in lipoprotein fractions 
  Control Treatments
4 
  
       
Fatty acid Fraction SM
1 
SO
2 
PHVO
3 
SED
5 
P-value
6 
       
mg/l HDL 21 29 28 0.87 0.668 
 LDL+VLDL 112 140 184 31.7 0.100 
       
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single 
administration per day; 
5
Standard errors of differences of means; 
6
P-value represents the probability of 
a treatment effect 
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2.3.6 Fatty acid composition of lipid subgroups within lipoproteins 
Total lipid concentration (mg/l) was not affected by treatments. Total lipid 
concentration was increased in LDL+VLDL-TG. 16:0 and 18:0 were not affected by 
treatments but were increased in LDL+VLDL-TG. Compared with control, SO and 
PHVO increased EA. EA was increased in LDL+VLDL-CE. Compared with control 
and SO, PHVO increased VA. VA was higher in CE and TG compared with PL 
subgroup. 18:1 cis 9 was not affected by treatments but was higher in LDL+VLDL-PL 
(Table 2.11a). 
18:2 trans 6 was not affected by treatments but was increased in HDL-TG. 18:2 cis 6 
was not affected by treatments but was higher in CE than PL and TG subgroups. 
18:3n6 was not affected by treatments but higher in HDL-TG. 18:3n3 was not affected 
by treatments but was higher in CE than TG and PL subgroups. 20:3n6 was not 
affected by treatments but was was higher in HDL-PL. Compared with SO, PHVO 
and control increased 20:5n3. 22:6n3 was not affected by treatments but was higher in 
TG than CE and PL subgroups (Table 2.11b). 
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Table 2.11a Lipid concentration and fatty acid content (g / 100 g) in each lipid 
subgroup of lipoprotein fractions in plasma from cows subjected to ruminal pulses   
     SED P-value 
Total lipid Treatment SM SO PHVO   
(mg / ml)  3004 2684 2587 209.1 0.117 
 Fraction HDL LDL    
  1536
b 
3980
a 
 170.7 <0.001 
 Lipid CE PL TG   
  2739
b 
1921
c 
3615
a 
209.1 <0.001 
16:0 Treatment SM SO PHVO   
  25.9 25.3 24.9 0.95 0.607 
 Fraction HDL LDL    
  23.7
b 
27.0
a 
 0.77 <0.001 
 Lipid CE PL TG   
  19.4
b 
27.6
a 
29.0
a 
0.95 <0.001 
18:0 Treatment SM SO PHVO   
  26.3 26.2 26.6 0.97 0.935 
 Fraction HDL LDL    
  25.2
b 
27.5
a 
 0.97 0.006 
 Lipid CE PL TG   
  18.5
c 
28.3
b 
32.3
a 
0.97 <0.001 
18:1 trans 9 Treatment SM SO PHVO   
  1.7
b 
2.0
a 
2.4
a 
0.11 <0.001 
 Fraction HDL LDL    
  1.5
b 
2.6
a 
 0.09 <0.001 
 Lipid CE PL TG   
  3.4
a 
0.9
c 
1.8
b 
0.11 <0.001 
18:1 trans 11 Treatment SM SO PHVO   
  1.3
b 
1.2
c 
1.5
a 
0.09 0.024 
 Fraction HDL LDL    
  1.3 1.4  0.07 0.161 
 Lipid CE PL TG   
  1.6
a 
0.7
b 
1.7
a 
0.09 <0.001 
18:1 cis 9 Treatment SM SO PHVO   
  6.1 6.8 7.3 0.54 0.126 
 Fraction HDL LDL    
  5.4
b 
8.1
a 
 0.44 <0.001 
 Lipid CE PL TG   
  5.8
b 
9.1
a 
5.3
b 
0.54 <0.001 
       
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; HDL = High density 
lipoprotein; LDL = Low density lipoprotein. CE = Cholesteryl ester; TC = triglyceride; PL = Phospholipid; 
a,b,c
 Means down column with different superscripts are different (P<0.05).  
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Table 2.11b Fatty acid content (g /100 g) in each lipid subgroup of lipoprotein 
fractions in plasma from cows subjected to ruminal pulses   
     SED P-value 
18:2 trans 6 Treatment SM SO PHVO   
  1.6 1.5 1.4 0.14 0.470 
 Fraction HDL LDL    
  1.9
a 
1.1
b 
 0.12 <0.001 
 Lipid CE PL TG   
  1.6
b 
0.9
c 
2.0
a 
0.14 <0.001 
18:2 cis 6 Treatment SM SO PHVO   
  9.0 8.9 8.9 1.09 0.993 
 Fraction HDL LDL    
  9.1 8.8  0.89 0.679 
 Lipid CE PL TG   
  18.7
a
 5.7
b 
2.5
c 
1.09 <0.001 
18:3n6 Treatment SM SO PHVO   
  1.5 1.3 1.5 0.09 0.081 
 Fraction HDL LDL    
  1.9
a 
1.1
b 
 0.08 <0.001 
 Lipid CE PL TG   
  1.9
a 
0.9
b 
1.7
a 
0.09 <0.001 
18:3n3 Treatment SM SO PHVO   
  2.1 2.3 2.3 0.23 0.785 
 Fraction HDL LDL    
  2.4 2.0  0.19 0.051 
 Lipid CE PL TG   
  4.8
a 
0.7
c 
1.2
b 
0.23 <0.001 
20:3n6 Treatment SM SO PHVO   
  1.0 1.1 1.0 0.09 0.730 
 Fraction HDL LDL    
  1.3
a 
0.8
b 
 0.07 <0.001 
 Lipid CE PL TG   
  0.7
c 
1.3
a 
1.1
b 
0.09 <0.001 
20:5n3 Treatment SM SO PHVO   
  0.7
a 
0.5
b 
0.7
a 
0.01 <0.001 
 Fraction HDL LDL    
  0.6 0.6  0.01 0.993 
 Lipid CE PL TG   
  0.6 0.6 0.6 0.01 0.619 
22:6n3 Treatment SM SO PHVO   
  6.6 6.6 6.9 0.40 0.662 
 Fraction HDL LDL    
  6.6 6.8  0.33 0.450 
 Lipid CE PL TG   
  6.8
b 
3.3
c 
10.0
a 
0.40 <0.001 
       
1
SM = Skim milk; 
2
SO = Soya oil; 
3
PHVO = Partially hydrogenated vegetable oil; HDL = High density 
lipoprotein; LDL = Low density lipoprotein. CE = Cholesteryl ester; TC = triglyceride; PL = Phospholipid; 
a,b,c
 Means down column with different superscripts are different (P<0.05).  
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2.3.7 Diurnal and daily variations in plasma and lipoprotein fractions on trans 
fatty acids 
Generally, sampling day affected tFA of plasma and lipoprotein fractions after cows 
were ruminally pulsed. Plasma concentrations of all 18:1 trans isomers linearly 
increased, and were higher on Day 3 than on Day 1 and 2 but plasma concentrations 
of 18:2 n-trans 6 did not differ between days (Table 2.12). Plasma concentrations of 
18:1 trans-4 were greater at 10:00 than other times of day; concentrations of 18:1 
trans-5 were greater at 11:00 and 15:00 than at other times of day; concentrations of 
the remaining 18:1 trans isomers were not affected by time of sampling. 
Table 2.12 Day and sampling time (h) effects in plasma trans fatty acids 
Fatty 
acid 
(g/100 g) 
    
  
SED
3
 P-
value
4
 
(Lin)
5 
(Quad)
6 
           
18:1  D
1 1 2 3       
trans-4  0.07
c 0.17b 0.24a   0.022 <0.001 <0.001 0.673 
 T
2 09:00 10:00 11:00 12:00 15:00     
  0.09
c 0.24a 0.15c 0.16b 0.15c 0.029 <0.001 0.910 0.058 
18:1  D 1 2 3       
trans-5  0.04
c 0.18b 0.30a   0.029 0.002 0.009 0.879 
 T 09:00 10:00 11:00 12:00 15:00     
  0.18
b 0.07c 0.25a 0.13b 0.25a 0.037 0.033 0.142 0.471 
18:1  D 1 2 3       
trans-9  0.10
c 0.16b 0.23a   0.025 <0.001 <0.001 0.992 
 T 09:00 10:00 11:00 12:00 15:00     
  0.15
 0.19 0.16 0.18 0.14 0.033 0.568 0.395 0.465 
18:1  D 1 2 3       
trans-10  0.08
c 0.18b 0.25a   0.015 <0.001 <0.001 0.698 
 T 09:00 10:00 11:00 12:00 15:00     
  0.17
 0.17 0.18 0.18 0.15 0.019 0.526 0.499 0.343 
18:1  D 1 2 3       
trans-11  0.80
 1.15 1.35   0.094 <0.001 <0.001 0.329 
 T 09:00 10:00 11:00 12:00 15:00     
  1.05 1.13 1.04 1.04 1.20 0.121 0.595 0.262 0.380 
18:1  D 1 2 3       
trans-12  0.19
a 0.28b 0.40a   0.028 <0.001 <0.001 0.624 
 T 09:00 10:00 11:00 12:00 15:00     
  0.27
c 0.36a 0.26c 0.26c 0.30b 0.036 0.034 0.898 0.340 
18:2  D 1 2 3       
n-trans 6  11.70 12.19 12.07   0.254 0.131 0.347 0.028 
 T 09:00 10:00 11:00 12:00 15:00     
  11.64 12.27 12.01 11.61 12.40 0.327 0.053 0.201 0.038 
           
1
Day; 
2
Time; 
3
Standard errors of differences of means; 
4
P-value represents the probability of a 
treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken during the 3 d collection period 
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HDL fraction concentrations of 18:1 trans-9, trans-11, and trans-12 linearly increased 
and were higher on Day 3 than on Day 1 and 2.  HDL fraction concentrations of 18:1 
trans-4 and 18:2 n-trans 6 had quadratic effect. HDL fraction concentrations of 18:1 
trans-4 were greater at 11:00 than at other times of day; concentrations of 18:1 trans-9 
were greater at 12:00 and 15:00 than at other times of day; concentrations of 18:2 n-
trans 6 had quadratic effect; concentrations of the remaining 18:1 trans isomers were 
not affected by time of sampling (Table 2.13). 
 
Table 2.13 Day and sampling time (h) effects in the HDL fraction trans fatty acids 
Fatty 
acid, 
g/100 g 
    
  
SED
3
 P-
value
4
 
(Lin)
5 
(Quad)
6 
           
18:1  D
1 1 2 3       
trans-4  0.07
b 0.10a 0.08b   0.010 0.029 0.818 0.008 
 T
2 09:00 10:00 11:00 12:00 15:00     
  0.09
b 0.09b 0.11a 0.04c 0.09b 0.013 0.016 0.599 0.229 
18:1  D 1 2 3       
trans-9  0.045
c 0.062b 0.088a   0.010 0.017 0.005 0.752 
 T 09:00 10:00 11:00 12:00 15:00     
  0.05
b 0.04b 0.05b 0.08a 0.09a 0.013 0.029 0.005 0.857 
18:1  D 1 2 3       
trans-11  0.54
b 0.57b 0.70a   0.023 <0.001 <0.001 0.128 
 T 09:00 10:00 11:00 12:00 15:00     
  0.58
 0.59 0.59 0.63 0.65 0.030 0.450 0.078 0.923 
18:1  D 1 2 3       
trans-12  0.16
c 0.19b 0.23a   0.007 <0.001 <0.001 0.972 
 T 09:00 10:00 11:00 12:00 15:00     
  0.19
 0.19 0.18 0.20 0.21 0.010 0.460 0.134 0.700 
18:2  D 1 2 3       
n-trans 6  0.03
a 0.02b 0.03a   0.003 0.022 0.261 0.011 
 T 09:00 10:00 11:00 12:00 15:00     
  0.03
b 0.02b 0.03b 0.04a 0.03b 0.004 0.029 0.044 0.480 
           
1
Day; 
2
Time; 
3
Standard errors of differences of means; 
4
P-value represents the probability of a 
treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken during the 3 d collection period 
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LDL+VLDL concentrations of 18:1 trans-9, trans-10, trans11, and trans-12 linearly 
increased and were higher on Day 3 than on Days 1 and 2, but LDL+VLDL fraction 
concentrations of 18:1 trans-4 and trans-5 and 18:2 n-trans 6 did not differ between 
days. LDL+VLDL fraction concentrations of 18:1 trans isomers were not affected by 
time of sampling (Table 2.14). 
 
Table 2.14 Day and sampling time (h) effects in the LDL+VLDL fraction trans fatty 
acids 
Fatty acid, 
g/100 g 
    
  
SED
3
 P-
value
4
 
(Lin)
5 
(Quad)
6 
           
18:1 trans-4 D1 1 2 3       
  0.11
 
0.09
 
0.13
 
  0.016 0.326 0.361 0.236 
 T2 09:00 10:00 11:00 12:00 15:00     
  0.09 0.08 0.09 0.14 0.14 0.020 0.121 0.009 0.717 
18:1 trans-5 D 1 2 3       
  0.16 0.15 0.16   0.026 0.985 0.963 0.868 
 T 09:00 10:00 11:00 12:00 15:00     
  0.17 0.12 0.12 0.23 0.14 0.034 0.113 0.906 0.457 
18:1 trans-9 D 1 2 3       
  0.13
c 
0.37
b 
0.45
a 
  0.049 <0.001 <0.001 0.176 
 T 09:00 10:00 11:00 12:00 15:00     
  0.31 0.35 0.28 0.31 0.34 0.064 0.958 0.838 0.802 
18:1 trans-10 D 1 2 3       
  0.24
c 
0.47
b 
0.64
a 
  0.026 <0.001 <0.001 0.343 
 T 09:00 10:00 11:00 12:00 15:00     
  0.50 0.41 0.44 0.45 0.44 0.034 0.424 0.485 0.441 
18:1 trans-11 D 1 2 3       
  1.11
c 
1.83
b 
2.27
a 
  0.125 <0.001 <0.001 0.360 
 T 09:00 10:00 11:00 12:00 15:00     
  1.73 1.76 1.57 1.93 1.67 0.161 0.622 0.905 0.661 
18:1 trans-12 D 1 2 3       
  0.29
c 
0.37
b 
0.49
a 
  0.032 <0.001 <0.001 0.548 
 T 09:00 10:00 11:00 12:00 15:00     
  0.35 0.38 0.35 0.40 0.46 0.041 0.344 0.061 0.589 
18:2  D 1 2 3       
n-trans 6  0.07 0.05 0.06   0.005 0.207 0.141 0.319 
 T 09:00 10:00 11:00 12:00 15:00     
  0.06 0.07 0.06 0.07 0.06 0.007 0.950 0.948 0.661 
           
1
Day; 
2
Time; 
3
Standard errors of differences of means; 
4
P-value represents the probability of a 
treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken during the 3 d collection period 
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2.3.8 Diurnal and daily variations in ruminal fermentation parameters 
Ruminal pH and NH3-N did not differ by between days. Ruminal pH linearly 
decreased and was lower at 15:00 than at other times of day. Ruminal NH3-N had 
quadratic effect and was greater at 12:00 than at other times of day. Total volatile FA 
were not affected by day and time of sampling. Concentrations of acetate, propionate, 
butyrate, valerate and isovalerate did not differ between days. Concentration of acetate 
linearly decreased and was lower at 12:00 than at other times of day; molar 
concentration of propionate linearly increased and was greater at 12:00 than at other 
times of day; molar concentrations of butyrate and isovalerate had quadratic effect and 
were greater at 10:00 than at other times of day, but molar concentration of valerate 
was not affected by time of sampling (Table 2.15). 
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Table 2.15 Day and time (h) effects on ruminal fermentation parameters  
1
Day; 
2
Time; 
3
Standard errors of differences of means; 
4
P-value represents the probability of a 
treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken during the 3 d collection period 
 
 
 
Parameters    
   
SED
3 
P-
value
4 
(Lin)
5 
(Quad)
6 
           
pH D
1 
1 2 3       
  6.49 6.50 6.47   0.028 0.435 0.430 0.308  
 T
2 
09:00 10:00 11:00 12:00 15:00     
  6.62
a 
6.51
b 
6.51
b 
6.52
b 
6.27
c 
0.036 <0.001 <0.001 0.152 
NH3-N,   D 1 2 3       
mM  13.9 10.1 12.1   2.81 0.100 0.296 0.060 
 T 09:00 10:00 12:00       
  11.0
c 
15.8
b 
17.4
a 
  2.81 0.002 0.550 <0.001 
Total  D 1 2 3       
VFA, mM  78.0 77.8 77.9   4.71 0.998 0.976 0.962 
 T 09:00 10:00 12:00       
  80.8 76.3 76.7   4.71 0.568 0.458 0.448 
Acetate D 1 2 3       
  62.0 62.1 60.8   0.94 0.310 0.191 0.427 
 T 09:00 10:00 12:00   
  63.4
a 
60.8
b 
60.7
b 
  0.94 0.010 0.017 0.052 
Propionate D 1 2 3       
  23.3 23.3 23.8   0.31 0.234 0.142 0.387 
 T 09:00 10:00 12:00       
  23.1
c 
23.4
b 
24.0
a 
  0.31 0.023 0.006 0.936 
Butyrate D 1 2 3       
  11.0 11.2 11.8   0.56 0.347 0.161 0.714 
 T 09:00 10:00 12:00       
  10.3
c 
12.0
a 
11.8
b 
  0.56 0.007 0.029 0.021 
Isobutyrate D 1 2 3       
  1.1 1.0 1.1   0.04 0.677 0.890 0.384 
 T 09:00 10:00 12:00       
  1.0 1.1 1.0   0.04 0.085 0.757 0.028 
Valerate D 1 2 3       
  1.0 1.0 1.0   0.07 0.547 0.864 0.280 
 T 09:00 10:00 12:00       
  0.8 1.1 1.1   0.07 <0.001 <0.001 0.001 
Isovalerate D 1 2 3       
  1.2 1.1 1.2   0.09 0.209 0.735 0.083 
  T 09:00 10:00 12:00       
  1.1
b 
1.3
a 
1.0
c 
  0.09 0.014 0.138 0.011 
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2.4 Discussion 
Overall, the results demonstrated that FA profile of plasma and lipoprotein fractions 
reflected the dietary FA source; ruminal parameters were affected by oil pulses and 
concentrations of tFA were different in plasma and both lipoprotein fractions. 
LDL+VLDL fraction was the main fraction involved in transport of tFA. 
The design of the experiment enabled examination of effects of different dietary lipids 
on FA profiles of plasma and lipoprotein fractions. In the current experiment, 250 g/d 
of SO or PHVO was ruminally pulsed accompanied by skimmed milk as a vehicle 
(Loor and Herbein, 2001). The aim was to increase tFA supply to the duodenum either 
as products of ruminal biohydrogenation (SO) or as preformed tFA (PHVO). The 
ruminal pulse amounts were of a magnitude similar to those used in other studies 
(Rogers et al., 1979; Ferlay and Doureau, 1992). Ferlay and Doreau (1992) compared 
two treatments, one in which rapeseed oil was continuously infused into the rumen at 
1000 g/d and another with a single administration of 250 g of rapeseed oil. However, 
they did not use any emulsifier to permit a homogenised release of the oil. They 
reported that the effects of lipid supplementation on ruminal digestion are less strong 
with a continuous supply than with a single administration. 
This experiment is the first to investigate concentrations of individual 18:1 tFA 
isomers in lipoprotein fractions of bovine plasma. The current experiment differs from 
previous research (Baumgard et al., 2002; Mosley et al., 2006; Tyburczy et al., 2008; 
Lock et al., 2008) mainly in the use of oils rather than using individual FA (i.e. CLA 
trans-10, cis-12; oleic acid, VA and EA), enriched oils (i.e. fish oil high in oleic acid; 
Amorocho et al., 2009) and combination of oils (i.e. fish oil+sunflower oil; Cruz-
Hernandez et al., 2007; Belenguer et al., 2010) that might be absorbed and transported 
differently to the mammary gland. Also, in this experiment, ruminal pulses were used, 
whereas, previous studies (Loor and Herbein, 2001; Baumgard et al., 2002; Mosley et 
al., 2006; Tyburczy et al., 2008) used abomasal infusion to study effects of dietary 
lipids on plasma and lipoprotein fractions mainly because the authors aimed to avoid 
ruminal biohydrogenation. Thus, differences in FA output in milk between abomasal 
infusion and oral treatments can be attributed to ruminal metabolism and intestinal 
bioavailability, or both (Castaneda-Gutierrez et al., 2007). The present experiment 
also differs from studies (Chilliard et al., 1991, DePeters et al., 2001) that used 
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duodenal infusions to investigate effects of dietary oils on milk fatty acid profile. The 
profile of FA absorbed in the duodenum can alter the FA profile of dairy and other 
animal products, especially modifying FA saturation and CLA concentration 
(Grummer, 1991; Mansbridge and Blake, 1997; Harvatine and Allen, 2006). 
 
The use of PHVO as ruminal pulse is another difference between other studies 
(Mosley et al., 2006; Tyburczy et al., 2008). Abomasal infusion of PHVO to dairy 
cows’ results in milk fat depression and this has been attributed to the high levels of 
18:1 trans isomers (Selner and Schultz, 1980; Gaynor et al., 1994; Romo et al., 1996). 
PHVO also contains a Gaussian distribution of 18:1 trans isomers (approximately 40 
to 60% of total FA), that undergo the hydrogenation process resulting in the formation 
of several conjugated and other unique FA isomers that are present in PHVO, and 
some of these could regulate milk fat synthesis (Lock et al., 2007; Bauman and 
Griinari, 2003; Shingfield and Griinari, 2007; Tyburczy et al., 2008). 
 
The concentration of EA in PHVO was higher than that in SO because EA is the 
major trans isomer found in PHVO (Meijer et al., 2001). On the other hand, while VA 
was not detectable in SO, after biohydrogenation high concentrations of VA were 
found in plasma and lipoprotein fractions following SO treatment. This is consistent 
with observations that inclusion of vegetable oils high in PUFA into concentrate diets 
raises VA and 18:2 cis-9, trans-11 content in milk fat (Bauman et al., 2000; Shingfield 
et al., 2006). Other studies have shown that diets with a higher forage-to-concentrate 
ratio of 60:40 (Bell et al., 2006) or 73:27 (Roy et al., 2006) and containing safflower 
oil (6%) or linseed oil (5%), respectively, also increased high levels of VA in milk. 
AbuGhazaleh et al. (2002) examined the effect of feeding fish oil, extruded soya 
beans, or their blend on the milk fat concentration of CLA cis-9, trans-11 and found 
that the concentration of VA in milk fat was increased 129% by the fish oil diet 
compared with the control diet, despite the fact that fish oil had low concentration (< 
3%) of both linoleic and linolenic acids, the precursors of VA produced by ruminal 
biohydrogenation. Milk VA concentration was also increased by 136% when extruded 
soya beans were fed, compared with the control diet. In the current experiment, 
linoleic acid and oleic acid were higher in the SO treatment; however, linoleic acid 
has been shown to be more effective than oleic acid in promoting high VA 
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concentrations in the milk (AbuGhazaleh et al., 2003) and in the rumen (AbuGhazaleh 
et al., 2003, 2005, 2007). 
 
CLA 18:2 cis-9, trans-11 was detected in skimmed milk (control) but not in SO nor 
PHVO. It is known that food products from ruminants, particularly dairy products, are 
the major dietary source of CLA for humans. Griinari et al., (1998) demonstrated that 
cows can synthesize CLA from VA. The major CLA isomer in food products from 
ruminants is 18:2 cis-9, trans-11, although other CLA isomers are present and these 
may vary under different rumen conditions (Griinari et al. 1997). CLA levels in food 
products derived from ruminants can be altered by affecting ruminal production of 
CLA or VA, or by dietary supplement with these fatty acids (Chouinard et al., 1999).  
 
Usually, supplementing cows with hydrogenated vegetable oils can decrease milk fat 
content due to their high content of 18:1 trans isomers and could raise the 
concentration of blood cholesterol. Selner and Schultz (1980) found that dairy cows 
supplemented with hydrogenated vegetable oil containing 13% tFA at 454 g per cow 
per day decreased slightly milk fat concentration and elevated plasma cholesterol from 
190 to 245 mg/100 ml and 18:1 tFA in milk fat from 4.2 to 6.2 g/100g. Hydrogenated 
vegetable oil containing 49% 18:1 tFA fed at 454 g/d decreased milk fat concentration 
from 3.9 to 3.1%. Short chain FA in milk fat triglycerides decreased and there were 
increases in 18:1 trans isomers (from 2.6 to 11.2 g/100g), 18:1 cis (from 22.9 to 29.0 
g/100g), and 18:2 trans (from 0.2 to 1.8 g/100g). In milk phospholipids 18:1 trans 
isomers increased from 0.3 to 3.1 g/100g in and 18:1 cis isomers increased from 20.5 
to 31.4 g/100g. Blood cholesterol esters were increased from 152 to 195 mg/100 ml. 
 
In the current experiment, SO contained high concentrations of UFA and PUFA. If 
dairy cows were fed with this oil, it could reduce milk fat yield and inhibit de novo FA 
synthesis and FA desaturation, although, in some experiments, oil supplementation 
has the potential to overcome reductions in de novo synthesis caused by PUFA found 
in vegetable oils (Loor et al., 2002). The origin of short-chain (4:0 to 8:0) and 
medium-chain FA (10:0 to 14:0) in ruminant milk fat is from de novo synthesis, while 
long-chain FA (> C:18) are derived from precursors in the blood (Bauman and 
Griinari, 2003). Storry (1972) proposed that long-chain FA taken up by the mammary 
gland inhibit de novo synthesis of short- and medium-chain FA, which was supported 
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by work with rats and humans (Barber et al., 1997). Neville and Picciano (1997) 
discussed and summarized studies to support the concept that FA play an integral role 
in regulating de novo FA synthesis in the lactating mammary gland, probably via 
actions on acetyl-CoA carboxylase  (Carroll et al., 2006).  
 
Likewise, Hervas et al. (2008) reported that dietary supplementation with sunflower 
oil led to an increase in 18:0 and 18:1 isomers in milk of dairy ewes. That response 
had been reported previously (Chilliard and Ferlay, 2004) in milk from cows and 
goats and has been also observed in milk fat from ewes supplemented with SO (Mele 
et al., 2006; Gomez-Cortes et al., 2008). In the current experiment, the increased of 
18:1 trans isomers found in plasma and lipoprotein fractions following SO pulse can 
be attributed to a shift in the biohydrogenation pathways, due to alterations in the 
rumen environmental conditions as a results of the ruminal pulsing. 
 
Kadegowda et al. (2008) found that dry matter intake was affected by abomasal 
infusion of highly UFA and to a less extend saturated LCFA. Their infusion mixtures 
contained both SFA and UFA and the maximum amount of FA infused was limited to 
400 g/d to avoid possible adverse effects on dry matter intake. 
 
2.4.1 Fatty acid composition of plasma and lipoprotein fractions 
The main hypothesis of this experiment was that concentrations of 18:1 tFA in plasma 
and lipoprotein fractions would be influenced by type of lipid pulsed. This hypothesis 
was supported by the differences in concentrations of 18:1 tFA in plasma and 
lipoprotein fractions observed between SO and PHVO.  
With a single administration, concentrations of treatments are higher during the first 
few hours after pulse and lower in subsequent hours. Generally, sampling day had 
linear effect on 18:1 trans isomers in plasma, HDL and LDL+VLDL.   Normally, 
dietary lipids cause a decreased in ruminal degradation (Ferlay and Doreau, 1992).  In 
this study, effects of treatments on tFA profile of plasma and lipoprotein fractions 
were observed within the first three hours post pulse. Sampling day affected tFA of 
plasma and lipoprotein fractions. The diurnal variation of tFA in the plasma and 
cholesterol fractions found in this study may indicate that fluctuations vary according 
to metabolic status (preprandial and postprandial status) (Diven et al., 1958).  The 
  
67 
amounts and composition of lipids circulating in the blood of dairy cattle are 
dependent upon a number of physiological variables. The nature of the diet, time since 
feeding, age, breed, pregnancy, and stage of lactation may all affect lipid content and 
composition (Christie, 1981). In this study, diurnal variations of plasma, lipoprotein 
fractions and ruminal fermentation parameters and showed that there may be an 
adaptation of ruminal microflora to the treatments and also reflected a cycle control 
mechanism balancing rate of lipid entry and rate of removal in the circulatory system. 
This is possibly related to regulation of lipid supply (diet, production, synthesis) and 
utilization by peripheral tissues (Bitman et al., 1990). 
Differences in tFA concentrations due to type of oil infused led to major changes in 
the profiles of most 18:1 trans isomers in plasma and lipoprotein fractions, in 
agreement with observations in plasma by Loor and Herbein (2001) in which ruminal 
infusions of CLA mixtures were used.  In the current experiment, SO treatment was 
higher in 18:1 cis-9 and 18:2 n-cis 6. Previous in vivo and in vitro observations 
indicated that ruminal biohydrogenation of 18:1 cis-9 and 18:2 n-6 give rise to 
geometrical isomers of 18:1 with double bonds at positions 6 to 16 of the carbon chain 
(Bickerstaffe et al., 1972; Kemp et al., 1975; Loor et al., 2002). Ruminal isomerisation 
of oleic acid is also associated with production of several 18:1 trans isomers but 
primarily 18:1 trans-6, 7, 8, 18:1 trans-9, and 18:1 trans-10 (Loor et al., 2002; Mosley 
et al., 2002). Under normal conditions, however, VA is by far the predominant 18:1 
trans isomer, resulting from hydrogenation of 18:2n-6 in the rumen (Loor et al., 2002). 
In the current experiment, SO treatment was higher in 18:0 which availability for 
endogenous 18:1 cis-9 production is crucial for milk fat synthesis (Donovan et al., 
2000; Chilliard et al., 2003; Loor et al., 2005).  
There are several possible processes for production of 18:1 trans isomers from 18:1 
cis-9. One could be that the rumen bacteria possess a multitude of cis / trans 
isomerases. It is accepted that there is an isomerase that converts the cis- 12 bond of 
linoleic and linolenic acids to a trans-11 bond. Another possibility could be that the 
18:1 trans isomers are formed as a result of simple chemical double bond migration 
(Griinari and Bauman, 1999). Ward et al. (1964) suggested that the accumulation of 
trans monoenes from biohydrogenation of 
14
C-labeled linoleic acid was due to double 
bond migration. This conclusion was based on the observation that the chemical 
hydrogenation of linoleic acid with a metal catalyst resulted in migration of the double 
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bond and formation of tFA. However, enzymatic and metal catalyzed hydrogenations 
are not parallel processes (Mosley et al., 2002). 
 
Compared with HDL fraction, concentrations of tFA were increased almost 3-fold in 
LDL+VLDL fraction. These results may indicate which lipoprotein fraction is 
involved in the transportation of tFA. The increase in trans isomers across plasma and 
lipoprotein fractions with SO and PHVO reflects modification of rumen microbial 
population and pathways of biohydrogenation usually caused by supplementation with 
dietary PUFA. Those changes promote formation and accumulation of 
biohydrogenation intermediates, some of which are potent inhibitors of milk fat 
synthesis (Bauman and Griinari, 2003). 
VA was significantly higher following ruminal pulse of SO compared with control 
and PHVO in plasma and lipoprotein fractions. EA was significantly higher following 
ruminal pulse of PHVO compared with control and SO treatments in plasma and 
lipoprotein fractions. This result is in agreement with observations in lipoprotein 
fractions by Meijer et al. (2001) in which EA and VA were supplemented in the diet 
of hamsters. In the current experiment, concentrations of tFA in plasma and 
lipoprotein fractions were significantly higher following ruminal pulse of SO 
compared with control and PHVO. This effect may be explained by the composition 
of the oils where SO had lower concentrations of VA and EA and the interaction 
effects of ruminal biohydrogenation. 
In the current experiment CLA 18:2 cis-9, trans-11 was too low to be detected in the 
HDL fraction, however, 18:2 cis-9, trans-11 was identified in plasma and 
LDL+VLDL but no difference was observed between control and treatments. The 
most predominant CLA isomer found in foods of ruminant origin is 18:2 cis-9, trans-
11. This CLA isomer is an intermediate in ruminal biohydrogenation of linoleic acid 
(Corl et al., 2002). 
 
2.4.2 Fatty acid composition of the lipoprotein lipids 
Ruminant plasma lipoprotein fractions are characterized by low concentrations of 
chylomicrons, VLDL and total TG, whereas more than 90% of plasma lipids are 
carried by HDL, mainly in the CE and PL lipid sub groups (Offer et al., 2001). In the 
current experiment concentrations of LDL+VLDL-TG appeared to be the major lipid 
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subgroups carrying plasma lipids. Because the LDL fraction contains 
chylomicrons/VLDL fractions, it is possible that TG found in the LDL fraction are 
associated with chylomicrons which contain dietary TG. 
In the current experiment, palmitic acid was increased in LDL+VLDL-TG compared 
with HDL. Palmitic acid is an important FA for the synthesis of triacylglycerol in the 
mammary gland (Hansen and Knudsen, 1987). Initiation of acylation of the sn-1 
position is a prerequisite for triacylglycerols synthesis, and palmitic acid is the most 
preferred substrate for the initial acylation of L-Į glycerolphosphate by 
acyltransferase to form sn-1-lysophosphatidic acid (Kinsella and Gross, 1973). It has 
been shown (Kinsella and Gross, 1973) that myristyl, stearyl, and oleyl coenzyme-A 
were rapidly acylated when sn-1-lysophosphatidic acid was used as a substrate, but 
were poorly acylated without the latter indicating that these FA are taken up mostly in 
the second step of triacylglycerol synthesis (Kadegowda et al., 2008). 
 
To study the transport of FA in bovine plasma, Offer et al. (2001) fed cows with 
dietary fish oil finding progressive milk depression from those cows supplemented 
with fish oil. They separated HDL, LDL and VLDL fractions and found that total 
lipids in the VLDL fraction were increased, although this did not reach statistical 
significance. The current experiment is different from Offer et al. (2001) because they 
used lactating cows, stage of lactation has an important effect on FA utilization 
needed to satisfy specific energy requirements and this may be reflected in the FA 
profile of lipoprotein lipid subgroups found in our experiment (non-lactating cows). 
Also, the current experiment involved release of treatments as ruminal pulses rather 
than supplementing oils in the diet. Despite the fact that the results are different from 
those of Offer et al. (2001), in the current experiment TG had the larger content of FA 
than CE and PL. That has implications for the theory that the ruminant mammary 
gland obtains FA required for assembly of milk lipids by the action of mammary 
lipoprotein lipase on the TG fraction of chylomicrons and VLDL.  
The difference between abomasal and ruminal pulses is probably another factor that 
may explain the variation in the concentrations of certain FA within each lipid sub 
group (Ashes et al., 2000; Offer et al., 2001). For example, DePeters et al. (2001) 
attributed changes in carbon number for TG structure to high concentrations of LCFA 
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and medium chain FA associated with canola oil infused either in the rumen or 
abomasum. 
In this experiment, PHVO pulse tended to increased VA in LDL+VLDL-TG, however, 
it did not reach significance. Because the mammary gland extracts FA primarily from 
TG fractions of plasma, FA in these LDL+VLDL lipid subgroups may possibly be 
available for milk synthesis in cows supplemented with PHVO. Increased in VA in 
LDL+VLDL-TG by PHVO might also be explained by the fact that concentrations of 
dietary or ruminally derived fatty acids in the major plasma lipid fractions are directly 
proportional to the amounts of fatty acids absorbed from the small intestine (Loor et 
al., 2002).  
2.4.3 Ruminal fermentation  
Sampling time had linear effect and decreased ruminal pH and acetate and linearly 
increased propionate. On the other hand, sampling time had quadratic effect on NH3-N, 
butyrate, isobutyrate, valerate and isovalerate. Those changes may indicate that 
dietary lipids had an impact on ruminal microflora affecting fermentation parameters.  
Dietary oil supplementation has been shown to affect ruminal fermentation in 
ruminants (Harfoot & Hazelwood, 1997). Yang et al. (2009) found that 
supplementation of soybean and linseed oils reduced the concentration of total VFA 
and increased ruminal NH3-N. Relatively few data exist relating to the effects of 
PHVO or SO on ruminal fermentation.  In the current experiment, ruminal pulses of 
both SO and PHVO had quadratic effect on ruminal NH3-N and total VFA 
concentrations, which suggests that dietary lipids inhibited microbial activity. Cieslak 
et al. (2009); supplemented linoleic acid on two rumen ciliate cultures (Entodinium 
caudatum and  Diploplastron affine) and reported a decreased in the concentration of 
ruminal NH3-N and no effects on total VFA concentration, methane production or 
concentration of acetate and butyrate in the Diploplastron affine culture. On the other 
hand, NH3-N was reduced in the Entodinium caudatum culture. Likewise, Hervas et al. 
(2008) found no difference in VFA and NH3-N in an in vitro study in which sunflower 
oil was incubated with ruminal fluid from dairy ewes. 
In agreement with the current experiment, Ivan et al. (2001) reported that NH3-N and 
total VFA concentrations were reduced in ruminal fluid of sheep supplemented with 
dietary sunflower seed oil compared with an unsupplemented diet. In the current 
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experiment, ruminal pulses of PHVO and SO affected VFA concentrations. It has 
been shown that dietary oils rich in saturated and unsaturated FA may reduce the 
number of ruminal protozoa both in vivo and in vitro, moreover, unsaturated C18 FA 
exert toxic effects on protozoan populations.  
Defaunation is known to decrease ruminal NH3-N which is related to decreased N 
recycling between bacteria, protozoa and ammonia pools resulting from engulfment 
and digestion of bacteria by protozoa. Another reason for the reduction of ruminal 
NH3-N is that there is an increase in demand for ammonia by ruminal bacteria that use 
it as substrate for cell synthesis (Dayani et al., 2007).   
Possibly a ruminal ecology (i.e., ruminal bacteria, fungi and protozoa) study would be 
a promising approach to truly understand how 18:1 trans isomers affect ruminal 
fermentation and bacterial populations.  
2.5 Conclusion 
The results of this experiment demonstrated that 18:1 tFA concentrations of plasma 
and lipoprotein fractions can be changed by altering dietary lipids. LDL+VLDL 
appears to be the main lipoprotein fraction involved in transportation of 18:1 trans 
isomers in bovine plasma. Overall, the current experiment demonstrates that dietary 
lipids rich in either PUFA or tFA can alter the rumen environment, and that both types 
of FA result in increased plasma and lipoprotein-fraction concentrations of tFA. The 
results therefore show how plasma FA profiles change when supplementary oils do 
not bypass the rumen and hence the lipids had extensive effects on rumen 
microorganisms, as indicated by concentrations of total VFA and ruminal NH3-N, and 
on the biohydrogenation process, as indicated by plasma and lipoprotein 18:1 trans 
isomers. Treatment effects are, therefore, in agreement with expectations from dietary 
supplementation of oils, but are independent of any effects of oil on palatability and 
feed intake data. 
2.6 Implications 
Although the results from this experiment suggests that the LDL+VLDL fraction is 
more responsive to supply of tFA and responsible for the transport of CLA isomers, 
further fractionation is required to distinguish between true LDL-fraction, 
chylomicrons and VLDL that are also present in this fraction.  
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In the current experiment concentrations of tFA were increased in both LDL+VLDL 
and HDL fractions suggesting that feeding cows with oils rich in UFA and tFA might 
produce milk with high concentrations of FA undesirable for human consumption and 
reduce intake of digestible energy (Harvatine and Allen, 2006), milk fat content and 
yield compared with typical diets (Griinari et al., 1998; Piperova et al., 2000; Peterson 
et al., 2003; Loor et al., 2005). On the other hand, recently, Brouwer et al. (2010) 
reported that all FA with a double bond in the trans configuration raise the ratio of 
plasma LDL to HDL regardless of FA origin (tFA industrially produced or from 
biohydrogenation in the rumen). However, findings from this experiment, shows that 
altering the supply of tFA from the rumen modifies the tFA content of LDL+VLDL 
fraction much more than HDL fraction. Thus if it were to alter tFA delivery to the 
mammary gland it is likely that it is through this fraction. 
 
Results from tFA content in plasma and lipoprotein fractions demonstrated that there 
are clear differences in their plasma transport that may exert an effect on mammary 
uptake and utilization of 18-carbon FA, and these results might be related to the 
location, orientation, and number of double bonds (Tyburczy et al., 2008). 
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CHAPTER 3 
3. Ruminal pulses of fatty acids in dairy cows: 2. Fish oil and partially 
hydrogenated vegetable oil 
 
3.1 Introduction 
Recently, nutritional recommendations for humans have emphasized the need to 
decrease intake of SFA and increase intakes of beneficial PUFA, in particular Į-
linolenic acid (18:3 n-3) and the LC-PUFA (20:5 n-3 and 22:6 n-3), in the diet (Lee et 
al., 2008). Ruminant products make an important contribution to the human diet but 
have caused concern due to their high SFA content. This is largely due to microbial 
biohydrogenation of dietary unsaturated fatty acids in the rumen, although some 
intermediates of biohydrogenation such as conjugated linolenic acid (CLA cis-9, 
trans-11) and 18:1 trans-11 (VA) could be important in human health (Lock and 
Bauman, 2004).  
 
It has been shown that fish oil (FO) either alone or in combination with vegetable oils 
results in increased concentrations of trans fatty acids (tFA) and CLA in duodenal 
fluid and milk fat tFA and CLA are intermediates in the rumen hydrogenation of 
PUFA (Lock and Bauman, 2004; Kim et al., 2008).  Moreover, inclusion of fish oil in 
lactating cow diets has been shown to increase CLA, VA and omega-3 fatty acids in 
milk fat (Abu-Ghazaleh et al., 2002). Fish oil has also been shown to interrupt the 
complete biohydrogenation of C18 PUFA, resulting in increased production of VA, 
the precursor for CLA (cis-9, trans-11) in the mammary gland (Piperova et al., 2002). 
 
The experiment reported in Chapter 2 demonstrated that pulses of partially 
hydrogenated vegetable oils (PHVO) or soya oil increased the tFA content of both 
HDL and LDL lipoprotein fractions, but responses varied according to fatty acid 
source. Because FO contains higher concentrations of long chain PUFA, compared 
with vegetable oils (Duckett and Gillis, 2010), it is hypothesized that differences in 
FA concentrations would be observed, particularly in C18:1 trans isomers and 18:2 
cis-9, trans-11, which would lead to differences in tFA concentrations of plasma and 
lipoprotein fractions. 
 
The objective of this experiment was to determine the effects of pulsing FO either 
alone or in combination with PHVO on plasma FA composition and to determine 
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which lipoprotein fractions are involved in tFA transport and whether there is a 
difference between tFA. This objective was achieved by comparing fatty acid profiles 
of plasma lipoprotein fractions in cows subjected to ruminal pulses of FO (to induce 
high concentrations of  18:1 tFA) or FO+PHVO (to induce high concentration of tFA). 
 
3.2 Materials and methods 
3.2.1 Animals and treatments 
Two non-lactating Holstein nuliparous cows, each with a rumen cannula were used in 
a 2 x 3 Crossover design with 3 d pulsing periods (adapted and modified from 
Kadegowda et al., 2008 and Castaneda-Gutierrez et al., 2007) followed by 4 d 
washout interval between treatments to minimize carryover effects  (Loor et al., 2005) 
(Figure 3.1).  
 
 
 
 
 
 
 
 
Figure 3.1: The experiment had three treatment periods, each followed by a 4-d washout interval. 
Cows were grouped in a 2 x 3 crossover design. 
Cows were treated with ruminal pulses of: 1) soya oil (SO; 250 ml/d in 500 ml/d of 
skimmed milk; SM) as control; 2) FO (250 g/d in 500 ml/d of SM) and 3) FO + 
PHVO (125 g/d FO + 125 g/d PHVO in 500 ml/d of SM). Fish oil was supplied by 
manufacturers (Rossyew Scotish Ltd.) and was based on salmon oil. Emulsions were 
prepared the day before each ruminal pulse (Ferlay and Doreau, 1992). To provide a 
homogenised release of treatments, skim milk was used (500 ml/d) to emulsify the oils 
(FO and FO+PHVO) using a laboratory mixer emulsifier (L2R Silverson, Machines 
Ltd., Waterside, Chesham, Bucks).  Before each pulsing time, emulsions were heated 
for 30 min at 60ºC using a water bath (Grant Y28, Cambridge Ltd., England). During 
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pulsing and sampling periods, cows were housed in tie stalls and had free access to 
water. Cows were fed a maintenance diet which comprised meadow hay (ad libitum) 
and a concentrate based on barley (25-40 g/kg), sugar beet pulp (8 g/kg) and wheat (8 
g/kg) and cane molasses (<5 g/kg), limestone flour (<5 g/kg), vitamins (<5 g/kg) and 
minerals (<5 g/kg) [1-2 kg/day at 12:00; Manor Farm Feeds (Owston) Ltd., Oakham].  
 3.2.2 Sampling, measurements and analyses 
Samples of ruminal fluid (50 ml) were collected from various parts of the rumen using 
a syringe screwed to a stainless tube. Ruminal fluid samples were collected prior to 
pulses (0 h) and at 1, and 3 h post pulsing during the 3 d collection periods. 
Immediately after fluid collection, 10 ml of ruminal fluid were used to determine pH 
by using a pH meter (Piccolo Plus, HI 1295, Hanna Instruments, Portugal). Samples 
were frozen (-20ºC) for later analysis. See Chapter 2 for ruminal VFA and NH3-N 
sample preparation and calculations. 
Blood samples (20 ml) were obtained via jugular catheter prior to the pulse (0 h), 1, 
and 3 h after pulse during the last day of each collection period for lipoprotein 
fractionation. Blood was transferred to tubes containing EDTA and immediately 
centrifuged for 10 min at 3,000 x g (Centaur 2 MSE, Milton Keynes, England) for 
harvesting plasma. Plasma samples for lipoprotein fractionation were obtained during 
the last day of each collection period. Plasma was ultracentrifuged at 39,000 x g for 
16h at a density of 1.006 g/ml (to remove VLDL fraction) and 20 h at a density of 
1.063 g/ml (to separate LDL and HDL fractions) at 12ºC using a Beckman XL-70 
ultracentrifuge. Another 20 ml plasma sample were collected and stored at -20ºC for 
analysis of FA profile. See Chapter 2 for more details on the sequential separation of 
lipoprotein fractions. Concentrations of lipoprotein fractions in plasma (LDL and 
HDL fractions) were determined using a Clinical Chemistry Autoanalyzer (Rx Imola; 
Randox Laboratories, Ltd.). 
Lipids from plasma, HDL, LDL, and VLDL fractions were extracted by adaptation of 
the method by Bligh and Dyer (1959) and methylated according to the method of 
Christie (1982) with modifications by Chouinard et al. (1999). For more details see 
Chapter 2. The lipid classes (triacylglycerol, phospholipid, and cholesteryl ester) of 
the lipoprotein fractions were isolated by thin layer chromatography, and their 
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constituent FA were analysed by capillary column GC as described previously for 
plasma and lipoprotein fractions. See Chapter 2 for methodology of TLC.  
3.2.3. Statistical analysis  
Using the GenStat 12
th
 statistical package (VSN International Ltd., Oxford), data were 
analyzed as a 2 x 3 crossover design with fixed effects of treatments, periods and 
sampling times; cow was included as a random effect to allow for repeated measures. 
Fatty acid composition of lipid subgroups within lipoproteins was analysed using a 
Factorial design based on treatments (3), fractions (3) and lipids (3). Diurnal 
variations were analysed as Factorial design using POLYANOVA based on days (3) 
and sampling times (3). Data are reported as least square mean ± SED.  
3.3 Results 
3.3.1 Treatment composition 
The FO/PHVO+SM blend contained higher concentrations of saturated (19 g/100g), 
MUFA  (43 g/100g), UFA (MUFA+PUFA)  (48 g/100g) and trans (19 g/100g) fatty 
acids and lower concentrations of polyunsaturated (5 g/100g) and long chain (8 
g/100g) fatty acids than FO+SM. Concentrations of VA (3 g/100g) and EA (9 g/100g) 
were higher in FO/PHVO+SM compared with FO+SM (Table 3.1). 
3.3.2 Ruminal fermentation parameters 
There was no difference between treatments in ruminal NH3-N and total VFA 
concentrations. Compared with control, FO and FO+PHVO resulted in higher 
concentrations of propionate (Table 3.2). 
 
3.3.3 Plasma samples and treatment effect 
Compared with control, all treatments resulted in lower concentration of SFA in 
plasma. Compared with control and FO, FO+PHVO resulted in higher concentrations 
of SFA in VLDL fraction; higher concentrations of MUFA in plasma and lipoprotein 
fractions; higher concentrations of UFA in plasma, LDL and VLDL fractions; and 
higher concentrations of tFA in plasma and VLDL fraction.   Compared with control 
and FO+PHVO, FO resulted in higher concentrations of PUFA in plasma and higher 
concentrations of LCFA in plasma, HDL and VLDL fractions (Table 3.3). 
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Treatment significantly affected concentrations of some 18:1 trans isomers in plasma. 
Compared with control and FO, FO+PHVO resulted in higher concentrations of  18:1 
trans 5, trans 6-8, trans 9, trans 10, trans 11, trans 12, cis 9, trans 15 and 18:2n trans 
6 (Table 3.4). 
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Table 3.1 Fatty acid composition of oils and skimmed milk emulsions used for 
ruminal pulses 
 Control      Oils        Treatments
 4 
      
Fatty acid  
(g/100 g) 
SO+SM
1 
FO
2 
SO PHVO
3 
FO+SM
 
FO/PHVO+SM
 
       
10:0  - 0.05 0.05 - - - 
11:0 - 0.12 - - 0.06 - 
12:0 - 0.09 - 0.42 0.06 0.25 
14:0 0.11 2.75 0.27 0.29 3.57 2.74 
14:1  - 0.07 - - 0.06 - 
15:0 - 0.22 - - 0.37 0.21 
16:0 9.84 6.81 11.55 8.24 8.43 10.15 
16:1 0.00 3.59 - - 4.05 3.25 
17:0 0.17 0.20 - - 0.21 0.18 
17:1 - 1.28 - - 0.72 0.12 
18:0 3.65 1.61 4.18 8.11 1.99 5.18 
18:1 trans-4 - - - 0.86 - 0.13 
18:1 trans-5 - - - 1.43 - 0.34 
18:1 trans-6-8 - - - - - 0.58 
18:1 trans-9  - - - 22.66 - 8.97 
18:1 trans-10 - - - - - 3.09 
18:1 trans-11 - 0.35 - 15.12 0.44 3.18 
18:1 trans-12 - 0.42 - 7.25 0.50 2.92 
18:1 cis-9 19.54 11.14 20.69 15.07 13.87 18.63 
18:2 n-trans 6 - - - 0.17 - - 
18:2 n-cis 6 48.73 3.68 52.12 0.55 4.85 3.75 
20:0 0.32 0.12 0.45 0.87 0.20 0.46 
18:3 n-6 - - - - 0.11 0.09 
20:1 - 1.48 - 0.19 1.81 2.18 
18:3 n-3 6.22 2.31 6.84 - 2.73 1.45 
18:2 cis-9, trans-11 - 1.08 - - 1.42 0.94 
20:2 - 0.39 - - 0.43 0.36 
22:0 0.35 - 0.41 0.55 - 0.27 
20.5 n-3 - 7.34 - - 10.32 5.34 
24:0 - 0.14 - 0.14 0.19 - 
22:6 n-3 - 8.48 0.21 - 9.21 8.05 
Saturated 14.45 12.11 16.86 18.61 15.08 19.45 
Monounsaturated 19.54 18.32 21.00 62.59 21.44 43.39 
Polyunsaturated 54.95 21.81 59.17 0.72 17.90 5.29 
Unsaturated (Mono+PUFA) 74.49 40.13 80.17 63.31 29.13 48.67 
Trans - 0.76 - 47.50 0.94 19.22 
Long chain fatty acids 0.63 35.04 0.63 4.02 22.86 8.25 
Unidentified
5 
11.06 11.96 2.34 18.07 21.78 4.40 
       
1
SO+SM = Soya oil + skim milk; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Single administration per day;
 5
Fatty acids < 0.03 g / 100g. 
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Table 3.2  Effects of treatments on ruminal fermentation parameters  
 Control Treatments
6 
  
      
Parameters SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
      
pH 6.3
b
 6.5
a
 6.3
b
 0.05 0.002 
NH3-N,  mM 19 12 14 2.8 0.074 
VFA, mM 84 81 73 9.4 0.508 
  Acetate 66 65 65 1.0 0.250 
  Propionate 29.3
b
 30.8
a
 31.6
a
 0.54 <0.001 
  Butyrate 16.3 17.3 16.3 0.56 0.117 
  Isobutyrate 1.7 1.8 1.8 0.08 0.545 
  Valerate 1.6 1.7 1.5 0.14 0.507 
  Isovalerate 2.3 2.5 2.2 0.17 0.173 
      
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect;
 6
Single administration 
per day; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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Table 3.3 Treatment effects on major fatty acid classes in plasma and lipoprotein 
fractions 
  Control Treatments
6 
  
       
Fatty acid, g/100 g Fraction SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
       
Saturated Plasma 40.6
a
 37.6
b
 38.2
b
 0.61 <0.001 
 HDL 38.5 36.7 37. 3.10 0.839 
 LDL 46.6 35.9 37.3 6.82 0.287 
 VLDL 44.4
a
 40.0
b
 44.6
a
 1.41 0.020 
Monounsaturated Plasma 20.8
a
 19.4
b
 24.7
a
 0.83 <0.001 
 HDL 23.8
b
 20.7
c
 26.5
a
 0.75 <0.001 
 LDL 16.2
b
 8.2
c
 21.1
a
 2.04 <0.001 
 VLDL 17.4
c
 22.4
b
 26.8
a
 1.24 <0.001 
Polyunsaturated Plasma 24.2
b
 27.2
a
 23.9
b
 0.74 <0.001 
 HDL 24.5 26.7 24.0 1.56 0.247 
 LDL 14.4 10.2 12.4 2.96 0.416 
 VLDL 11.5 14.5 11.5 1.50 0.141 
Unsaturated Plasma 45.1
b
 46.6
b
 48.6
a
 0.77 <0.001 
(Mono+PUFA) HDL 48.3 47.4 50.5 1.16 0.067 
 LDL 30.7
a
 18.5
b
 33.5
a
 3.58 0.007 
 VLDL 29.0
b
 36.9
a
 38.4
a
 2.32 0.008 
Trans Plasma 3.5
b
 3.8
b
 4.9
a
 0.57 0.046 
 HDL 4.4 5.3 5.7 1.02 0.489 
 LDL 3.7 2.0 6.0 1.68 0.114 
 VLDL 4.8
b
 9.2
a
 10.4
a
 0.85 <0.001 
Long chain fatty acids Plasma 0.8
b
 1.1
a
 0.8
b
 0.08 <0.001 
 HDL 0.7
b
 1.4
a
 0.9
b
 0.22 0.045 
 LDL 2.5 3.8 1.1 1.93 0.431 
 VLDL 1.3
a
 1.6
a
 0.9
b
 0.21 0.029 
Unidentified Plasma 12.3 12.6 12.0 0.59 0.349 
 HDL 13.1 15.8 12.1 4.23 0.674 
 LDL 7.0 7.6 13.6 8.54 0.277 
 VLDL 26.4
a
 22.5
a
 16.6
b
 2.77 0.022 
       
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect; 
6
Single administration 
per day; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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Table 3.4 Fatty acid distribution in plasma  
 Control Treatments6   
      
Fatty acid, g/100 g SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
      
10:0 2.3
a
 0.8
b
 0.1
b
 0.54 <0.001 
12:0 0.2 0.3 0.08 0.21 0.450 
13:0 0.2 0.2 0.08 0.08 0.096 
14:0 0.4 0.4 0.3 0.08 0.328 
14:1 0.3
a
 0.2
b
 0.3
a
 0.06 0.041 
15:0 0.7
b
 0.7
b
 0.8
a
 0.04 0.014 
15:1 0.1
b
 0.1
a
 0.09
b
 0.02 0.014 
16:0 14.4
a
 13.1
b
 13.9
a
 0.36 0.002 
16:1 1.1
b
 1.1
b
 1.3
a
 0.07 <0.001 
17:0 1.0
b
 1.2
a
 1.2
a
 0.05 0.004 
17:1 0.4
a
 0.3
b
 0.5
a
 0.04 0.023 
18:0 20.1 19.9 20.7 0.61 0.410 
18:1 trans-5 0.1 0.1 0.1 0.04 0.669 
18:1 trans-6-8 0.1
b
 0.1
b
 0.2
a
 0.01 <0.001 
18:1 trans-9  0.3
b
 0.1
b
 0.5
a
 0.09 <0.001 
18:1 trans-10 0.2
b
 0.2
b
 0.4
a
 0.05 <0.001 
18:1 trans-11 1.7 1.5 1.9 0.26 0.412 
18:1 trans-12 0.3
c
 0.4
b
 0.6
a
 0.09 0.007 
18:1 cis-9 13.8
b
 12.4
c
 15.8
a
 0.41 <0.001 
18:1 trans-15 1.1
b
 1.1
b
 1.2
a
 0.05 0.027 
18:1 cis-11 0.3
b
 0.2
b
 0.4
a
 0.05 0.003 
18:1 cis-12 0.1 0.1 0.2 0.03 0.871 
18:1 cis-13 0.1 0.1 0.1 0.02 0.589 
18:1 cis-14+ trans-15 0.2
b
 0.3
a
 0.2
b
 0.03 0.006 
18:2n-trans 6 0.1
b
 0.1
a
 0.1
a
 0.02 0.013 
18:2n-cis 6 11.0 11.5 10.8 0.53 0.455 
20:0 0.1 0.09 0.1 0.03 0.043 
18:3n6 0.07 0.1 0.1 0.01 0.004 
20:1 0.05
b
 0.1
a
 0.1
a
 0.02 <0.001 
18:3n3 1.7 1.7 1.7 0.07 0.595 
18:2 cis-9, trans-11 0.3
a
 0.2
c
 0.3
b
 0.01 <0.001 
20:2 0.1 0.2 0.2 0.04 0.421 
22:0 0.1 0.1 0.1 0.02 0.094 
20:3n6 2.4
a
 2.7
a
 2.1
b
 0.15 <0.001 
22:1n9 0.08
b
 0.09
b
 0.1
a
 0.02 0.011 
20:3n3 0.00 0.02 0.04 0.01 0.175 
20:4n6 6.0
b
 6.6
a
 5.9
b
 0.18 0.001 
23:0 0.2 0.1 0.2 0.07 0.807 
22:2 0.2 0.2 0.1 0.09 0.302 
24:0 0.00
b
 0.06
a
 0.05
a
 0.01 0.008 
20:5n3 1.5
b
 2.6
a
 1.6
b
 0.18 <0.001 
24:1 0.4 0.4 0.3 0.05 0.168 
22:6n3 0.8
b
 1.1
a
 0.8
b
 0.08 <0.001 
      
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect;
 6
Single administration 
per day; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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3.3.4 Lipoprotein fractions and treatments effects 
No effect of treatments was observed on plasma concentrations of lipoprotein 
fractions (Table 3.5). Compared with control and FO, FO+PHVO resulted in higher (P 
< 0.05) concentrations of 18:1 trans 9 and trans 12 in the HDL fraction (Table 3.6). 
Compared with control and FO, FO+PHVO resulted in higher (P < 0.05) 
concentrations of EA in the LDL fraction (Table 3.7). Compared with control and FO, 
FO+PHVO resulted in higher (P < 0.05) concentrations of 18:1 trans 5, trans 9 and 
trans 12 in the VLDL fraction (Table 3.8). 
Significant interactions (P < 0.05) between treatments and lipoprotein fractions were 
observed in concentrations of 18:1 trans 4 and trans 11. Compared with control and 
FO+PHVO, FO resulted in higher concentrations of 18:1 trans 4 in the HDL and LDL 
fractions. Compared with control and FO+PHVO, FO resulted in higher 
concentrations of 18:1 trans 11 in the HDL and VLDL fractions (Table 3.9).  
Table 3.5 Concentrations of HDL and LDL+VLDL fractions in plasma 
 Control Treatments
6 
  
      
Parameters (mg/l) SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
      
HDL 0.9 0.9 1.0 0.06 0.230 
LDL+VLDL 0.3 0.2 0.2 0.02 0.107 
      
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect; 
6
Single administration 
per day. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
84 
Table 3.6 Fatty acid distribution in the HDL fraction 
 Control Treatments
6 
  
Fatty acid, g/100 g SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
      
10:0 0.1 0.1 0.1 0.02 0.554 
11:0 0.09 0.1 0.09 0.00 0.171 
12:0 0.1 0.1 0.1 0.03 0.781 
13:0 0.1 0.1 0.1 0.03 0.241 
14:0 0.2 0.1 0.1 0.02 0.503 
14:1 0.3 0.2 0.3 0.20 0.996 
15:0 0.9 0.9 0.9 0.08 0.880 
15:1 0.5 0.4 0.5 0.39 0.988 
16:0 13.7 12.9 13.3 1.12 0.771 
16:1 0.9 1.0 1.1 0.16 0.398 
17:0 0.9 1.2 1.0 0.24 0.387 
17:1 0.4 0.3 0.2 0.10 0.346 
18:0 20.7 19.1 19.8 1.88 0.719 
18:1 trans-4 0.2 0.6 0.2 0.27 0.287 
18:1 trans-5 0.8 0.5 0.8 0.80 0.939 
18:1 trans-9  0.2
b
 0.2
b
 0.5
a
 0.04 <0.001 
18:1 trans-11 1.5 1.8 1.5 0.20 0.201 
18:1 trans-12 0.3
b
 0.5
a
 0.6
a
 0.10 0.017 
18:1 cis-9 15.7
a
 11.7
b
 17.1
a
 1.62 0.026 
18:1 trans-15 1.1 1.3 1.3 0.14 0.388 
18:1 cis-11 0.4
a
 0.2
b
 0.5
a
 0.06 0.004 
18:1 cis-12 0.4 0.3 0.3 0.13 0.730 
18:1 cis-13 - 0.2 0.2 0.02 0.074 
18:2n-trans 6 0.02 0.07 0.06 0.05 0.543 
18:2n-cis 6 10.9 9.3 9.3 0.83 0.164 
20:0 0.02 0.02 0.06 0.04 0.554 
18:3n6 0.7 0.3 0.5 0.73 0.831 
20:1 0.1 0.1 0.04 0.06 0.103 
18:3n3 1.3 1.2 1.3 0.11 0.417 
18:2 cis-9, trans-11 0.4
a
 0.2
b
 0.5
a
 0.06 0.013 
20:2 0.2
b
 0.5
a
 0.4
b
 0.09 0.013 
22:0 0.1
a
 0.1
a
 0.1
b
 0.01 0.010 
20:3n6 2.6 3.0 2.3 0.25 0.079 
22:1n9 0.3 0.4 0.1 0.19 0.361 
20:3n3 - 0.03 0.2 0.18 0.438 
20:4n6 6.1 6.4 5.8 0.55 0.621 
23:0 0.9 1.3 0.7 0.35 0.367 
22:2 0.6 1.1 1.1 0.44 0.398 
24:0 0.03 0.04 0.03 0.03 0.924 
20:5n3 1.3
b
 3.0
a
 1.7
b
 0.35 0.004 
24:1 0.2 0.2 0.2 0.11 0.983 
22:6n3 0.7
b
 1.4
a
 0.9
b
 0.21 0.045 
      
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect; 
6
Single administration 
per day; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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Table 3.7 Fatty acid distribution in the LDL fraction 
 Control Treatments
6 
  
Fatty acid, g/100 g SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
      
10:0 2.3
b
 4.2
a
 2.0
b
 0.60 0.004 
13:0 2.0 2.6 0.7 1.76 0.634 
14:0 1.3 1.3 0.3 1.22 0.682 
15:0 9.6 13.0 5.5 3.55 0.168 
16:0 12.3
a
 6.9
b
 12.3
a
 1.65 0.017 
16:1 0.5
a
 0.00
b
 0.8
a
 0.22 0.015 
17:0 0.3 0.1 0.7 0.27 0.117 
18:0 19.7
a
 8.0
b
 16.9
a
 2.77 0.007 
18:1 trans-4 0.1 1.3 0.4 0.24 0.066 
18:1 trans-9  0.1
b
 0.1
b
 0.2
a
 0.18 0.004 
18:1 trans-11 3.1 1.0 2.4 1.17 0.235 
18:1 trans-12 0.5 0.8 0.9 0.06 0.052 
18:1 cis-9 9.1
a
 3.1
b
 11.1
a
 1.32 <0.001 
18:1 trans-15 0.9 0.4 0.9 0.11 0.053 
18:1 cis-11 0.5 0.5 0.5 0.21 0.753 
18:2n-cis 6 6.5
a
 1.7
c
 5.0
b
 0.98 0.003 
18:3n6 1.7 1.5 0.5 0.85 0.571 
20:1 - - 0.1 0.07 0.250 
18:3n3 0.8
a
 0.00
b
 0.6
a
 0.15 <0.001 
20:2 0.1 0.2 0.2 0.17 0.971 
22:0 - - 0.1 0.08 0.169 
20:3n6 0.7
b
 0.1
b
 1.1
a
 0.30 0.037 
22:1n9 0.4 0.7 0.2 0.37 0.510 
20:3n3 - - 0.3 0.23 0.246 
20:4n6 2.5 2.1 2.2 1.07 0.926 
23:0 0.4 0.8 0.1 0.49 0.428 
22:2 0.1 0.6 0.4 0.34 0.415 
24:0 0.02 0.0 0.03 0.05 0.853 
20:5n3 0.3 0.4 0.9 0.39 0.379 
24:1 2.4 2.4 2.0 0.84 0.910 
22:6n3 2.5 3.8 1.1 1.94 0.431 
      
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect; 
6
Single administration 
per day; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
86 
Table 3.8 Fatty acid distribution in the VLDL fraction 
 Control Treatments
6 
  
Fatty acid, g/100 g SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
      
10:0 0.7 0.5 0.3 0.16 0.116 
11:0 0.7 0.3 0.4 0.13 0.077 
12:0 1.2
a
 0.6
b
 0.6
b
 0.20 0.018 
13:0 0.6
a
 0.2
b
 0.3
b
 0.11 0.037 
14:0 1.5 1.4 1.4 0.19 0.965 
15:0 6.0
a
 3.4
b
 3.6
b
 0.81 0.022 
15:1 0.5 0.5 0.7 0.15 0.600 
16:0 14.0 15.3 16.7 0.80 0.032 
16:1 1.6 1.6 1.7 0.22 0.870 
17:0 0.3
b
 1.0
a
 0.9
a
 0.22 0.038 
17:1 0.07 0.1 0.2 0.11 0.241 
18:0 16.2 14.5 17.1 1.44 0.254 
18:1 trans-4 1.8
a
 0.9
b
 0.9
b
 0.31 0.030 
18:1 trans-5 0.3
b
 0.3
b
 1.4
a
 0.15 0.027 
18:1 trans-9  0.1
b
 0.7
b
 1.3
a
 0.33 0.028 
18:1 trans-11 2.7
b
 4.6
a
 3.9
a
 0.55 0.020 
18:1 trans-12 0.7
c
 1.1
b
 1.4
a
 0.10 0.002 
18:1 cis-9 7.7
b
 8.5
b
 11.9
a
 0.91 0.004 
18:1 trans-15 1.5 1.4 1.4 0.04 0.055 
18:1 cis-11 0.3 0.3 0.4 0.07 0.488 
18:1 cis-12 0.1 0.3 0.4 0.03 0.129 
18:2n-cis 6 4.3 4.6 4.2 0.63 0.838 
20:0 0.7 0.6 1.1 0.62 0.670 
18:3n6 1.7
a
 0.7
b
 0.8
b
 0.32 0.035 
20:1 0.01
c
 0.7
a
 0.3
b
 0.12 0.001 
18:3n3 0.5
b
 1.2
a
 1.0
a
 0.19 0.018 
20:2 0.2 0.3 0.08 0.13 0.224 
22:0 0.06 0.2 0.3 0.09 0.081 
20:3n6 1.0 1.0 0.7 0.53 0.752 
22:1n9 1.5
a
 0.7
b
 0.4
b
 0.30 0.014 
20:3n3 0.1
b
 0.4
a
 0.5
a
 0.13 0.031 
20:4n6 1.9 2.3 1.9 0.40 0.535 
23:0 0.8 0.7 0.9 0.48 0.883 
22:2 0.1 0.5 0.2 0.15 0.106 
24:0 - 1.0 0.02 0.03 0.059 
20:5n3 0.3
b
 2.0
a
 1.1
b
 0.37 0.005 
24:1 1.2
a
 0.6
b
 0.4
b
 0.25 0.027 
22:6n3 1.3
a
 1.6
a
 0.9
b
 0.21 0.029 
      
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect; 
6
Single administration 
per day; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05).  
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Table 3.9 Interactions between treatments and lipoprotein fractions for concentrations 
of 18:1 trans isomers 
  Control Treatments6   
Fatty acid 
g/100 g 
Fraction SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
       
18:1 trans-4 HDL 0.2
b 
0.6
a 
0.2
b 
0.30 0.049 
 LDL 0.7
b 
1.1
a 
0.4
b 
  
 VLDL 1.8
a 
0.9
b 
0.9
b 
  
18:1 trans-5 HDL 0.8 0.5 0.8 0.64 0.254 
 LDL - - 0.8   
 VLDL - 0.2 1.5   
18:1 trans-9  HDL 0.2 0.2 0.5 0.21 0.089 
 LDL 0.08 0.08 0.8   
 VLDL 0.1 0.7 1.3   
18:1 trans-11 HDL 1.5
b 
1.8
a 
1.5
b 
0.75 0.014 
 LDL 3.1
a 
1.0
b 
2.4
b 
  
 VLDL 2.7
b 
4.6
a 
3.9
a 
  
18:1 trans-12 HDL 0.3 0.5 0.6 0.15 0.270 
 LDL 0.5 0.5 0.9   
 VLDL 0.7 1.1 1.4   
18:1 trans-15 HDL 1.1 1.3 1.3 0.13 0.407 
 LDL 0.8 0.8 0.9   
 VLDL 1.4 1.4 1.4   
18:2n-trans 6 HDL 0.01 0.07 0.06 0.05 0.228 
 LDL 0.1 0.2 0.2   
 VLDL 0.3 0.3 0.4   
       
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of fraction-treatment effect; 
6
Single 
administration per day; 
a,b,c
 Means in the same row with different superscripts are different (P<0.05). 
 
3.3.5 Total amount of trans fatty acids in lipoprotein fractions 
Compared with control and FO, FO+PHVO resulted in higher (P < 0.05) total amount 
(mg/l) of trans fatty acids in the VLDL fraction (Table 3.10).  
Table 3.10 Treatment effects on trans fatty acids in lipoprotein fractions 
Fatty acid Fraction SO
1 
FO
2 
FO/PHVO
3 
SED
4 
P-value
5 
       
mg/l HDL 26 31 33 1.1 0.315 
 LDL 7 3 14 1.0 0.110 
 VLDL 9
c 
29
b 
33
a 
1.8 0.032 
       
1
SO = Soya oil; 
2
FO = Fish oil; 
3
PHVO = Partially hydrogenated vegetable oil; 
4
Standard errors of 
differences of means; 
5
P-value represents the probability of a treatment effect; 
6
Single administration 
per day. 
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3.3.6 Fatty acid composition of lipid subgroups within lipoproteins 
Concentrations (mg/l) of total lipid were not affected by treatment but were higher in 
HDL-TG. 16:0 was not affected by treatments but higher in VLDL-CE. 18:0 was 
higher in LDL than HDL and VLDL fractions. 18:1 trans-9 was not affected by 
treatments but higher in LDL-CE. 18:1 trans-11 was not affected by treatments but 
higher in TG than CE and PL subgroups. Compared with control and FO, FO+PHVO 
increased the concentration of oleic acid in HDL-PL (Table 3.11a). 
18:2 trans-6 was not affected by treatments but higher in CE than TG and PL 
subgroups. 18:2 cis-6 was not affected by treatments but higher in HDL-TG. 18:3n6 
was not affected by treatments but higher in CE than in TG and PL subgroups. 18:3n3 
was not affected by treatments but higher in HDL-TG.Compared with control and 
FO+PHVO, FO increased 20:3n6 in LDL-CE and increased 20:5n3 in LDL-TG. 
Compared with FO and FO+PHVO, SO increased 22:6n3 in VLDL-CE (Table 3.11b). 
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Table 3.11a Lipid concentration and fatty acid content (g/100g) in lipid subgroups of 
each lipoprotein fraction of plasma from cows subjected to ruminal pulses  
     SED P-value 
Total lipid Treatment SO FO FO+PHVO   
(mg / ml)  573 675 683 50.6 0.056 
 Fraction HDL LDL VLDL   
  714
a 
586
b 
631
b 
50.6 0.041 
 Lipid CE PL TG   
  658
b 
406
c 
867
a 
50.6 <0.001 
16:0 Treatment SO FO FO+PHVO   
  20.3 20.9 20.3 0.69 0.604 
 Fraction HDL LDL VLDL   
  20.1
b 
19.9
c 
21.5
a 
0.69 0.038 
 Lipid CE PL TG   
  22.3
a 
19.9
b 
19.3
b 
0.69 <0.001 
18:0 Treatment SO FO FO+PHVO   
  24.6
a 
23.0
b 
23.0
b 
0.66 0.022 
 Fraction HDL LDL VLDL   
  21.3
c 
26.0
a 
23.2
b 
0.66 <0.001 
 Lipid CE PL TG   
  24.3 23.4 22.9 0.66 0.098 
18:1  Treatment SO FO FO+PHVO   
trans 9  1.7 2.0 1.7 0.18 0.260 
 Fraction HDL LDL VLDL   
  1.9
b 
2.2
a 
1.3
c 
0.18 <0.001 
 Lipid CE PL TG   
  2.6
a 
1.0
c 
1.9
b 
0.18 <0.001 
18:1  Treatment SO FO FO+PHVO   
trans 11  2.3 2.3 1.9 0.19 0.172 
 Fraction HDL LDL VLDL   
  2.1 2.1 2.3 0.19 0.614 
 Lipid CE PL TG   
  2.4
b 
0.9
c 
3.1
a 
0.19 <0.001 
18:1 cis 9 Treatment SO FO FO+PHVO   
  5.7
b 
5.4
b 
6.7
a 
0.35 <0.001 
 Fraction HDL LDL VLDL   
  7.1
a 
6.4
b 
4.4
c 
0.35 <0.001 
 Lipid CE PL TG   
  2.8
c 
10.0
a 
5.1
b 
0.35 <0.001 
       
1SO = Soya oil; 2FO = Fish oil; 3FO+PHVO = Partially hydrogenated vegetable oil; HDL = High density lipoprotein; 
LDL = Low density lipoprotein; VLDL = Very low density lipoprotein. CE = Cholesteryl ester; TC = triglyceride; PL 
= Phospholipid; a,b,c 
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Table 3.11b Fatty acid content (g/100g) in lipid subgroups of each lipoprotein fraction 
of plasma from cows subjected to ruminal pulses  
     SED P-value 
18:2  Treatment SO FO FO+PHVO   
trans 6  2.0 1.9 1.9 0.14 0.530 
 Fraction HDL LDL VLDL   
  1.9 2.0 2.0 0.14 0.438 
 Lipid CE PL TG   
  2.7
a 
1.7
b 
1.5
c 
0.14 <0.001 
18:2 cis 6 Treatment SO FO FO+PHVO   
  4.4 4.8 5.1 0.45 0.348 
 Fraction HDL LDL VLDL   
  9.7
a 
4.8
b 
0.1
c 
0.45 <0.001 
 Lipid CE PL TG   
  0.8
c 
5.4
b 
8.1
a 
0.45 <0.001 
18:3n6 Treatment SO FO FO+PHVO   
  2.7 3.0 2.4 0.43 0.292 
 Fraction HDL LDL VLDL   
  2.6 3.2 2.3 0.43 0.075 
 Lipid CE PL TG   
  4.0
a 
1.4
c 
2.6
b 
0.43 <0.001 
18:3n3 Treatment SO FO FO+PHVO   
  2.0 2.1 2.1 0.09 0.688 
 Fraction HDL LDL VLDL   
  3.2
a 
1.8
b 
1.2
c 
0.09 <0.001 
 Lipid CE PL TG   
  2.3
b 
0.8
c 
3.2a
 
0.09 <0.001 
20:3n6 Treatment SO FO FO+PHVO   
  1.6
b 
1.7
a 
1.4
c 
0.08 0.010 
 Fraction HDL LDL VLDL   
  1.6
b 
1.9
a 
1.2
c 
0.08 <0.001 
 Lipid CE PL TG   
  2.1
a 
1.3
c 
1.4
b 
0.08 <0.001 
20:5n3 Treatment SO FO FO+PHVO   
  1.1
c 
1.7
a 
1.1
b 
0.07 <0.001 
 Fraction HDL LDL VLDL   
  1.5
a 
1.5
a 
0.8
b 
0.07 <0.001 
 Lipid CE PL TG   
  1.3
b 
1.1
c 
1.4
a 
0.07 <0.001 
22:6n3 Treatment SO FO FO+PHVO   
  4.9
a 
3.0
b 
3.9
b 
0.48 0.001 
 Fraction HDL LDL VLDL   
  1.3
c 
3.2
b 
7.3
a 
0.48 <0.001 
 Lipid CE PL TG   
  4.3
a 
4.0
b 
3.4
b 
0.48 0.145 
       
1SO = Soya oil; 2FO = Fish oil; 3FO+PHVO = Partially hydrogenated vegetable oil; HDL = High density lipoprotein; 
LDL = Low density lipoprotein; VLDL = Very low density lipoprotein. CE = Cholesteryl ester; TC = triglyceride; PL 
= Phospholipid; a,b,c Means down column with different superscripts are different (P<0.05).
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3.3.7 Diurnal and daily variations in plasma and lipoprotein fractions on trans fatty 
acids 
In general, sampling day affected tFA of plasma and lipoprotein fractions after cows 
were ruminally pulsed. Plasma concentrations of all 18:1 trans isomers linearly 
increased and were higher on Day 3 than on Day 1 and 2 except for 18:1 trans-9. 
Plasma concentrations of all 18:1 trans isomers were not affected by time of sampling 
(Table 3.12). HDL concentrations of all 18:1 trans isomers were not affected by time 
of sampling (Table 3.13). LDL concentrations of all 18:1 trans isomers were not 
affected by time of sampling except for 18:1 trans-9 (Table 3.14).  VLDL 
concentrations of all 18:1 trans isomers were not affected by time of sampling except 
for 18:1 trans-12 (Table 3.15).   
 
Table 3.12 Day and sampling time (h) effects in plasma trans fatty acids 
Fatty acid, 
g/100 g 
    SED
3
 P-
value
4
 
(Lin)
5 
(Quad)
6 
         
18:1 trans-9 D
1 
1 2 3     
  0.2
c 
0.2
b 
0.3
a 
0.03 0.049 0.028 0.247 
 T
2 
09:00 10:00 12:00     
  0.2 0.3 0.2 0.03 0.321 0.302 0.271 
18:1 trans-10 D 1 2 3     
  0.2
c 
0.2
b 
0.3
a 
0.03 0.012 0.004 0.620 
 T 09:00 10:00 12:00     
  0.2 0.2 0.3 0.03 0.621 0.358 0.757 
18:1 trans-11 D 1 2 3     
  1.1
c 
1.7
b 
2.2
a 
0.09 <0.001 <0.001 0.602 
 T 09:00 10:00 12:00     
  1.6 1.7 1.7 0.09 0.774 0.528 0.742 
18:1 trans-12 D 1 2 3     
  0.3
c 
0.4
b 
0.6
a 
0.03 <0.001 <0.001 0.765 
 T 1 2 3     
  0.4 0.4 0.4 0.03 0.971 0.855 0.876 
18:2 n-trans 6 D 1 2 3     
  0.06
c 
0.08
b 
0.13
a 
0.01 0.004 0.001 0.340 
 T 09:00 10:00 12:00     
  0.08 0.09 0.12 0.01 0.273 0.113 0.805 
         
1
Day; 
2
Time; 
3
Standard errors of differences of means; 
4
P-value represents the probability of a 
treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken during the 3 d collection period 
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Table 3.13 Sampling time (h) effect in the HDL fraction trans fatty acids 
Fatty acid, 
g/100 g 
   SED
1
 P-value
2
 (Lin)
5 
(Quad)
6 
        
18:1 trans-4 09:00 10:00 12:00     
 0.2 0.3 0.6 0.20 0.441 0.233 0.708 
18:1 trans-5 09:00 10:00 12:00     
 0.8 0.1 1.1 0.79 0.497 0.522 0.330 
18:1 trans-9 09:00 10:00 12:00     
 0.3 0.3 0.3 0.03 0.896 0.702 0.801 
18:1 trans-11 09:00 10:00 12:00     
 1.6 1.7 1.6 0.16 0.817 0.871 0.548 
18:1 trans-12 09:00 10:00 12:00     
 0.4 0.5 0.5 0.06 0.677 0.413 0.778 
18:2 n-trans 6 09:00 10:00 12:00     
 0.06 0.02 0.06 0.042 0.606 0.866 0.336 
        
1
Standard errors of differences of means; 
2
P-value represents the probability of a treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken at the last day of each collection period 
 
Table 3.14 Sampling time (h) effect in the LDL fraction trans fatty acids 
Fatty acid, 
g/100 g 
   SED
1
 P-value
2
 (Lin)
5 
(Quad)
6 
        
18:1 trans-4 09:00 10:00 12:00     
 0.7 0.7 0.4 0.15 0.472 0.307 0.553 
18:1 trans-9 09:00 10:00 12:00     
 0.3
b 
0.1
c 
0.5
a 
0.08 0.041 0.061 0.060 
18:1 trans-11 09:00 10:00 12:00     
 2.1 1.8 2.6 0.43 0.447 0.365 0.379 
18:1 trans-12 09:00 10:00 12:00     
 0.7 0.5 0.9 0.06 0.110 0.117 0.094 
        
1
Standard errors of differences of means; 
2
P-value represents the probability of a treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken at the last day of each collection period 
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Table 3.15 Sampling time (h) effect in the VLDL fraction trans fatty acids 
Fatty acid, 
g/100 g 
   SED
1
 P-value
2
 (Lin)
5 
(Quad)
6 
        
18:1 trans-4 09:00 10:00 12:00     
 1.2 1.1 1.3 0.23 0.894 0.739 0.747 
18:1 trans-5 09:00 10:00 12:00     
 0.9 0.8 0.7 0.12 0.585 0.375 0.746 
18:1 trans-9 09:00 10:00 12:00     
 0.6 0.8 0.6 0.12 0.583 0.814 0.323 
18:1 trans-11 09:00 10:00 12:00     
 3.7 3.9 3.7 0.45 0.946 0.922 0.757 
18:1 trans-12 09:00 10:00 12:00     
 1.1
b 
1.1
a 
0.8
c 
0.04 0.004 0.002 0.077 
        
1
Standard errors of differences of means; 
2
P-value represents the probability of a treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples were taken at the last day of each collection period 
 
3.3.8 Diurnal and daily variations in ruminal fermentation parameters 
Ruminal pH, NH3-N and total VFA were not affected by time of sampling. Molar 
concentration of propionate linearly increased and was greater at 12:00 than at other 
times of day; molar concentration of butyrate and valerate linearly decreased and were 
greater at 09:00 than at other times of day; molar concentration of isobutyrate had 
quadratic effect and was higher at 09:00 than at other times of day; but molar 
concentration of acetate and isovalerate were not affected by time of sampling (Table 
3.16). 
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Table 3.16 Day and time (h) effects on ruminal fermentation parameters  
Parameters   
  
SED
3 
P-
value
4 
(Lin)
5 
(Quad)
6 
         
pH T
1 
09:00 10:00 12:00     
  6.45 6.40 6.40 0.054 0.529 0.425 0.505 
NH3-N,  mM D
2
 1 2 3     
  15.2 13.5 15.5 2.81 0.742 0.930 0.445 
 T
 
09:00 10:00 12:00     
  11.00 15.80 16.40 2.81 0.072 0.040 0.292 
Total VFA,  T 09:00 10:00 12:00     
mM  76.2 85.8 76.7 8.62 0.461 0.854 0.221 
Acetate T 09:00 10:00 12:00     
  65.7 65.8 64.7 0.68 0.482 0.274 0.613 
Propionate T 09:00 10:00 12:00     
  29.2
c 
30.7
b 
31.9
a 
0.39 <0.001 <0.001 0.258 
Butyrate T 09:00 10:00 12:00     
  17.6
a 
16.7
b 
15.5
c 
0.33 <0.001 <0.001 0.697 
Isobutyrate T 09:00 10:00 12:00     
  1.9
a 
1.6
c 
1.7
b 
0.06 0.005 0.023 0.017 
Valerate T 09:00 10:00 12:00     
  1.8
a 
1.6
b 
1.5
c 
0.09 0.032 0.015 0.322 
Isovalerate T 09:00 10:00 12:00     
  2.4 2.2 2.2 0.12 0.447 0.300 0.465 
         
1
Time; 
2
Day; 
3
Standard errors of differences of means; 
4
P-value represents the probability of a 
treatment effect; 
5
Linear effect; 
6
Quadratic effect; Samples analyzed for pH and VFA samples were 
taken at the last day of each collection period 
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3.4 Discussion 
The current experiment focused on the transport of tFA by bovine plasma VLDL 
fraction (that also contained chylomicrons - lipoprotein derived from the intestine) 
because the previous experiment demonstrated that pulses of PHVO and SO increased 
tFA content in both HDL and LDL fractions. Further fractionation was required to 
distinguish between true LDL and VLDL fractions that are present in the LDL 
fraction. The approach was similar to the previous experiment; hence ruminal pulses 
were used to study effects of dietary lipids on plasma and lipoprotein fractions. As in 
Chapter 2, the results may differ from other studies because the treatments did not 
bypass the rumen and hence the biohydrogenation process had an extensive effect on 
concentrations of FA observed in plasma and lipoprotein fractions. The main 
hypothesis was that differences in FA concentrations would be observed, particularly 
in 18:1 trans isomers and 18:2 cis-9, trans-11. This hypothesis was supported by the 
differences in concentrations 18:1 tFA isomers and 18:2 cis-9, trans-11 in plasma and 
lipoprotein fractions, particularly in the VLDL fraction. 
This experiment was the first to compare the response to ruminal pulses of PHVO, FO 
and their blend on concentrations of individual tFA isomers in lipoprotein fractions of 
bovine plasma. The use of PHVO was discussed in Chapter 2; however, FO was used 
in this experiment to increase the formation of 18:1 trans isomers in the rumen. FO is 
also interesting because it is often included in ruminant diets to increase the content of 
long chain n-3 PUFA (22:6n-3 and 20:5n-3; DHA and EPA) for human health reasons 
(vascular and heart diseases, immune and inflammatory responses and in early 
development) (Offer et al, 2001; Loor et al., 2005).  
In the current experiment, differences in 18:1 trans isomers in plasma and lipoprotein 
fractions are in agreement with the previous experiment and with observations by 
Loor and Herbein (2001) in which a mixture of CLA (41% 18:2 cis-9, trans-11 and 
44% 18:2 trans-10,cis-12) was ruminally infused causing alterations in plasma and 
milk fatty acid profiles. Concentrations of CLA are higher in milk fat from cows 
offered fresh compared with conserved forages, and can also be increased using whole 
oilseeds (e.g. SO) or oil supplements (e.g. FO and PHVO) (Griinari and Bauman, 
1999), but larger responses have been obtained using FO (Offer et al., 1999). The 
response mechanism remains unclear, but FO has been shown to increase 18:1 trans 
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isomers in milk fat and the flow of 18:1 tFA entering the duodenum (Wonsil et al., 
1994), suggesting that FO modifies biohydrogenation of dietary PUFA in the rumen 
(Shingfield et al., 2003).   
 
In the current experiment, compared with PHVO, FO increased VA in plasma and 
lipoprotein fractions. That response is in agreement with AbuGhazaleh et al. (2007) 
who compared the effect of FO and sunflower oil supplementation on milk CLA cis-9, 
trans-11 when dairy cows were managed on pasture or in confinement. They found 
that FO and sunflower oil supplementation resulted in higher milk concentrations and 
yields of VA, CLA cis-9, trans-11 and lower 18:1 trans-10 in pasture-fed cows 
compared with confinement-fed cows. Likewise, Cruz-Hernandez et al. (2007) 
evaluated different levels of inclusion of sunflower oil (15, 30 and 45 g/kg of DM) 
and a constant level of FO (5 g/kg of DM) to increase VA and RA in milk and 
examine the content and composition of CLA and 18:1 trans isomers.  They found 
that supplementation with sunflower oil and FO reduced milk fat but milk protein and 
lactose levels were not affected. There was a linear decrease in all short- and medium-
chain SFA in milk fat after 10 d and a corresponding linear increase in total 18:1 trans 
isomers and total CLA.  
 
In this experiment, 18:2 cis-9, trans-11 was detected in FO and FO+PHVO, earlier 
studies revealed that CLA content in milk fat is highest when diets are supplemented 
with a blend of FO and linoleic acid-rich oils. Cows on pasture diets have been shown 
to have higher concentrations of CLA (Kelly et al., 1998; Lawless et al., 1998; White 
et al., 2001; Boken et al., 2005) in their milk than those consuming conserved forages. 
It has also been shown that milk CLA concentration can be enhanced in pasture 
grazing cows when their feed is supplemented with oils (Lawless et al., 1998; Boken 
et al., 2005; AbuGhazaleh and Holmes, 2007). Inclusion of FO in total mix ratios is an 
effective means of increasing milk CLA cis-9, trans-11 content (Donovan et al., 2000; 
Whitlock et al., 2002). This appears to occur because of the inhibitory effect of 
docosahexaenoic acid (DHA) in FO on VA reduction to 18:0 (AbuGhazaleh and 
Jenkins, 2004). Milk CLA cis-9, trans-11 response to FO is further enhanced when 
given in combination with linoleic or linolenic acid-rich oil sources (AbuGhazaleh et 
al., 2002, 2003). AbuGhazaleh et al. (2003) concluded that supplementing dairy cow 
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diets with a combination of FO and linoleic acid-rich oils is the most effective dietary 
regime to increase milk CLA cis- 9, trans-11 content. 
 
Castaneda-Gutierrez et al. (2005) demonstrated that when Ca salts of FO are fed 
through a rumen fistula, the negative effects of FO on DM intake and lactation 
performance were decreased compared to feeding the free oil. In that study, infusion 
of FO into the rumen clearly suppressed DM intake and milk fat yield compared with 
abomasal infusion of FO or feeding of Ca salts of FO. Their data indicated that Ca 
salts of FO minimized the negative effects of FO on rumen fermentation. When FO 
was supplemented unprotected, at 145 g/day (Castaneda-Gutierrez et al., 2005), 206 
g/day (Petit et al., 2002) or 290 to 612 g/day (Donovan et al., 2000), milk fat content 
and yield were depressed. Donovan et al. (2000) demonstrated a linear negative effect 
of FO (added at 0, 10, 20 and 30 g/kg of diet DM) on milk fat content and yield. FO 
supplementation greater than 10 g/kg of DM (290 g/day) decreased DM intake and 
milk production, although cows fed 10 g/kg FO produced more milk than cows not 
supplemented with FO. Moreover, Juchem et al., (2008) reported that negative effects 
of FO on DM intake and yields of milk and milk fat can be modulated by two factors. 
Firstly, when FO is protected; this is likely to minimize its effects on the rumen 
microflora (Castaneda-Gutierrez et al., 2005). Secondly, the amount of FO 
supplementation; in their experiments, cows were fed FO at approximately 80 g/day 
(3.2 g/kg diet DM), so the amount of FO consumed by cows was significantly less 
than that demonstrated to affect performance (Donovan et al., 2000). It has been also 
reported that along with CLA cis-9, trans-11 the concentration of VA, a substrate for 
endogenous synthesis of CLA cis-9, trans-11 in human tissues (Pariza et al., 2001), 
also increased in milk fat in response to dietary FO (Chilliard et al., 2001; Loor et al., 
2005). 
 
Studies have identified that availability of 18:0 for endogenous 18:1 cis-9 production 
seems to be crucial for milk fat synthesis (Donovan et al., 2000; Chilliard et al., 2003; 
Loor et al., 2005). Furthermore, the reduction in 18:0 availability seems to be the 
strongest association among all previous studies dealing with milk fat depression 
induced by FO supplementation (Chilliard et al., 2001; Donovan et al., 2000; 
Shingfield et al., 2003; Loor et al., 2005; Gama et al., 2008). Inhibition of the 
reduction of 18:1 trans isomers to 18:0 by FO could be related to greater ruminal 
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protozoa numbers or toxic effects of DHA and eicosapentaenoic acid (EPA), which 
can in turn lower concentrations of ruminal bacteria associated not only with the final 
reduction step but also with the overall process of biohydrogenation (Loor et al., 
2005). Moreover, at a given dose of incorporation, marine oils or algae rather than 
unsaturated vegetable oils in dairy diets seem to be more effective for increasing milk 
CLA cis-9, trans-11 concentration (Chilliard et al., 2000).  
 
3.4.1 Fatty acid profile of plasma and lipoprotein fractions 
As discussed in Chapter 2, sampling day and time affected 18:1 tFA of plasma. 
Generally, sampling day had linear effect on 18:1 trans isomers on plasma. On the 
other hand, only 18:1 trans-12 from VLDL fraction had linear effect on sampling time.  
With a single administration, concentrations of treatments are higher during the first 
few hours after pulse and lower in subsequent hours (Ferlay and Doreau, 1992).  In 
this study, effects of treatments on tFA profile of plasma and lipoprotein fractions 
were observed within the first three hours post pulse. The diurnal variation of tFA in 
the plasma and cholesterol fractions found in this study may indicate that fluctuations 
vary according to metabolic status (preprandial and postprandial status) (Diven et al., 
1958).  The amounts and composition of lipids circulating in the blood of dairy cattle 
are dependent upon a number of physiological variables. The nature of the diet, time 
since feeding, age, breed, pregnancy, and stage of lactation may all affect lipid content 
and composition (Christie, 1981). In this study, diurnal variations of plasma, 
lipoprotein fractions and ruminal fermentation parameters and showed that there may 
be an adaptation of ruminal microflora to the treatments and also reflected a cycle 
control mechanism balancing rate of lipid entry and rate of removal in the circulatory 
system. This is possibly related to regulation of lipid supply (diet, production, 
synthesis) and utilization by peripheral tissues (Bitman et al., 1990). 
 
Concentrations (g/100g) of tFA were almost 2 times greater in VLDL than HDL and 
LDL fractions. These results may support the suggestion from the previous 
experiment that further fractionation was necessary to distinguish true LDL fraction 
from chylomicrons and VLDL that are also present in this fraction. However, such 
comparisons in bovine lipoprotein fractions have not been evaluated in previous 
studies (Loor and Herbein, 2001; Mosley et al., 2006; Tyburczy et al., 2008).  In this 
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experiment, compared with control, FO and FO/PHVO increased 18:1 trans isomers 
in plasma and VLDL fraction, that may be attributed to an inhibition of the 
biohydrogentation reduction steps of 18:1 trans isomers to 18:0 by LC-PUFA present 
in FO (Shingfield et al., 2003; AbuGhazaleh and Jenkins, 2004; Lee et al., 2005; Loor 
et al., 2005; Or-Rashid et al., 2008). 
 
In the current experiment, 18:2 cis-9, trans-11 was increased by SO and FO+PHVO in 
plasma and HDL fraction but was not detected in LDL and VLDL fractions. 
Vegetable or marine oils elevate the concentration and yield of CLA and tFA isomers 
in milk fat (Chilliard et al., 2000). In this experiment, SO and FO+PHVO increased 
18:2 cis-9, trans-11 in plasma and HDL fraction probably because its concentration of 
18:2 n-cis 6 was enough to inhibit  hydrogenation of  18:1 isomers to 18:0 (Loor  and 
Herbein, 2001). 
 
In the current experiment, the presence of plasma CLA 18:2 cis-9, trans-11 in HDL 
probably reflects the predominance of HDL fraction lipid in cattle plasma. Normally, 
70-90% of bovine plasma lipids are in the HDL fraction; thus it is expected that the 
preponderance of 18:2 cis-9, trans-11 would also be in this fraction (Herdt et al., 
1995). 
 
Capper et al. (2007) evaluated the effects of supplementing pregnant and lactating 
ewes with FO and vitamin E upon the performance of lactating ewes and sucking 
lambs. They found that the total FA concentration in sucking lamb plasma was 
reduced by FO supplementation of the ewe. Maternal FO supplementation reduced 
plasma concentrations of 16:0, 18:0, 18:1 cis-9, 18:2n-6 and 20:4n-6 in sucking lambs. 
By contrast, increases in 18:1 trans isomers; CLA cis-9, trans-11, 18:3n-3, EPA and 
DHA were obtained by supplementing ewes with FO.  
 
Addition of FO to the ruminant diet has been shown to increase plasma concentrations 
of both 18:1 trans isomers and CLA produced by incomplete ruminal 
biohydrogenation of PUFA (Baumgard et al., 2000; Wachira et al., 2000; Chikunya et 
al., 2004), results that agree with the increase in 18:1 tFA conferred by FO and 
FO/PHVO treatments within the current experiment. Increases in n-3 PUFA conferred 
by FO supplementation are often accompanied by a corresponding increase in plasma 
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20:4n-6 concentration resulting from increased dietary supply (Kitessa et al., 2001). In 
the current experiment, increased 20:4n-6, EPA and DHA are in agreement with data 
presented by Capper et al. (2007). They found that significant increase in plasma EPA 
and DHA in ewes offered diets containing FO were a direct result of increased dietary 
supply of preformed long-chain PUFA. However, Wachira et al. (2002) and Chikunya 
et al. (2004) reported the presence of EPA and DHA within muscle and plasma FA of 
sheep fed diets in which these FA were not detected.  
 
Alternatively, proliferation of bacteria capable of conversion of 18:3 and 18:2 through 
to 18:0 might be inhibited by the LCPUFA in FO, resulting in increased VA. A study 
by Wasowska et al. (2006) showed that addition of EPA or DHA (50 mg/l) to pure 
cultures inhibited growth and isomerase activity of B. fibrisolvens, whereas FO, in 
which the FA were present in triacylglycerols, had no effect. Other reports (Kim et al., 
2008) suggested that accumulation of 18:2n-6 in the rumen (by feeding more 18:2n-6 
to the ruminant) causes incomplete biohydrogenation. 
 
 
3.4.2 Fatty acid composition in the lipoprotein lipids  
In the current experiment, HDL-CE had higher concentrations (g/100g) of VA, EA 
and 18:2 trans6 in bovine plasma. This high concentration of plasma tFA in HDL-CE 
probably reflects the predominance of HDL fraction lipid in cattle plasma. Normally, 
70-90% of bovine plasma lipids are in the HDL fraction; thus it is expected that the 
preponderance of tFA would also be in this fraction (Herdt et al., 1995). However,  it 
also depends on whether tFA are coming directly from the intestine (in which case 
tFA will be present in the VLDL fraction) or whether tFA get incorporated into tissues 
and then released again (in which case tFA can be found in LDL and/or HDL 
fractions). 
 
Ruminant plasma lipoprotein profile is characterized by low concentrations of 
chylomicrons, VLDL and total TG, whereas approximately 90% of plasma lipid is 
carried by HDL, mainly in the form of CE and PL (Offer et al., 2001). Offer et al. 
(2001) studied the selective incorporation of dietary FA into plasma lipoprotein 
classes in cows supplemented with FO (300 g/d). They found that VLDL-TG was not 
altered by FO supplementation. In the current experiment concentration of VLDL-TG 
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appeared to be the major lipid sub group carrying plasma FA. These results are 
different from previous studies (Ashes et al., 2000; Offer et al., 2001) probably due to 
the fact that FA treatments were given as single ruminal pulses and were exposed to 
direct ruminal biohydrogenation rather than being supplemented in the diet. Also, 
because non-lactating cows were used, FA profiles reported may be different from 
lactating cows because milk fat composition is affected by stage of lactation. More 
importantly, FA metabolism is affected by lactation, which greatly increases 
metabolic demand for FA and precursors (Belyea et al., 1990; Palmquist et al., 1993). 
The effect of FO and FO/PHVO as ruminal pulses is another factor that may explain 
variation in concentrations of certain FA within each lipid sub group. For example, 
DePeters et al. (2001) attributed changes in carbon number for TG structure to high 
proportions of LCFA and medium chain FA associated with canola oil infused either 
into the rumen or abomasum. Also in the current experiment non-lactating cows were 
used, whereas Offer et al. (2001) used mid-lactation cows and hence that may have an 
effect on FA utilization to satisfy different energy requirements. 
There is evidence (Palmquist, 1976; Moore and Christie, 1979; Christie et al., 1986; 
Scow and Chernick, 1987; Barber et al., 1997) that the ruminant mammary gland 
obtains FA required for assembly of milk lipids by the action of mammary lipoprotein 
lipase on the TG fraction of chylomicrons and VLDL. Studies on lactating cows and 
goats, utilizing arterio-venous difference measurements, mammary gland perfusions 
and infusions of radioactively labelled lipids, all indicated that the TG component of 
chylomicrons and VLDL is the main source of milk lipid. Although much larger 
amounts of CE and PL are present, mainly in HDL, these are poor substrates for 
lipoprotein lipase and thus make only modest contributions to the formation of milk 
fat (Offer et al., 2001). The dynamics of lipid transport cannot be inferred simply from 
the analysis of plasma lipoprotein concentrations. The high fractionation removal rate 
(~ 0.5 per min) of VLDL from lactating cow plasma (Palmquist and Mattos, 1978) 
and the large increase in plasma VLDL concentration which takes place at the end of 
lactation (Palmquist, 1976), supports the high state of flux of this lipoprotein, with 
influx being balanced by mammary uptake. The efficient delivery of any dietary FA 
from the small intestine to the mammary gland depends on partitioning of FA into the 
TG fraction during assembly of chylomicrons / VLDL in the intestinal epithelium. If 
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FA are instead incorporated only into the PL and CE fractions of lipoproteins, then 
they will be unavailable to the mammary lipoprotein lipase system (Offer et al., 2001). 
 
Another consideration is that high-oil feed ingredients increase availability of UFA 
and rumen-derived 18:1 trans isomers in blood for uptake and incorporation into milk 
fat. VA and 18:2 cis-9, trans-11 are the major intermediates of dietary 18:2n-6 
hydrogenation. In contrast, 18:1 trans-6/7/8 and trans-9 are the major intermediates 
produced during isomerization of 18:1 cis-9. This is in agreement with the decreased 
of EA in LDL-PL and VLDL-FFA caused by FO in the current experiment. Despite 
its ruminal origin, the majority of 18:2 cis-9, trans-11 in milk fat is synthesized within 
the mammary gland from VA via ǻ9 desaturase. Transfer of dietary 18:2 trans-10, cis-
12 into milk fat may be low due to its preferential incorporation into plasma 
phospholipids (Loor et al., 2003). 
 
3.4.3 Ruminal fermentation  
Ruminal NH3-N and propionate linearly increased and butyrate and valerate linearly 
decreased across sampling times. Conversely, Shingfield et al. (2010) studied the 
effects of incremental amounts (0, 8, 16 and 24 g/kg of DM) of FO as a source of EPA 
and DHA on ruminal lipid metabolism and the flow of FA at the duodenum in steers 
fed maize silage-based diets, and reported that the inclusion of FO in the diet had no 
effect on rumen pH and NH3-N concentrations. They also observed that 
supplementing FO increased linearly molar concentration of propionate and reduced 
linearly butyrate, with a trend towards a linear decrease in molar proportions of 
acetate in rumen VFA. Likewise, Toral et al. (2009), supplemented ewes with a diet 
that included sunflower oil (20 g/kg of DM) and FO (10 g/kg of DM) to investigate 
the impact of the addition of oils on ruminal fermentation parameters; they found no 
effect on ruminal pH, NH3-N, lactate and VFA concentrations and concluded that its 
use to improve the nutritional value of ruminant sub products cannot be precluded. 
The effect of FO on ruminal fermentation parameters may be due to the level of 
inclusion in diets, for example, Lee et al. (2008), examined the effects of incremental 
amounts (0, 10, 20 and 30 g/kg DM) of FO on biohydrogenation in steers fed sole 
forage diets based on ensiled grass or red clover. They found that FO in the diets had 
no effect on rumen pH but decreased rumen NH3-N concentrations when added at 30 
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g/kg diet DM. Regardless of the forage fed, FO supplements had no effect on total 
VFA concentrations or VFA molar proportions. 
Amorocho et al. (2009) evaluated catfish oil as a dietary ingredient for dairy cows at 
different levels (0, 15 and 30 g/kg); they found that total VFA concentrations in 
ruminal fluid were similar across levels of inclusion; molar proportion of acetate 
decreased with increasing concentrations of catfish oil, whereas propionate 
concentration increased by adding catfish oil in the diet. Doreau and Chilliard (1997) 
also reported a decrease in molar proportion of acetate and an increase in propionate 
in ruminal fluid of cows fed diets supplemented with 370 g/d of menhaden fish oil. 
Onetti et al. (2001) and Lewis et al. (1999) reported similar results when tallow was 
the source of fat. A possible explanation for such effects is that UFA can alter the 
ruminal ecosystem by suppression of methanogenic (and to a lesser extent cellulolytic) 
bacteria and protozoa (Van Soest, 1994). A decrease in methane production alters 
rumen fermentation, leading to an increase in propionate production to maintain the 
ruminal fermentation balance (Amorocho et al., 2009).  
As described before, the effect of lipid supplementation on ruminal fermentation relies 
mainly on three factors: first, the type of oil (Wachira et al., 2000), second, the level 
of oil inclusion in the diet (Shingfield et al., 2008) and third, the dietary 
forage:concentrate ratio, since animals fed a concentrate-rich diet might be more 
likely to be adversely affected by oil supplementation (Ueda et al., 2003). In lactating 
cows, a high-forage diet supplemented with a combination of sunflower and FO only 
induced a transient reduction in total VFA concentration at 2 h post feeding, but no 
effect was observed at 6 h (Palmquist and Griinari, 2006).  
It would be interesting to study further the effect of FO and its blend with PHVO to 
understand alterations to ruminal ecosystem.  As previously reported (AbuGhazaleh 
and Jenkins, 2004; Boeckaert et al., 2007, 2008; Scollan et al., 2001) marine products, 
such as FO and algae, proved highly effective at inhibiting rumen biohydrogenation of 
UFA because LC-PUFA (EPA and/or DHA) are active compounds in this process. 
Supplementation with LC-PUFA can reduce 18:0 production, resulting in 
accumulation of various hydrogenation intermediates, predominantly VA and 18:1 
trans-10 (Boeckaert et al., 2008). 
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3.5 Conclusion 
Differences in FA concentrations between plasma and lipoprotein fractions were 
observed, particularly in 18:1 trans isomers. This experiment reinforces findings 
reported in Chapter 2 and helps to understand which lipoprotein is involved in the 
transport of tFA. In this experiment, VLDL appeared to be the main transport 
mechanism of 18:1 trans isomers in bovine plasma. Overall, results from Chapters 2 
and 3 demonstrates that dietary lipids rich in PUFA can alter the rumen environment 
and result in increased plasma and lipoprotein-fraction concentrations of tFA. The 
results therefore show how plasma FA profiles change when supplementary oils do 
not bypass the rumen and hence the lipids had extensive effects on the 
biohydrogenation process, as indicated by plasma and lipoprotein 18:1 trans isomers.  
 
3.6 Implications 
In this experiment, VLDL fraction appeared to be the major fraction involved in the 
transportation of tFA. However, further research is needed to understand the 
metabolism of FA at the cellular level within the mammary gland. 
The phenomenon of milk fat depression induced by PUFA supplementation in 
lactating ruminants has been reviewed in detail (Peterson et al., 2003; Bauman et al., 
2006) and it is clear that specific FA produced as intermediates during ruminal 
biohydrogenation of 18:2n-6 play a significant role in reducing milk fat synthesis 
through inhibitory effects on mammary gene expression (Peterson et al., 2003). This 
mechanism would explain the decrease in milk fat concentration conferred by FO 
supplementation, in combination with effects of diet upon milk yield and milk fat 
yield (Capper et al., 2008). Hence, use of dietary FO in the dairy diet has to be 
carefully balanced to avoid milk fat depression and increase the nutritional value of 
milk fat. 
It is becoming clear that the VA and rumenic acid contents in milk fat depend not only 
on dietary forage-to-concentrate ratio and carbohydrate sources, but also on amounts 
and types of supplementary oils, with FO being most effective in small quantities. 
Efforts should be made to reduce the level of other 18:1 trans and CLA isomers 
because no beneficial effect has so far been attributed to these isomers (Cruz-
Hernandez et al., 2007).  
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This experiment helps to understand the basis of the beneficial effect of adding oils to 
the ruminant diet on FA composition plasma and lipoprotein fractions. However, a 
better understanding of how ruminal biohydrogenation is modified via differential 
toxicity to ruminal bacteria of different PUFA including the FO fatty acids is needed. 
If we can understand how selective FA toxicity, or indeed other factors, affects the 
physiology of biohydrogenating bacteria in the rumen, we may be able to suggest new, 
rational dietary modifications that will eventually lead to ruminant products that are 
healthier for human consumption (Maia et al., 2010). 
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CHAPTER 4 
4. Using a bovine mammary epithelial cell line (MAC- T) to study fatty acid 
metabolism 
4.1 Introduction 
Lipids in milk are present in fat globules formed chiefly of triacylglycerols enclosed 
within a membrane derived from the secretory epithelial mammary cell (Jensen, 2002; 
Heid and Keenan, 2005). Although the general outlines of lipid droplet formation, 
growth, movement, and secretion are known, few studies have been performed on 
lipid absorption and secretion in mammary gland cells (Ernens et al., 2007).   
 
Selective uptake of lipoprotein fractions or specific FA could affect milk fat 
composition by determining the substrates available for TAG synthesis (Offer et al., 
2001). The use of cell cultures allows studying specific aspects of lipid uptake without 
the interference from the cow’s digestive system and general metabolism. The main 
hypothesis being tested in this experiment was that LCFA and tFA might influence 
TAG accumulation and FA profile in cytosol of mammary epithelial cells. The 
objective was to elucidate how cytosolic TAG are accumulated and whether this is 
influenced by tFA, SFA and UFA. This objective was achieved by adding different 
FA to a FA-free medium used to culture MAC-T cells. 
 
4.2 Material and methods 
4.2.1 Cell culture 
Bovine mammary epithelial cells (MAC-T; provided by Juan J. Loor, University of 
Illinois, USA) were grown in HyQ RPMI-1640 media (Hyclone) supplemented with 
foetal bovine serum (10%, F7524, Sigma) and ABAM (Antibiotic-antimycotic 
solution; 10,000 units penicillin, 10 mg streptomycin DQGȝJDPSKRWHULFLQ%SHU
ml; A5955, Sigma) in sterile 75 cm
2
 flasks coated with Poly-D-Lysine or Collagen I 
(to ensure cell attachment and facilitate growth) (156472-Nunclon, Fisher Scientific).  
 
Cultures were maintained in a water-jacket incubator at 37°C in the presence of 5% 
CO2.  Culture medium was changed every 48 h and cells were sub-cultured to 70 to 
80% confluence (Figure 4.1) by rinsing once with 3 ml of 0.25% trypsin, and 
incubated at 37°C until there was evidence of cell detachment. Trypsin activity was 
inhibited by addition of 25 ml of fresh culture media at 37°C (Kadegowda et al. 2009). 
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MAC-T cells at ~40% confluence 
 
Figure 4.1 MAC-T cells at ~100% (“cobblestone” morphology; Huynh et al. 1991) 
 
4.2.2 Basal medium 
Approximately 48 h prior to the last subculture before initializing the experiment, 
cells were allowed to grow in a basal medium similar to that of Peterson et al. (2004), 
with modifications. The basal medium was composed of Minimum Essential 
Medium/Earle’s Balanced Salts HyQ (MEM/EBSS, HyClone) with insulin (5 mg/l, 
I6634, Sigma, St. Louis, MO), hydrocortisone (1 mg/l, H0888, Sigma), transferrin (5 
mg/l76LJPDDVFRUELFDFLGȝM/l, A4544, Sigma), sodium acetate (5 mM/l, 
S5636, Sigma), and ABAM (10,000 units penicillin, 10 mg streptomycin DQGȝJ
amphotericin B per ml; A5955, Sigma). The basal medium was supplemented with 
  
109 
foetal bovine serum (10%, F7524, Sigma) and growth-promoting hormones (1 mg/l of 
SURJHVWHURQH 3 6LJPD  ODFWDOEXPLQ / 6LJPD  Į-lactose, 
47287-U, Sigma). All basal medium components were filtered before use (sterile 
syringe filter; pore size: 0.20 µm). 
 
Cells were seeded at a concentration of 1.0 x 10
4
 cells / well (Yonezawa et al., 2004; 
Keating et al., 2008) in sterile 12-well (well diameter: 22.1 mm) cell culture clusters 
with flat bottom (Costar 3513, Corning Incorporated, USA). 
 
4.2.3 Lactogenic medium 
Approximately 24 h before applying treatments (approximately 90% confluence), 
cells were cultured in a lactogenic medium as reported by Kadegowda et al. (2009), 
with modifications. The lactogenic medium was prepared as the basal medium, except 
that high-glucose Dulbecco’s modified Eagle’s medium (HG-DMEM, HyClone) was 
used. The lactogenic medium was devoid of foetal bovine serum and was 
supplemented with BSA (Bovine serum albumin; 1 g/l) and prolactin (2.5 mg/l). All 
lactogenic medium components were filtered before use (sterile syringe filter; pore 
size: 0.20 µm). 
 
4.2.4 Preparation of LCFA solutions 
Stock solutions of 30 mM LCFA were prepared in 13 x 100 mm Pyrex glass tubes 
with screw caps at 42°C with an equimolar solution of NaOH in water. Sodium salts 
of the individual FA were suspended in ethanol to obtain a final solution of 95% 
ethanol. After preparation, the LCFA stock solutions were stored at -20°C until use 
(Olofsson et al., 2004; Kadegowda et al., 2009) (Tables 4.1 and 4.2). 
 
4.2.5 Treatment of MAC-T cell with exogenous fatty acids 
Treatments consisted of adding LCFA (palmitate, stearate, oleate, linoleate, CLA, 
elaidate and vaccenate) solutions to the lactogenic medium at varying concentrations 
and culturing cells for a 24-hr incubation period. Ethanol was used as a control. 
Concentrations of individual FA in the lactogenic medium were 100, 200, 300 and 
400 mM. At the end of each incubation, lipids from media and cell lysates were 
extracted in situ using hexane:isopropanol (3:2 v/v). 
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Table 4.1 Preparation of stock LCFA 
Fatty acid Molecular weight 
(g/mol) 
mg of FA µl of 1M 
NaOH 
ml of absolute 
ethanol
8 
Palmitic
1 
256.43 25.7 112.2 3.34 
Stearic
2 
284.40 21.1 83.10 2.47 
Linoleic
3 
280.46 26.6 94.80 3.16 
Oleic
4 
282.47 28.5 112.89 3.36 
Conjugated linoleic acid
5 
280.45 25.4 101.36 3.01 
Vaccenic
6 
282.46 28.8 114.24 3.40 
Elaidic
7 
282.46 23.5 92.96 2.76 
1
P0500-SIGMA ; 2S4751-SIGMA *&3L1376-SIGMA  4SIGMA O1008 
(GC); 
5
16413-SIGMA Conjugated (9Z, 11E) linoleic acid analytical standard  6GRQDWHG
by INRA, France; 
7
Elaidic donated by Nestle; 
8
Absolute ethanol from Fishers Scientific E/0650DF/P17. 
 
Table 4.2 Concentration of stock
1
Concentration (µM) 
 LCFA - 30 mM (30nmoles / µl) 
Amount (µl / ml)
2 
100 3.3 
200 6.6 
300 9.9 
400 13.2 
1
Stock LCFA is not sterile; 
2 
Amount required per ml of media; LCFA were filtered (sterile syringe 
filter; pore size: 0.20 µm) along with the lactogenic medium. 
 
4.2.6 Measurement of the TAG, DNA and protein content in cytosol 
Cultured cells on 12-well plates (COSTAR 3513) were washed once with ice-cold 
PBS (phosphate buffered saline) + albumin (to remove FA traces) and twice with PBS, 
scraped off into 200 µl of 0.05M trisodium citrate (Fishers S/3320/60) for DNA and 
protein quantification and stored at -20°C until analysis. Cells were sonicated 
(Soniprep 150, MSE, UK, Ltd.) at 5 microns for 10 seconds to disrupt cell membranes 
and release cellular contents. 
DNA quantification was performed by the Hoechst fluorometric method. Hoechst 
33258 Dye was used (this binds to the thymine-adenine rich regions of double 
stranded DNA and exhibits enhanced fluorescence under high ionic strength 
conditions) for DNA quantification. For this measurement, sensitivity of the Hoechst 
33258 Dye assay was approximately 10 ng/ml. The linear dynamic range extended 
over 3 orders of magnitude from 10 ng/ml to 1 µg/ml DNA. 
Protein was determined by the Lowry et al. (1951) protein assay. This method is based 
on the reactivity of peptide nitrogen with copper ions under alkaline conditions and 
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the subsequent reduction of the Folin-Ciocalteay phosphotungstic acid to 
heteropolymolybdenum blue by the copper-catalyzed oxidation of aromatic acids. 
Concentration of the reduced Folin reagent was measured by absorbance at 655 nm. 
Optical density was read using a microplate reader (Microplate Manager Bio-Rad 
Laboratories, Inc.). 
TAG in the cell lysates was extracted using hexane:isopropanol (3:2 v/v) and 
quantified using a Triglyceride reagent (Infinity Triglyceride, Thermo Scientific, 
TR22421). The linear range was 0 to 10 mmol/l (885 mg/dl). Optical density was read 
using a microplate reader (Microplate Manager Bio-Rad Laboratories, Inc.). The 
measurement wavelength was 550 nm and 655 nm for reference wavelength. Each 
assay was performed in triplicate and repeated at least 3 times. 
4.2.7 Fatty acid analysis from cells and media 
Lipids from cells and media were extracted using an adaptation of the method of Bligh 
and Dyer (1959) and methylated according to the method of Christie (1982) with 
modifications by Chouinard et al. (1999). All chemicals and solvents used for these 
methods were of analytical grade. For analysis of FA in cells and media, a GC system 
(Agilent, GC 6890 series) equipped with a CP-Sil 88 fused-silica capillary column 
(100 m x 0.25 mm i.d., with 0.2 µm film thickness; Varian Inc., Oxford) was used. 
The GC conditions were as follows: the oven temperature was initially set at 110°C 
for 4 min after injection, and then increased to 240°C with equilibration time of 2 min. 
The inlet and flame-ionization detector temperatures were 260°C, the split ratio was 
15:1 and a 2 µl injection volume was used. The hydrogen carrier gas flow to the 
detector was 25 ml/min, airflow was 400 ml/min, and the flow of nitrogen makeup gas 
was 40 ml/min. Fatty acid peaks were identified by using a fatty acid methyl ester 
standard (FAME; Supelco 37 Component FAME mix, Bellefonte, PA) and a tFA 
reference standard (trans 11- C18:1, methyl ester, Supelco, Bellefonte, PA). The 
concentration of each FA (g/100g) was calculated for 16:0 to 22:6n3 FA with 
concentrations higher than 0.3 g/100g. 
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4.3 Statistical analysis and design 
Using the GenStat 12
th
 statistical package (VSN International Ltd., Oxford); cytosolic 
TAG, protein and DNA data was analyzed as Linear Mixed Models with fixed effects 
of LCFA and concentration; the random effects were run, plate, strips and wells. In 
the current experiment different runs (of which there were 8) were carried out to 
obtain replication for each of the measurements. To avoid biased results, treatments 
were added randomly to different wells (of which there were 408), strips (of which 
there were 3 in each 12-well plate) and plates (of which there were 35) for each run. 
Cytosolic fatty acid profile from cell and media data was analyzed as a Linear Mixed 
Models with fixed effects of LCFA and concentration; the random effect was plate. 
Data are reported as least square means ± SED across different concentrations (100, 
200, 300 and 400 µM). 
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4.4 Results 
4.4.1 Accumulation of cytosolic triacylglycerol 
Addition of stearate, oleate, elaidate, vaccenate, linolate and CLA increased cytosolic 
TAG (from 100 to 400 µM). Compared with control, cytosolic TAG was increased by 
palmitate and elaidate. Compared with 100 µM (initial concentration), cytosolic TAG 
content was increased by 300 and 400 µM. Concentration effect linearly increased and 
had quadratic effect (Table 4.3 and Figure 4.2). 
 
Table 4.3 Cytosolic triacylglycerol content (mmol / well) 
 Concentration (µM)      
Fatty acid 100 200 300 400 SED
2 
P-value
 
  
         
Control 0.39 0.35 0.37 0.44 0.062 <0.001
3
   
Palmitate 0.46 0.43 0.43 0.57     
Stearate 0.25 0.26 0.27 0.36  
   
Oleate 0.38 0.45 0.64 0.71  
   
Elaidate 0.35 0.35 0.50 0.66     
Vaccenate 0.38 0.41 0.57 0.70     
Linoleate 0.47 0.50 0.66 0.84     
CLA
1 
0.28 0.52 0.68 0.97     
 
        
 Fatty acid effect     
         
 Control  0.39  0.036 <0.001
4 
  
 Palmitate  0.47      
 Stearate  0.28      
 Oleate  0.54      
 
Elaidate  0.47      
 Vaccenate  0.51      
 Linoleate  0.61      
 CLA
 
 0.61      
         
 Concentration effect   (Lin)
6 
(Quad)
7 
         
Concentration  100  0.37  0.020 <0.001
5 
<0.001 <0.001 
(µM) 200  0.41      
 300  0.51      
 400  0.65      
         
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; 
4
P-value represents the 
probability of a treatment effect;
 5
P-value represents the probability of a concentration effect; 
6
Linear 
effect; 
7
Quadratic effect. 
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Figure 4.2 Cytosolic triacylglycerol content (mmol / well). Fatty acids (top) and concentration (bottom) 
effects. 
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4.4.2 Cytosolic protein content 
Compared with control, cytosolic protein content was increased by oleate, vaccenate 
and linoleate. Cytosolic protein content was not affected by concentration or 
treatment-concentration interaction (Table 4.4). 
Table 4.4 Cytosolic protein content (mg / ml) 
 Concentration (µM)      
Fatty acid 100 200 300 400 SED
2 
P-value
 
  
         
Control 1.42 1.48 1.47 1.32 0.311 0.947
3
   
Palmitate 1.84 1.63 1.40 1.25  
   
Stearate 1.12 1.31 1.31 1.25  
   
Oleate 2.33 2.47 2.53 2.55     
Elaidate 1.57 1.57 1.64 1.56     
Vaccenate 2.03 2.02 2.11 2.00     
Linoleate 2.72 2.80 2.46 2.21     
CLA
1 
1.36 1.29 1.48 1.35     
         
 Fatty acid effect     
         
 Control  1.42  0.176 <0.001
4 
  
 Palmitate  1.53      
 Stearate  1.25      
 Oleate  2.47      
 
Elaidate  1.59      
 Vaccenate  2.04      
 Linoleate  2.55      
 CLA
 
 1.37      
         
 Concentration effect   (Lin)
6 
(Quad)
7 
         
Concentration  100  1.80  0.105 0.298
5 
0.045 0.398 
(µM) 200  1.82      
 300  1.80      
 400  1.69      
         
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; 
4
P-value represents the 
probability of a treatment effect;
 5
P-value represents the probability of a concentration effect; 
6
Linear 
effect; 
7
Quadratic effect. 
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4.4.3 Cytosolic DNA content 
Compared with control, cytosolic DNA content was increased by vaccenate and 
decreased by palmitate. Cytosolic DNA content was not affected by concentration and 
there was no treatment-concentration interaction (Table 4.5). 
Table 4.5 Cytosolic DNA content (µg / ml) 
 Concentration (µM)      
Fatty acid 100 200 300 400 SED
2 
P-value
 
  
         
Control 3.36 3.38 2.73 2.65 0.403 0.542
3
   
Palmitate 2.87 2.37 2.32 1.86  
   
Stearate 2.63 2.79 2.95 2.95  
   
Oleate 3.08 2.77 3.26 2.83     
Elaidate 2.80 2.89 2.92 2.94     
Vaccenate 3.52 3.84 3.75 3.70     
Linoleate 2.92 3.38 2.65 2.59     
CLA
1 
2.70 2.82 2.80 2.78     
 
        
 Fatty acid effect     
         
 Control  3.03  0.219 <0.001
4 
  
 Palmitate  2.36      
 Stearate  2.83      
 Oleate  2.98      
 
Elaidate  2.88      
 Vaccenate  3.70      
 Linoleate  2.89      
 CLA
 
 2.78      
         
 Concentration effect   (Lin)
6 
(Quad)
7 
         
Concentration  100  2.99  0.138 0.187
5 
0.044 0.303 
(µM) 200  3.03      
 300  2.92      
 400  2.79      
         
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; 
4
P-value represents the 
probability of a treatment effect;
 5
P-value represents the probability of a concentration effect; 
6
Linear 
effect; 
7
Quadratic effect. 
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4.4.4 Accumulation of cytosolic triacylglycerol normalized for protein content 
Addition of palmitate, elaidate, vaccenate and linolate increased (from 100 to 400 µM) 
cytosolic TAG content corrected for protein (µg of TAG / mg protein). Compared 
with control, cytosolic TAG was increased by palmitate, vaccenate, linoleate and CLA. 
Concentration effect linearly increased and had quadratic effect. Compared with 100 
µM (initial concentration), cytosolic TAG content was increased by 300 and 400 µM 
(Table 4.6 and Figure 4.3). 
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Table 4.6 Accumulation of triacylglycerol contents (µg / mg protein) 
 Concentration (µM)     
Fatty acid 100 200 300 400 SED
2 
P-value
 
  
         
Control 138.1 200.1 157.5 235.2 120.0 0.002
3
   
Palmitate 352.3 392.7 590.3 817.3  
   
Stearate 314.2 343.1 209.5 292.1  
   
Oleate 189.1 145.6 338.6 511.9     
Elaidate 227.8 322.6 340.3 394.3     
Vaccenate 284.7 365.2 427.0 508.0     
Linoleate 221.9 275.0 510.3 919.4     
CLA
1 
294.1 281.2 499.5 583.1     
         
 Fatty acid effect     
         
 Control  182.7  71.96 <0.001
4
   
 Palmitate  538.1      
 Stearate  289.7      
 Oleate  296.3      
 
Elaidate  321.3      
 Vaccenate  396.2      
 Linoleate  481.7      
 CLA
 
 414.5      
         
 Concentration effect   (Lin)
6 
(Quad)
7 
         
Concentration  100  252.8  39.58 <0.001
5
 <0.001 0.020 
(µM) 200  290.7      
 300  384.1      
 400  532.7      
         
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; 
4
P-value represents the 
probability of a treatment effect;
 5
P-value represents the probability of a concentration effect; 
6
Linear 
effect; 
7
Quadratic effect. 
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Figure 4.3 Accumulation of triacylglycerol contents (µg / mg protein). Fatty acids (top) and 
concentration (bottom) effects. 
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4.4.5 Accumulation of cytosolic triacylglycerol normalized DNA content 
Addition of palmitate, oleate, vaccenate and CLA increased (from 100 to 400 µM) 
cytosolic TAG content (µg of TAG / µg of DNA). Compared with control, cytosolic 
TAG content was increased by palmitate and CLA. Concentration effect linearly 
increased and had quadratic effect. Compared with 100 µM (initial concentration), 
cytosolic TAG content was increased by 300 and 400 µM (Table 4.7 and Figure 4.4).  
Table 4.7 Accumulation of triacylglycerol contents (µg of TAG / µg of DNA) 
 Concentration (µM)     
Fatty acid 100 200 300 400 SED
2 
P-value
 
  
         
Control 137.8 126.2 139.9 183.8 28.59 0.026
3
   
Palmitate 145.9 158.0 167.4 284.0  
   
Stearate 126.6 115.5 115.0 140.1  
   
Oleate 112.5 112.7 148.5 164.9     
Elaidate 131.9 128.6 162.8 225.7     
Vaccenate 105.7 109.8 129.9 165.2     
Linoleate 126.9 114.8 175.1 235.8     
CLA
1 
122.3 189.7 223.0 298.5     
         
 Fatty acid effect     
         
 Control  146.9  15.60 <0.001
4 
  
 Palmitate  188.8      
 Stearate  124.3      
 Oleate  134.7      
 
Elaidate  162.3      
 Vaccenate  127.6      
 Linoleate  163.2      
 CLA
 
 208.4      
         
 Concentration effect   (Lin)
6 
(Quad)
7 
      
   
Concentration  100  126.2  9.81 <0.001
5 
<0.001 <0.001 
(µM) 200  131.9      
 300  157.7      
 400  212.3      
         
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; 
4
P-value represents the 
probability of a treatment effect;
 5
P-value represents the probability of a concentration effect; 
6
Linear 
effect; 
7
Quadratic effect. 
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Figure 4.4 Accumulation of triacylglycerol contents (µg of TAG / µg of DNA). Fatty acids (top) and 
concentration (bottom) effects. 
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4.4.6 Cytosolic fatty acid profile 
4.4.6.1 Saturated fatty acids 
x Cytosolic 16:0 concentration was decreased by linoleate (from 100 to 400 µM) 
and CLA (from 100 to 400 µM). 
x Cytosolic 18:0 concentration was decreased by CLA (from 100 to 400 µM).  
x Cytosolic 20:0 concentration was increased by linoleate (from 100 to 400 µM), 
but for other fatty acid treatments 20:0 remained below 1.5 g / 100g (from 100 
to 400 µM) of fatty acid (See appendix 3). 
 
4.4.6.2 Monounsaturated fatty acids and trans fatty acids 
x Cytosolic 16:1 concentration was decreased by CLA (from 100 to 400 µM).  
x Cytosolic 18:1 trans-9 concentration was increased by elaidate (from 200 to 
400 µM); for other fatty acid treatments 18:1 trans-9 remained around 10 g / 
100g from 100 to 400 µM of fatty acid or not detectable.  
x Cytosolic 18:1 cis-9 concentration was increased by oleate (from 100 to 300 
µM).  
x Cytosolic 24:1 concentration was increased by palmitate (from 100 to 400 µM); 
for all other fatty acid treatments 24:1remained below 2.5 g / 100g from 100 to 
400 µM of fatty acid (See appendix 3). 
 
4.4.6.3 Polyunsaturated fatty acids 
x Cytosolic 18:2n-cis 6 concentration was increased by linoleate (from 100 to 
400 µM) and decreased by palmitate (from 100 to 400 µM); for the other fatty 
acid treatments 18:2n-cis 6 remained below 3.5 g / 100g from 100 to 400 µM 
of fatty acid.  
x Cytosolic CLA concentration was increased by CLA (from 100 to 400 µM); 
for all other fatty acid treatments CLA remained below 5g / 100g from 100 to 
400 µM of fatty acid or not detectable.  
x Cytosolic 20:4n6 concentration was decreased by oleate, vaccenate, and 
linoleate (from 100 to 400 µM); for all other fatty acid treatments 20:4n6 
remained below 1.7g / 100g from 100 to 400 µM of fatty acid or not detectable 
(See appendix 3). 
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4.4.6.4 Major fatty acid classes in cytosol 
x MUFA concentration was increased by oleate (from 100 to 300 µM) and 
elaidate (from 200 to 400 µM).  
x PUFA concentration was increased by CLA (from 100 to 400 µM).  
x SFA concentration was increased by linoleate (from 100 to 400 µM) and 
decreased by CLA (from 100 to 400 µM). 
x Trans fatty acid concentration was increased by vaccenate (from 100 to 300 
µM) and elaidate (from 200 to 400 µM).  
x UFA concentration was decreased by palmitate (from 100 to 300 µM), and 
increased by oleate and CLA (from 100 to 400 µM) (See appendix 3). 
 
4.4.7 Media fatty acid profile 
4.4.7.1 Saturated fatty acids 
x Media 18:0 concentration was decreased by palmitate (from 100 to 400 µM), 
vaccenate (from 200 to 400 µM) and CLA (from 200 to 400 µM) and increased 
by stearate (from 100 to 300 µM).  
x Media 21:0 concentration was increased by stearate (from 100 to 300 µM) 
(See appendix 3). 
 
4.4.7.2 Monounsaturated fatty acids 
x Media 18:1 cis-9 concentration was increased by oleate (from 200 to 400 µM) 
and palmitate (from 100 to 300 µM) (See appendix 3). 
 
4.4.7.3 Polyunsaturated fatty acids 
x Media 18:2n-cis 6 concentration was increased by linoleate (from 100 to 400 
µM); for the other fatty acid treatments 18:2n-cis 6 remained below 2.5 g / 
100g from 100 to 400 µM of fatty acid.  
x Media CLA concentration was increased by CLA (from 100 to 400 µM); for 
all other fatty acid treatments CLA was not detectable (See appendix 3). 
 
4.4.7.4 Major fatty acid classes in the media 
x Media trans fatty acids concentrations were increased by elaidate and 
vaccenate (from 100 to 400 µM) (See appendix 3). 
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4.5 Discussion 
This experiment is the first to study effects of FA (SFA, UFA, PUFA and tFA) at 
increasing concentrations on cytosolic TAG, protein and DNA contents, and FA 
profiles in mammary gland epithelial cells. The design of the experiment allowed 
analysis of cytosolic and media FA profiles whereas previous studies (Jayan and 
Herbein, 2000; Peterson et al., 2004; Yonezawa et al., 2004; Keating et al., 2008; 
Sorensen et al., 2008; Kadegowda et al., 2009; Thering et al., 2009; Kadegowda et al., 
2009) focussed on different aspects of mammalian physiology (i.e., enzymatic activity 
and gene expression). This experiment contributes to knowledge on lipid metabolism 
in bovine mammary gland cells and its biological significance in milk production 
because it allowed the study of lipid uptake without the interference from the cow’s 
digestive system and general metabolism. 
 
Milk fat is assembled in the mammary alveolar cells from FA derived partly by de 
novo synthesis from acetate within these specialized cells, and partly by absorption 
from the blood. Lipids produced by lactating bovine mammary cells are distinctive, 
which facilitates assessment of the biochemical fidelity of these cells when used in 
vitro (Kinsella et al., 1968). MAC-T cells have normal physiological responses to 
prolactin in that they produce milk constituents including Į- DQGȕ- casein and lactose. 
These cells thus provide a method of studying aspects of milk production in vitro 
(Turner et al., 1993).  
 
The design of the current experiment enabled examination of effects of different 
LCFA including tFA on cytosolic TAG accumulation and protein and DNA 
concentration. In the current experiment, control was used to show if there was any 
effect of increasing amounts of ethanol. Concentrations of the individual FA were 100, 
200, 300 and 400 µM. These concentrations were different from Jayan and Herbein 
(2000; 25, 50 and 100 µM of FA) and Keating et al. (2008; 15, 20, 30, 35, 37.5 and 
150 µM of FA) but similar to those used by Yonezawa et al. (2004, 2008; 50, 100, 200, 
300 and 400 µM of FA). In the current study, lower concentrations (< 100 µM of FA) 
were tested in a pilot experiment; however, cytosolic TAG accumulation was not 
enough to be measured. In experiments of Keating et al. (2008) and Yonezawa et al. 
(2004, 2008), FA were bound to bovine serum albumin. Albumin is the most abundant 
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serum protein and one of its main physiological functions is to bind and transport 
LCFA (Spector, 1986). Based on previous studies (Olofsson et al., 2004; Kadegowda 
et al., 2009; Thering et al., 2009), in the current experiment, ethanol was used to 
dissolve sodium salts of FA to avoid additional limitations on LCFA uptake by 
mammary epithelial cells (FA albumin binding process is selective due to varying 
degrees of configurational adaptability to its binding sites as FA increase in length; 
Ashbrook et al., 1975; Spector, 1975).   
 
4.5.1 Cytosolic TAG accumulation (mmol / well) 
Mammary epithelial cells accumulate TAG in their cytosol; in these cells, esterified 
FA such as TAG are derived either from plasma lipids or by de novo synthesis from 
acetate and butyrate (Clegg et al., 2001; Heid and Keenan, 2005). After lipoprotein 
lipase hydrolysis all FA are absorbed as free FA. The main hypothesis of the current 
experiment was that cytosolic TAG accumulation (mmol / well) may be stimulated by 
addition of LCFA at different concentrations and that LCFA may affect the FA profile 
of cytosolic FFA.  In the current experiment palmitate and elaidate increased 
accumulation of cytosolic TAG content. UFA treatments induced greater cytosolic 
TAG accumulation than SFA treatments suggesting that SFA are subjected to another 
metabolic pathway (or not absorbed by cells), and not either TAG synthesis or lipid 
droplet formation (Yonezawa et al., 2004). In this experiment, treatment 
concentrations linearly increased cytosolic TAG accumulation and had quadratic 
effect; this agrees in part with the increase in a concentration dependent manner in 
cytosolic TAG accumulation observed in primary cultured bMEC cells by Yonezawa 
et al., (2004).  
 
4.5.2 Cytosolic TAG accumulation normalized for protein (µg / mg protein) and 
DNA (µg of TAG / µg of DNA) contents 
In the current experiment, cytosolic TAG accumulation was normalized for protein 
(µg / mg protein) and DNA contents (µg of TAG / µg of DNA). Usually in cell 
cultures, protein content is used as cell proliferation indicator to eliminate variances 
from cell cultures and allow data comparisons with greater confidence. Normalization 
is a process by which data are corrected to remove sample-to-sample variability 
caused by factors other than those being tested in the experiment. These factors 
included variabilities in cell plating and pipetting inconsistencies (Schagat et al., 
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2007). Because MAC-T cells synthesise protein for inclusion in milk, cytosolic TAG 
accumulation normalized for protein may not be appropriate for this experiment. 
However, each cell has a fixed amount of DNA, so DNA content per well reflects the 
number of cells per well. Hence, when cytosolic TAG is corrected for DNA a measure 
of TAG per cell can be obtained and this is why it is more accurate than normalising 
for protein content.  
 
In the current experiment, when cytosolic TAG was normalized for protein content 
(µg / mg protein), palmitate, vaccenate, linoleate and CLA increased cytosolic TAG 
content. This is in agreement with Yonezawa et al. (2004), who reported that palmitate, 
and linoleate increased cytosolic TAG (µg / mg protein) in primary culture bovine 
mammary epithelial cells isolated from the mammary gland of a 102-d-pregnant 
Holstein heifer. However, in this experiment, cytosolic TAG accumulation (from 
221.9 to 919.4 µg / mg protein) achieved by MAC-T cells was greater than Yonezawa 
et al. (2004; from 54.8 to 122.6 µg / mg protein). In this experiment, treatment 
concentrations linearly increased cytosolic TAG (µg / mg protein) accumulation and 
had quadratic effect; this agrees in part with the increase in a concentration dependent 
manner in cytosolic TAG accumulation observed in primary cultured bMEC cells by 
Yonezawa et al., (2004).  
 
On the other hand, in the current experiment, palmitate and CLA increased cytosolic 
TAG adjusted for DNA content (µg of TAG / µg of DNA) and treatment 
concentrations linearly increased cytosolic TAG and had quadratic effect. Previous 
studies (Jayan and Herbein, 2000; Yonezawa et al., 2004, 2008) did not quantify 
cytosolic DNA contents.   
 
As Yonezawa et al. (2004, 2008), in this experiment, MAC-T cells were left for a 24 h 
incubation period. In the current experiment, sodium salts of LCFA were prepared 
using *&SXULW\DQGVXVSHQGHGLQDEVROXWHHWKDQROZKHUHDV<RQH]DZDHWDO
(2004, 2008) prepared their treatments (palmitate, stearate, oleate and linoleate) 
coupled with 0.5% FA free bovine serum albumin. In the study of Jayan and Herbein 
(2000), FA (stearic, oleic and vaccenic acids) were bound to bovine serum albumin, 
all media contained a basal concentration of 100 µM stearic acid and the cells were 
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left for a 3-d incubation period. In those studies, the chemical nature of the FA was 
not described.  
4.5.3 Cytosolic and media fatty acid profiles 
Results from cytosolic FA profiles were consistent with most of the FA treatments 
added to MAC-T cells. Oleate increased oleic acid (from 100 to 300 µM of FA), 
elaidate increased EA (from 200 to 400 µM of FA), linoleate increased linoleic acid 
(from 100 to 400 µM of FA), and CLA increased CLA (from 100 to 400 µM of FA). 
In the current experiment, effects on cytosolic FA concentrations were not consistent 
within FA classes (tFA, SFA and UFA):  
 
x SFA treatments: palmitate decreased UFA 
x Trans FA treatments: elaidate increased cytosolic MUFA and tFA 
x UFA treatments: oleate increased MUFA and UFA; linolate increased SFA; 
CLA increased PUFA and UFA and decreased SFA 
 
In the current experiment, stearate increased stearic acid (from 100 to 300 µM of FA), 
oleate increased oleic acid (from 200 to 400 µM of FA), linoleate increased linoleic 
acid (from 100 to 400 µM RI)$DQG&/$LQFUHDVHGĮ-linoleic acid (from 100 to 400 
µM of FA), in media samples. Only tFA class was affected by treatments. Media tFA 
concentrations were increased by elaidate and vaccenate (from 100 to 400 µM of FA). 
Those results may be explained due to the media enrichment of each individual FA 
added and perhaps the FA extraction method (Bligh and Dyer, 1959) included some of 
the FFA added as well as TAG.   
 
Perhaps the different effects of individual FA found in the current experiment may be 
due to specific activity that each FA has on enzymes (acetyl-CoA carboxylase; ACC 
and FA synthetase; FAS) involved in the biosynthesis of SFA and SCD responsible 
for catalyzing biosynthesis of UFA from SFA precursors in MAC-T cells (Jayan and 
Herbein, 2000). The ability for PUFA to down regulate the expression of genes for 
enzymes involved in FA synthesis, including ACC, FAS and SCD, has been 
recognised on membrane lipid composition (Salter and Tarling, 2007).  
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4.5.4 Cytosolic versus media fatty acid profiles 
 
Cytosolic stearate ranged from 34 to 46 g/100g whereas media ranged from 24 to 30 
g/100g at 100 to 400 µM of FA. Cytosolic oleate ranged from 18 to 37 g/100g 
whereas media ranged from 5 to 14 g/100g at 100 to 400 µM of FA. Cytosolic 
linoleate ranged from 14 to 34 g/100g whereas media ranged from 2 to 11 g/100g at 
100 to 400 µM of FA. Cytosolic CLA ranged from 6 to 38 g/100g whereas media 
ranged from 2 to 12 g/100g at 100 to 400 µM of FA. The tFA concentrations were 
decreased (from 0.1 to 13 g/100g) in media compared with cytosolic FA profiles 
(from 2 to 50 g/100g).  
Results from media FA profiles showed disappearance of some FA and that may 
indicate which FA were not incorporated and absorbed into cytosol of MAC-T cells. 
Only media FA profiles of stearate, oleate, linoleate and CLA were detected. Results 
found in the currents experiment may be attributed to different roles of LCFA in 
cellular metabolism. LCFA are taken up by cells and used for a large number of 
biological functions such as energy generation and storage, LCFA also contribute to 
phospholipid synthesis which are necessary for the structure, integrity and function of 
plasma membranes. FA modulate the function of enzymes and regulate the expression 
of multiple genes involved in FA metabolism (Hajri and Abumrad, 2002). 
The cellular uptake of LCFA may be due to passive diffusion through the lipid bilayer 
and protein-facilitated transport. The relative contribution of each component depends 
on the concentrations and molar ratios of FA and albumin in the circulation (Hajri and 
Abumrad, 2002).  In the circulation and extracellular medium, FA are carried 
quantitatively bound to albumin. Complexes of FA and albumin are used in uptake 
assays in vitro because FA adsorption to assay tubes and pipette walls and FA 
aggregation may have complications. In the absence of albumin or other FA binding 
protein, the concentration of LCFA that can be used is very low and is depleted by 
cells instantaneously; meaning that linear portion of the uptake time course would be 
too short to measure (Hajri and Abumrad, 2002). In the current experiment, ethanol 
used to dissolve sodium salts of FA probably affected FA uptake of LCFA (palmitic, 
stearic, oleic, linoleic and conjugated linoleic acids) and tFA (elaidic and vaccenic 
acids).  
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4.5.5 Cytotoxicity (lipotoxicity) 
In the current experiment, LCFA did not decrease cytosolic protein (mg / ml) or DNA 
(µg / ml) contents. However, it is well documented that accumulation of excess lipids 
in tissues leads to cell dysfunction or cell death (Shaffer, 2003). When cells 
accumulate more FFA than are required for anabolic or catabolic processes, excess 
lipid is esterified and stored as TAG in lipid droplets. Although TAG accumulation is 
essentially a condition of lipid overload, cellular TAG accumulation may initially 
serve a protective role. Accumulation of excess FFA in TAG pools diverts these 
molecules from pathways that lead to cytotoxicity and may thus serve as a buffer 
against lipotoxicity (Shaffer, 2003). 
 
4.5.6 Importance of FA groups on lipid metabolism 
LCFA have numerous roles in biological functions of cells, not only as an energy 
substrate but also as substrates for cell membrane synthesis and as precursors for 
intracellular signalling molecules (McArthur et al., 1999). Excess LCFA are stored as 
TAG in lipogenic tissues such as the adipose, liver, testis, ovary and the mammary 
gland. In the lead up to-, and during lactation, energy metabolism of cells is 
dramatically modified in order to enable synthesis of milk components (Barber et al., 
1997). Animals accordingly diminish the storage of nutrients, particularly of TAG, in 
adipose tissue. The lactating mammary gland thus uses LCFA which are derived from 
dietary fats and TAG released from the adipose tissue. Lactating mammary epithelial 
cells are highly active in synthesis of FA de novo (Clegg et al., 2001). Bovine 
mammary epithelial cells have the ability to produce a remarkable amount of lipid; 
hence, this lipogenic capacity probably affected results from the current experiment 
and influenced the transfer of some FA from cytosol to media by decreasing TAG 
accumulation in cytosol.  
 
In the current experiment, MAC-T cells incubated with SFA (palmitic and stearic 
acids), UFA (oleic acid), PUFA (linoleic and conjugated linoleic acids), tFA (elaidic 
and vaccenic acids), increased cytosolic TAG content; however, when TAG content 
was normalised for cytosolic DNA content SFA (palmitic acid) and PUFA (CLA) 
noticeably increased the amount of cytosolic TAG content. Hence, these findings may 
indicate that mammary epithelial cells accumulate lipids depending on chain length of 
the FA, degree of unsaturation and configuration. 
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Although activity of lipogenetic enzymes in mammary gland cells was not evaluated, 
the findings (cytosolic and media FA profiles) from the present study may 
complement previous studies. For example, Jayan and Herbein (2000) studied 
exogenous factors that were related to the synthesis of SFA and UFA in MAC-T cells. 
They analyzed effects of oleic and vaccenic acids on activities of ACC, FAS and SCD. 
ACC and FAS are major enzymes involved in biosynthesis of SFA in eukaryotic cells 
and SCD is responsible for biosynthesis of UFA from their saturated precursors. Jayan 
and Herbein (2000) reported that VA depressed activity of ACC and FAS, along with 
simultaneous enhancement of mammary desaturase activity and explained that the 
effects of exogenous FA on ACC and FAS in MAC-T cells were related to the 
biological function of FA in cells and tissues. For example, FA are components of cell 
membranes, and FA provided in the media of cultured mammary epithelial cells are 
primarily incorporated into cell membrane PL. Inhibition of lipogenesis in various 
tissues by LC-UFA has been reported; in rats, oleic acid and VA inhibited hepatic 
FAS activity and inhibited the conversion of glucose to lipids (Clarke et al., 1990).  
 
Fatty acids are components of cell membranes, and FA provided in the media of 
cultured mammary epithelial cells are primarily incorporated into cell membrane 
phospholipids (Baughman, 1995). The relative amounts of SFA and UFA, as well as 
the chain length of FA that constitute membranes, are important factors that determine 
membrane fluidity. In general, fluidity has an inverse relationship to chain length and 
a direct relationship to degree of unsaturation of FA. Jayan and Herbein (2000) noted 
that excess incorporation of unsaturated oleic acid and VA into cell membranes, 
especially at the expense of the corresponding saturated isomer, would increase 
membrane fluidity above normal limits. SC-SFA have the same effect on membrane 
fluidity as LC-UFA, meaning that both these groups enhance membrane fluidity when 
compared with LC-SFA. Therefore inhibition of ACC and FAS activities by the 
monounsaturated isomers could be a cellular response to reduce synthesis of SC-SFA. 
 
4.5.7 Trans fatty acids in lipid metabolism 
In the present study, at concentrations of 100, 200, 300 and 400 µM, EA and VA 
increased cytosolic TAG content (mmol / well). Jayan and Herbein (2000) found a 
concentration-dependent uptake of VA complexed to FA-free bovine serum albumin 
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at concentrations of 25, 50 and 100 µM; however, this is the first experiment using EA 
on MAC-T cells.  
 
Jayan and Herbein (2000) found that the position and geometry of the double bond is 
a factor deciding the influence of UFA on lipogenic enzyme activity. When compared 
with cis double bonds, trans double bonds have a more rigid structure and are less 
fluid in nature. It is possible that VA may compete with oleic acid for incorporation 
into cell membranes (oleic acid will be produced in bovine mammary epithelial cells 
by desaturation of stearic acid). Excess incorporation of VA at the expense of oleic 
acid would reduce fluidity of cell membranes and therefore enhanced synthesis of cis-
UFA from available substrates or precursors is prefered.  
 
 
4.6 Conclusions 
Overall, the results of this experiment demonstrate that cytosolic TAG accumulation is 
stimulated by addition of palmitate and EA at different concentrations, which affects 
FA profile of cytosolic FFA. Effects on cytosolic TAG accumulation are not 
consistent within FA classes (tFA, SFA and UFA) but depend on individual FA 
structure (chain length of the FA, degree of saturation and configuration, and number 
and orientation of FA double bonds). At concentrations of 100, 200, 300 and 400 µM, 
LCFA (palmitic, stearic, oleic, linoleic, elaidic, vaccenic and conjugated linoleic acids) 
did not have detrimental effects on MAC-T cells as determined by cytosolic protein 
and DNA content, presumably reflecting their role in lipid accumulation and secretion.  
 
4.7 Implications 
In this experiment, EA resulted to stimulate cytosolic TAG accumulation and based 
on protein and DNA content it did not have deleterious effect on mammary gland cells. 
This finding is important to dairy industry because it is known that MFD is caused by 
direct inhibition of mammary lipogenesis by tFA formed during the biohydrogenation 
of dietary UFA in the rumen. 
 
Data reported in the current experiment enhances knowledge on the regulation of milk 
fat synthesis which is vital to the development of nutritional strategies to improve the 
nutritional value of milk, decrease milk energy secretion and improve the energy 
balance of lactating ruminants. FA treatments used in the current experiment included 
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different lipid classes because in normal conditions dairy cow diets are supplied with 
lipids containing different FA classes, however, TAG accumulation and uptake into 
the mammary gland cell will depend on their individual structure.  
 
Understanding the regulation of milk fat synthesis is vital to the development of 
nutritional strategies to enhance the nutritional value of milk, decrease milk energy 
secretion and improve the energy balance of lactating ruminants. The current 
experiment did not assess enzymatic activity; however, it may be necessary to 
evaluate activity of lipogenic enzymes in mammary gland cells due to its importance 
on ruminal lipid metabolism and mammary specific regulation of cellular processes 
(Shingfield et al., 2010). 
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CHAPTER 5 
5. General discussion and conclusions 
5.1 General discussion  
Supplementation of ruminant diets with FA exerts a broad range of effects on milk 
composition, especially in the milk fat profile. Of particular interest to the current 
study were plasma transport and mammary uptake of tFA in dairy cows. Effects of 
dietary source of FA on the FA composition of plasma and lipoprotein fractions were 
studied, as well as effects of dietary lipids on tFA transportation within lipoprotein 
fractions and uptake of LCFA in epithelial mammary gland cell cultures (MAC-T 
cells). Characterization of the mechanisms by which dietary FA are transported and 
transferred to milk should improve current understanding of effects of dietary FA 
effects on milk FA profile and MFD.  
 
Ruminant diets typically contain a low percentage of fat, although a significant intake 
of PUFA is generated from forages and oilseeds and in some cases from fat 
supplements. Dietary FA are metabolized by ruminal microbes resulting in a large 
difference between dietary profile and FA profile absorbed from the small intestine 
(Doreau and Chilliard, 1997; Chilliard et al., 2000). Most dietary FA are esterified, 
and are almost completely hydrolyzed to free FA in the rumen. Unsaturated free FA 
are then isomerized (double-bond position and/or orientation changed) and reduced 
(saturation of double bond; Wallace et al., 2007). The resulting SFA and some of the 
biohydrogenation intermediates escape the rumen and are subsequently absorbed 
(Harvatine et al., 2009) (Figure 5.1). Trans FA isomers originate from incomplete 
ruminal biohydrogenation of UFA and might contribute to the development of MFD. 
Previous studies (Bauman and Griinari, 2001 and 2003; Shingfield and Griinari, 2007) 
have demonstrated a clear relationship between tFA and MFD. Although feeding 
unsaturated oils induced MFD, feeding completely hydrogenated (SFA) oils had 
minimal effects on milk fat yield.  
 
The aim of this thesis was to extend the knowledge on lipid metabolism of dairy cows. 
The experiments in this thesis studied the changes that dietary FA undergo in the 
rumen (during biohydrogenation), blood transport (plasma and cholesterol fractions) 
(Chapters 2 and 3) and mammary gland cell uptake (Chapter 4) (Figure 5.2).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Biochemical pathways for ruminal biohydrogenation and endogenous synthesis of FA in dairy cows (
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Figure 5.2 The experiments in this thesis studied some of the changes that occur in dietary FA from mouth to mammary gland  
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5.2 Ruminal pulses of dietary oils 
Ruminal pulses were used in the experiments described in Chapters 2 and 3 in order to 
include the impact of the biohydrogenation process on different 18:1 trans isomers. 
Previous studies used abomasal (Loor and Herbein, 2001; Mosley et al., 2006; 
Tyburczy et al., 2008) and duodenal (Chilliard et al., 1991, DePeters et al., 2001) 
infusions to specifically avoid biohydrogenation effects on dietary treatments. 
Supplementary oils did not bypass the rumen in these experiments and hence lipids 
had extensive effects on rumen microorganisms, as indicated reflected by changes in 
fermentation parameters, and on the biohydrogenation process, as indicated by plasma 
and lipoprotein FA profiles.  
 
Addition of lipids to the diet generally induces a decrease in ruminal degradation, 
especially of fibre. There are several factors responsible for variations in ruminal 
digestion (Doreau and Ferlay, 1992):  
 
1) Nature of FA supplied in the diet 
 
2) Percentage of lipids added to the diet, type of fat and any protection process 
 
3) Nature of the basal diet (ruminal digestive disturbances are greater with 
corn silage-based diets than with hay-based diets)  
 
Numerous experiments with oil supplements have been carried out in recent years; 
however, the effects of lipids are not completely explained by the factors just 
mentioned. Therefore, ruminal pulses were chosen to test if FA profiles (particularly 
tFA concentrations) of plasma and lipoprotein fractions are different depending on 
source of the dietary lipids. 
 
Fatty acids obtained after ruminal pulses resulted from extensive biohydrogenation of 
unsaturated FA (Doreau and Ferlay, 1994; Glasser et al., 2008). Rumen pulses do not 
bypass biohydrogenation hence FA supply to the duodenum will be more similar to 
when oilseeds or oils are included in the diet. Therefore rumen pulses are more 
representative of FA normally available to the animal. Post-ruminal infusions can be 
used to test hypotheses about intestinal uptake, but they only mimic rumen protected 
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lipids (Glasser et al., 2008). In real production conditions, there is a loss of FA from 
the rumen either by absorption across the ruminal epithelium or by catabolism to VFA 
or C02. In addition, microbes synthesize FA de novo from carbohydrate precursors. 
Therefore, lipids reaching the duodenum consist of FA from both dietary and 
microbial origins (Jenkins, 1993). 
 
The relative short treatment (single administration per day), sampling (3 d) and 
washout periods (4 d) in Chapters 2 and 3 were selected to include the extensive 
biohydrogenation effects on oil pulses that are often observed during the first few 
hours after administration (Doreau et al., 1989).  Oil administration method can affect 
how long the oil remains in the rumen. With continuous infusion, oil concentration in 
the rumen varied slightly throughout the day and night. With single administration, oil 
concentration is higher during the first few hours after administration and lower 
during the subsequent hours (Ferlay and Doreau, 1992). Because cows were ruminally 
pulsed with less than 300 g/d of oil, a 3 d sampling period was chosen (adapted and 
modified from Loor and Herbein, 2001; Kadegowda et al., 2008 and Castaneda-
Gutierrez et al., 2007) with a 4 d whashout period.  
 
5.3 Ruminal fermentation 
Dietary lipids rich in either PUFA or tFA alter the rumen environment. The data in 
Chapters 2 and 3 indicated that dietary oil supplementation affects ruminal 
fermentation in ruminants. In the first experiment, ruminal pulses of both SO (high in 
PUFA) and PHVO (high in preformed tFA) reduced ruminal NH3-N and total VFA 
concentrations, which suggests that dietary lipids inhibited microbial activity. On the 
other hand in Chapter 3, FO (used to induce high concentrations of tFA, CLA and LC-
PUFA) resulted in higher concentrations of propionate than FO/PHVO (used to induce 
high concentration of tFA) and there was no differential effect between them on 
ruminal NH3-N and total VFA concentrations. The lack of FA treatment effects on 
ruminal NH3-N and total VFA concentrations is in agreement with the findings of 
Shingfield et al. (2010) who studied the effects of incremental amounts (0, 8, 16 and 
24 g/kg of DM) of FO as a source of EPA and DHA on ruminal lipid metabolism and 
duodenal flow of FA in steers fed maize silage-based diets. They reported that 
inclusion of FO in the diet had no effect on rumen pH and NH3-N concentrations but 
as in these experiments, tended to decreased total rumen VFA concentrations. The 
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effect of lipid supplementation on ruminal fermentation relies mainly on three factors: 
firstly, the type of oil (Wachira et al., 2000), secondly, the level of oil inclusion in the 
diet (Shingfield et al., 2008) and thirdly, the dietary forage:concentrate ratio, since 
animals fed a concentrate-rich diet might be more likely to be adversely affected by 
oil supplementation (Ueda et al., 2003). Dietary factors that affect ruminal 
fermentation (e.g. high carbohydrate fermentability, high oil) modify ruminal FA 
metabolism through complex associative effects that result in altered ruminal 
microbial populations, altered pathways of PUFA biohydrogenation and ruminal 
outflow of a wide range of biohydrogenation intermediates and this is reflected in the 
milk FA composition. The predominant metabolic pathways and the microbial 
capacity for isomerization and biohydrogenation depend on the microbial population 
and the ruminal environment (Allen, 2000; Palmquist et al., 2005; Jenkins et al., 
2008).  18:1 trans isomers from ruminal biohydrogenation serve as precursors for the 
synthesis of SFA in the rumen and of CLA within the tissues of the animal. For 
H[DPSOH9$LVUHGXFHGLQWKHUXPHQWRIRUPRULVGHVDWXUDWHGE\ǻ9-desaturase 
in the mammary tissue, producing 18:2 cis-9, trans-11, the most abundant CLA 
isomer in milk (Griinari and Bauman, 1999). This isomer has been shown to have 
antioxidant and anticarcinogenic properties (McDonald, 2000). Another CLA isomer, 
18:2 trans-10, cis-12, which can be produced in the rumen, has been linked to 
decreased body fat deposition in animals and humans (Blankson et al., 2000; Gavino 
et al., 2000). This isomer has also been shown to be responsible for decreased milk fat 
synthesis (Baumgard et al., 2000). Furthermore, the concentration of 18:1 trans-10 in 
milk fat is directly correlated with milk fat depression (Griinari et al., 1998).   
 
5.4 Plasma fatty acid profile 
The biohydrogenation process had an extensive effect on concentrations of FA 
observed in plasma and lipoprotein fractions. The main hypothesis being tested in 
those experiments was that FA profiles of plasma and lipoprotein fractions would be 
different depending on source of the dietary lipids (SO, PHVO and FO), which would 
lead to differences in 18:1 trans isomers (Chapter 2 and 3). This hypothesis was 
supported by the differences in the tFA isomers concentrations of plasma and 
lipoprotein fractions, particularly in the LDL+VLDL (Chapter 2) and VLDL (Chapter 
3) fractions.  
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Results from the in vivo experiments confirmed that treatments had the desired effect 
on tFA concentrations of plasma and lipoproteins, for example, in Chapter 2 
concentration of EA in PHVO was higher than SO because EA is the major trans 
isomer found in PHVO (Meijer et al., 2001). On the other hand, undetectable VA 
concentrations were observed in SO, but biohydrogenation resulted in high 
concentrations of VA in plasma and lipoprotein fractions. Inclusion of vegetable oils 
high in PUFA into concentrate diets raises VA and 18:2 cis-9, trans-11 content in 
milk fat (Bauman et al., 2000; Shingfield et al., 2006). Compared with HDL fraction, 
concentrations of tFA were increased almost 3-fold in LDL fraction. These results 
indicate which lipoprotein fraction is involved in transportation of tFA. SO and PHVO 
increased plasma concentrations of tFA. The increase in trans isomers across plasma 
and lipoprotein fractions with SO and PHVO reflects modification of rumen microbial 
population and pathways of biohydrogenation usually caused by supplementation with 
dietary PUFA. Those changes promote formation and accumulation of 
biohydrogenation intermediates, some of which are potent inhibitors of milk fat 
synthesis (Bauman and Griinari, 2003). 
 
In Chapter 3, compared with PHVO, FO increased VA in plasma and lipoprotein 
fractions which is in agreement with AbuGhazaleh et al. (2007) who compared the 
effect of FO and sunflower oil supplementation on milk CLA cis-9, trans-11 when 
dairy cows were managed on pasture or in confinement. They found that FO and 
sunflower oil supplementation resulted in higher milk VA, CLA cis-9, trans-11 and 
lower 18:1 trans-10 concentrations and yields in pasture-fed cows compared with 
confinement-fed cows. Likewise, Cruz-Hernandez et al. (2007) evaluated different 
levels of inclusion of sunflower oil (1.5, 3 and 4.5 % of DM) and a constant level of 
FO (0.5 % of DM) to increase VA and RA in milk and examine the content and 
composition of CLA and 18:1 trans isomers, and found that supplementation of 
sunflower oil and FO reduced milk fat but milk protein and lactose levels were not 
affected.  
Changes found in tFA isomers of plasma and lipoprotein fractions are a result of 
biohydrogenation effects and type of oil pulsed. Trans FA and CLA isomers are the 
predominant intermediates produced from ruminal metabolism of linoleic acid 
(Harfoot and Hazelwood, 1988); however, ruminal biohydrogenation pathways are 
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dynamic, allowing the production of a wide range of positional and geometric isomers 
as well as modified FA such as hydroxy and keto derivatives (Palmquist et al., 2005; 
Jenkins et al., 2008). These isomers are absorbed and incorporated into milk fat, 
thereby allowing the milk FA profile to be used as a proxy for changes occurring in 
the rumen. Although linoleic acid give raise to different FA intermediates in the 
biohydrogenation process, other PUFA including the long-chain n-3 FA are also 
biohydrogenated and likely produce unique FA intermediates (Harvatine et al., 2009). 
Milk fat depression induced by PUFA supplementation in lactating ruminants 
(Peterson et al., 2003; Bauman et al., 2006)  is caused by 18:1 trans isomers produced 
as intermediates during ruminal biohydrogenation of 18:2n-6 which affect milk yield 
and milk fat yield (Capper et al., 2008). Hence, supplementing oils in dairy cow diets 
has to be carefully balanced to avoid milk fat depression and increase the nutritional 
value of milk fat for human consumption. 
5.5 Lipoprotein fractions 
In Chapters 2 and 3, differences in tFA concentrations due to type of oil pulsed led to 
major changes in most 18:1 trans isomers in plasma and lipoprotein fractions, this is 
in agreement with observations in plasma by Loor and Herbein (2001) in which 
ruminal infusions of CLA mixtures were used.   
 
In Chapter 2, SO and PHVO increased 18:1 trans isomers in HDL and LDL+VLDL 
fractions whereas FO and FO/PHVO increased 18:1 trans isomers in the VLDL 
fraction in Chapter 3, that may be attributed to an inhibition of the biohydrogentation 
reduction steps of 18:1 trans isomers to 18:0 by LC-PUFA present in SO, FO and 
PHVO (Shingfield et al., 2003; AbuGhazaleh and Jenkins, 2004; Lee et al., 2005; 
Loor et al., 2005; Or-Rashid et al., 2008).  
 
In Chapter 2, concentrations of tFA were 2 times greater in LDL+VLDL than HDL 
fraction; however, concentrations of tFA were 2 times greater in VLDL than HDL and 
LDL fractions in Chapter 3. These results supported findings from Chapter 2 in which 
further fractionation was suggested to distinguish between true LDL fraction and 
chylomicrons, and VLDL that are also present in this fraction.  
Overall, results from Chapters 2 and 3 showed that VLDL fraction is the main tFA 
transport mechanism. Most of the FA is associated with TG (and perhaps 
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phospholipids). Normally, 70-90% of bovine plasma cholesterol is in the HDL 
fraction; thus it is expected that the preponderance of tFA would also be in this 
fraction (Herdt et al., 1995). However, if tFA are coming directly from the intestine, 
they will be present in the chylomicron/VLDL fraction, but if they are incorporated 
into tissues and then released again, they will be found in LDL (which is formed from 
VLDL) and/or HDL fractions. 
 
5.6 Fatty acid composition of the lipoprotein lipids 
Results from Chapter 2 and 3 differ from those reported by Offer et al. (2001) because 
treatments were administrated as ruminal pulses and were exposed to a direct ruminal 
biohydrogenation rather than being supplemented in the diet. The differences between 
FA profile of oils supplied as ruminal pulses is another factor that may explain the 
variation in concentrations of certain FA within each lipid sub group (Ashes et al., 
2000; Offer et al., 2001). For example, DePeters et al. (2001) attributed changes in 
carbon number for TG structure to high proportions of LCFA and medium chain FA 
associated with canola oil infused either in the rumen or abomasum. Also, stage of 
lactation has an important effect on FA utilization needed to satisfy specific energy 
requirements and this may be reflected in the FA profile of lipoprotein lipid subgroups 
found in our in vivo experiments (non-lactating cows) compared with those reported 
by Offer et al. (2001) (mid-lactational cows). The results presented make an important 
contribution to our understanding of the transfer mechanisms of long-chain PUFA 
from diet to milk due to selective incorporation of FA into certain plasma lipoprotein 
classes (i.e., cholesteryl esters, triglycerides, and phospholipids) which may be 
ineffective in delivering FA to the mammary gland.  
 
In Chapter 2, concentrations of LDL+VLDL-TG appeared to be the major lipid 
subgroups carrying plasma lipids and tFA, however after further lipoprotein 
separation (Chapter 3), concentrations of HDL-TG appeared to be the major lipid 
subgroups carrying plasma lipids and LDL-CE the main lipid sub group involved in 
the transportation of some 18:1 trans isomers (VA, EA and 18:2 trans6) in bovine 
plasma. Approximately, more than 90% of plasma FA are carried by HDL fraction, 
mainly in the CE and PL lipid subgroups (Offer et al., 2001), conversely, the 
mammary gland appears to take up TAG from chylomicrons, VLDL and LDL 
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fractions, but not from HDL fraction, and it does not use esterified FA from LDL or 
HDL fraction (Christie, 1981).  
 
5.7 Cellular fatty acid metabolism  
Findings from Chapter 4 enhance knowledge of lipid metabolism in bovine mammary 
gland cells and its biological significance in milk production because they allowed the 
study of lipid uptake without interference from the cow’s digestive system and general 
metabolism. Chapter 4 reported effects of different FA groups (SFA, UFA, PUFA and 
tFA) on concentrations on cytosolic TAG, protein and DNA contents to explore 
whether there was any significant discrimination on absorption of exogenous FA by 
mammary gland epithelial cells. The design of the experiment allowed analysis of 
cytosolic and media FA profiles whereas previous studies (Jayan and Herbein, 2000; 
Peterson et al., 2004; Yonezawa et al., 2004; Keating et al., 2008; Sorensen et al., 
2008; Kadegowda et al., 2009; Thering et al., 2009; Kadegowda et al., 2009) focused 
on enzymatic activity and gene expression.  
 
Although albumin complexes carry FA derived from stored TAG in adipose tissue  
(Spector, 1986), based on previous studies (Olofsson et al., 2004; Kadegowda et al., 
2009; Thering et al., 2009), ethanol was used to dissolve sodium salts of FA to avoid 
additional limitations (The FA-albumin binding process is selective due to varying 
degrees of configurational adaptability to albumin binding sites as FA increases in 
length; Ashbrook et al., 1975; Spector, 1975) for LCFA uptake by epithelial 
mammary cells.  
 
Information is also provided on LCFA metabolism from bovine mammary gland cells. 
LCFA have many roles in the biological function of cells, not only as energy 
substrates but also as substrates for cell membrane synthesis and as precursors for 
intracellular signalling molecules. Excess LCFA are stored as TAG in lipogenic 
tissues such as adipose, liver, testis, ovary or mammary gland. During the 
periparturient period, the energy metabolism of cells is dramatically modified in order 
to enable synthesis of milk components. Animals accordingly diminish storage of 
nutrients, particularly TAG, in adipose tissue. The lactating mammary gland thus 
utilizes LCFA which are derived from dietary fats and TAG released from adipose 
tissue. Lactating mammary epithelial cells are also highly active in de novo FA 
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synthesis. Each gram of mammary gland tissue is known to produce 1 to 2 ml of milk 
per day, and 2 to 600 g fat/l milk depending on the animal species. Thus, mammary 
epithelial cells have the ability to produce a remarkable amount of lipid (Yonezawa et 
al., 2008). When cells accumulate FFA for anabolic or catabolic processes, lipids are 
esterified and stored as TAG in lipid droplets (Schaffer, 2003). Although it is known 
that accumulation of excess lipids in many tissues leads to cell dysfunction or cell 
death, LCFA and tFA treatments did not appear to have detrimental effects on MAC-T 
cells as determined by cytosolic protein (mg / ml) and DNA (µg / ml) content, 
presumably reflecting their role in lipid accumulation and secretion.  
 
Palmitate and elaidate increased accumulation of cytosolic TAG (mmol/well) content. 
However, Yonezawa et al. (2004) reported that palmitate, stearate, oleate and linoleate 
increased cytosolic TAG (µg / mg protein) in primary culture bovine mammary 
epithelial cells. UFA treatments induced greater cytosolic TAG accumulation than 
SFA treatments suggesting that SFA are subjected to another metabolic pathway (or 
not absorbed by cells), and not either TAG synthesis or lipid droplet formation 
(Yonezawa et al., 2004). 
 
Palmitate and CLA increased cytosolic TAG adjusted for DNA content (µg of TAG / 
µg of DNA). However, previous studies (Jayan and Herbein, 2000; Yonezawa et al., 
2004, 2008) did not quantify cytosolic DNA content. Cytosolic TAG accumulation 
was normalized for protein (µg / mg protein) and DNA content (µg of TAG / µg of 
DNA). However, as each cell has a fixed amount of DNA, changes in DNA content 
reflects the number of cells present. Hence, when cytosolic TAG is corrected for DNA 
a measure of TAG per cell can be obtained and this is why it is probably more 
accurate than normalising for protein content. Moreover, because MAC-T cells 
synthesise protein for inclusion in milk, cytosolic TAG accumulation normalization 
for protein may not be appropriate for this experiment. 
 
When cytosolic and media FA profiles were compared, it was found that tFA 
concentrations were decreased (from 0.1 to 13 g/100g) in media compared with 
cytosolic FA profiles (from 2 to 50 g/100g). Compared with cytosolic FA profiles, 
only stearate, oleate, linoleate and CLA were detected in media. These results are 
attributed to different roles of LCFA in cellular metabolism. LCFA are taken up by 
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cells and used for a large number of biological functions such as energy generation 
and storage, LCFA also contribute to phospholipid synthesis which is necessary for 
the structure, integrity and function of plasma membranes. FA modulate the function 
of enzymes and regulate the expression of multiple genes involved in FA metabolism 
(Hajri and Abumrad, 2002). 
The design of the current experiment was different to previous studies (Jayan and 
Herbein, 2000; Yonezawa et al., 2004, 2008) in the following ways: 
 
x Use of MAC-T cells 
x Use of ethanol to couple FA treatments 
x Individual FA concentrations 
x Quantification of DNA (to normalise cytosolic TAG content) 
The effects of FA treatments on cytosolic TAG accumulation and FA profiles found in 
cytosol and media may be due to: 
 
x Specific activity that each FA has on enzymes involved in FA 
biosynthesis 
x Competition between different FA for uptake 
x Chain length of the FA, degree of saturation and configuration 
x Number and orientation of FA double bond 
x FA extraction might include some of the FFA added as well as TAG 
 
5.8 Importance of the results shown in this thesis 
Overall, results reported in this thesis are important in that they extend our knowledge 
of lipid metabolism of dairy cows. In this thesis, the design of the experiments aided 
understanding of how FA (especially tFA isomers) are transported in blood. On the 
other hand, accumulation of TAG was studied in mammary epithelial cells to 
comprehend how FA are metabolised and absorbed in mammary epithelial cells, 
therefore findings from this thesis cover some aspects that help to understand 
synthesis of milk FA. This is important because milk fat plays a central role in dairy 
products and farm efficiency, fat is a major contributor to the energy concentration of 
whole milk and is essential to many of the physical properties, manufacturing qualities 
and organoleptic characteristics of dairy products.  
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From the producers’ perspective, milk fat represents a major component of the value 
of milk, but it is also a significant portion of the energy cost of lactation. Fat is the 
most variable component of milk and is affected by many factors including genetics, 
physiological state and environment. However, milk fat is especially responsive to 
nutrition, providing a practical tool to alter its yield and composition. Diet induced 
MFD, or low-fat milk syndrome, is characterized by a decrease in milk fat yield of up 
to 50%, with no change in milk yield or in the yield of other milk components 
(Bauman and Griinari, 2001). MFD is classically observed in ruminants fed highly 
fermentable diets or in diets that contain plant or FO supplements. MFD is also a 
useful variable for evaluating herd management; in many cases onset of diet induced 
MFD is an indication of modified ruminal fermentation and in more pronounced cases 
this can be associated with ruminal acidosis and reduced ruminal efficiency (Bauman 
and Griinari, 2001). Trans 18:1 isomers have received much less attention due to the 
technical challenges of making purified preparations, however, in this thesis, oils high 
in EA and VA were fed in vivo whereas purified EA and VA were used in cultured 
mammary cell experiments. 
 
In this thesis, VLDL fraction was found to be the lipoprotein responsible for the 
transport of the majority of tFA. Traditionally, trans and saturated FA in milk fat have 
caused concern among human health experts, although more recently milk fat has 
garnered appreciation as a functional food due to the health-promoting potential of 
some FA found specifically in ruminant-derived products (Bauman et al., 2006). 
During recent decades, increasing emphasis has been placed on the contribution of 
ruminant derived foods on the development or prevention of chronic human diseases 
including cancer, cardiovascular disease and insulin resistance. Milk and dairy 
products are the main source of 12:0 and 14:0 in the human diet and also provide a 
major contribution to total 16:0 and tFA consumption in industrialized countries 
(Givens and Shingfield, 2006). Production of ruminant milk with a FA profile more in 
line with public health recommendations has the potential to improve long-term 
human health without requiring substantial changes in consumer eating habits 
(Shingfield et al., 2010). Findings reported in this thesis showed how tFA are 
transported and accumulated into mammary gland epithelial cells hence these data can 
be used to predict the amount of FA secreted in milk with positive human health 
effects such as VA and CLA when cows are supplied with SO and FO. 
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Understanding the role of diet on milk fat synthesis and the underlying mechanisms 
regulating mammary lipogenesis in ruminants is central to the formulation of diets 
and/or supplements for strategic changes in milk fat content and composition. 
Numerous reviews have considered the effect of nutrition on milk fat synthesis in 
ruminants (Bauman and Griinari, 2003; Chilliard et al., 2007; Shingfield and Griinari, 
2007), whereas several appraisals have considered possible molecular mechanisms 
underlying diet-induced changes in mammary lipogenesis and fat secretion (Bauman 
et al., 2008; Bernard et al., 2008; Harvatine et al., 2009). Recent evidence on factors 
regulating mammary lipogenic enzyme activity and gene expression in ruminants is 
also considered within the context of highlighting areas for further investigation and 
providing an insight into the possible causes for variable milk fat secretion responses 
to changes in diet composition between ruminant species (Shingfield et al., 2010). 
 
5.9 Limitations 
There are several factors affecting milk fat composition that were not studied in the 
experiments described. Ruminant milk FA composition is linked to intrinsic (animal 
species, breed, genotype, pregnancy and lactation stages) or extrinsic (environmental) 
factors (Palmquist et al., 1993; Chilliard and Ferlay, 2004; Chilliard et al., 2007). In a 
given animal species, the effects linked to breed or genotypes are significant but 
restricted and they can only be achieved over long terms. For example, the effect of 
lactation stage on milk fat content and FA composition is perceptible and mainly 
associated to body fat mobilization in early lactation (Chilliard et al., 1991, 2007), but 
it only lasts a few weeks each year.  
 
Because non-lactating cows were used in Chapters 2 and 3; caution is needed when 
data are extrapolated to real dairy production conditions. FA profiles reported in those 
chapters may be different from lactating cows because milk fat composition is 
affected by stage of lactation. More importantly, FA metabolism is affected by 
lactation, which greatly increases metabolic demand for FA and precursors. At 
initiation of lactation, cows are in negative energy balance, causing mobilization of 
adipose FA and incorporation of these LCFA into milk fat. However, high uptake of 
LCFA inhibits de novo synthesis of short chain FA by mammary tissue (Belyea et al., 
1990; Palmquist et al., 1993). For example, Auldist et al. (1998) found that milk from 
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early lactation (30 d) contained less short chain FA (4:0 to 12:0) than milk from 
middle (120 d), and late (210 d) lactation periods in New Zealand cows. Such effects 
were attributed to the physiological inability of dairy cows in early lactation to 
consume enough dry matter to meet their energy requirements. Synthesis of 4:0 to 
12:0 in the mammary gland increased during early lactation then decreased whereas 
mobilization of FA from adipose tissue was increased (Palmquist et al., 1993; Jensen, 
2002). Garnsworthy et al. (2006) reported variations in the concentration of milk 
citrate (constituent of milk that affects milk processing characteristics) with regard to 
stage of lactation. This fluctuation was associated to de novo synthesis of FA and 
independent to diet and milk yield. 
 
For any dietary strategy to be useful, it must not compromise rumen fermentation and, 
concomitantly, dry matter intake and animal production and/or performance 
(Lourenço et al., 2010). As in the present experiments, others have often report the 
effect of different nutritional strategies on lipid metabolism, but no further information 
is given on the impact of a particular strategy on the whole ruminal function and 
adaptation processes. It may be possible that the 3-day pulsing periods used in 
Chapters 2 and 3 were not enough to evaluate the extensive effects of oils (SO, FO 
and PHVO) on ruminal microbiota given that in real production conditions the 
ruminal microbial ecosystems can adapt to different diets and hence FA profiles 
reported for plasma and lipoproteins may be underestimated (Fernando et al., 2010). 
Moreover, extended pulsing periods could reflect time-dependent ruminal adaptations 
to supplied lipids, which would lead to alterations in the formation of specific 
biohydrogenation intermediates (tFA and CLA isomers) (Shingfield et al., 2006) and 
might also affect the animal’s general metabolism and feed intake. 
 
Despite the fact that ruminal pulses were used to study the effect of SO, FO and 
PHVO on the biohydrogenation process, results may be more useful for dairy 
production systems if cows were fed a total mix ration including those oils. Practically, 
supplying dairy cow diets with supplements that increase VA production in the rumen 
can improve the ratio of unsaturated to saturated FA in milk fat (Jayan and Herbein, 
2000). In Chapter 4, EA and VA were used along with other purified FA treatments, 
however in real dairy production conditions; supplementing cows with specific FA is 
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not possible because it would be too expensive. In dairy farms, feeding grass and 
linseed is commonly used to increase VA production in the rumen.  
 
Because in Chapter 4 ethanol was used to dissolve sodium salts of FA allowing FA 
uptake into the cytosol of epithelial cells, cytosolic TAG, DNA and protein contents 
may be different if FA treatments were bound to albumin.  
 
5.10 Implications 
Data reported in Chapters 2 and 3, showed that different sources of tFA (SO, FO and 
PHVO) augmented tFA contents in HDL, LDL and VLDL fractions. Such findings 
suggest that feeding cows with oils rich in UFA and tFA might produce milk with 
high concentrations of FA undesirable for human consumption and reduce intake of 
digestible energy (Harvatine and Allen, 2006), milk fat content and yield compared 
with typical diets (Griinari et al., 1998; Piperova et al., 2000; Peterson et al., 2003; 
Loor et al., 2005).  
 
Milk fat depression induced by PUFA supplementation in lactating ruminants has 
been reviewed in detail (Peterson et al., 2003; Bauman et al., 2006) and it is clear that 
specific FA produced as intermediates during ruminal biohydrogenation of 18:2n-6 
play a significant role in reducing milk fat synthesis (Peterson et al., 2003). This 
mechanism would explain the decrease in milk fat concentration conferred by FO 
supplementation, in combination with effects of diet upon milk yield and milk fat 
yield (Capper et al., 2008). Hence, use of dietary SO and PHVO (Chapter 2) or FO 
(Chapter 3) in the dairy diet has to be carefully balanced to avoid milk fat depression 
and increase the nutritional value of milk fat. 
Data reported in Chapter 4 enhances knowledge on the regulation of milk fat synthesis 
which is vital to the development of nutritional strategies to improve the nutritional 
value of milk, decrease milk energy secretion and improve the energy balance of 
lactating ruminants. FA treatments used in Chapter 4 included different lipid classes 
because in normal conditions dairy cow diets are supplied with lipids containing 
different FA classes. Results from Chapter 4 showed that FA uptake of mammary 
gland cells depends on FA individual chemical structures (chain length of the FA, 
degree of saturation and configuration, and number and orientation of FA double 
bonds). Likewise, results from tFA content in plasma and lipoprotein fractions in 
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Chapter 2 and 3 demonstrated that there are clear differences in their plasma transport 
that may exert an effect on mammary uptake and utilization of 18-carbon FA, and 
these results might be related to the location, orientation, and number of double bonds 
(Tyburczy et al., 2008).  
 
5.11 Future work 
Overall, data presented in this thesis are helpful in understanding transport and 
mammary uptake of tFA. However, further studies are needed to see if the same 
responses are found in lactating cows and with different sources of FA. 
 
Further studies are required to explore mechanisms by which PUFA exert their toxic 
effects. If we can understand how selective FA toxicity, or indeed other factors, 
affects the physiology of biohydrogenating bacteria in the rumen, we may be able to 
suggest new, rational dietary modifications that will eventually lead to ruminant 
products that are healthier for human consumption (Maia et al., 2010). 
 
There is a growing concern about environmental impact of animal production systems, 
for that reason, more research would be desirable to understand how dietary tFA 
interact with methanogenic Archae. Manipulating metabolism of lipids in dairy cows 
may be helpful to reduce environmental impact of dairy production systems. Plant oils 
and oilseeds in ruminant diets decrease methanogenesis in ruminants (Machmüller et 
al., 2003; Martin et al., 2008; Beauchemin et al., 2009). Due to the interrelationship 
between diet composition, rumen metabolism and mammary lipogenesis, on-farm 
feeding regimens for decreasing greenhouse gas emissions or altering milk FA 
composition can also be expected to influence milk fat content (Chilliard et al., 2009) 
depending on diet composition and ruminant species.  
 
Understanding the regulation of milk fat synthesis is vital to the development of 
nutritional strategies to enhance the nutritional value of milk, decrease milk energy 
secretion and improve the energy balance of lactating ruminants. Molecular based 
techniques have provided an insight into the molecular mechanisms underlying the 
nutritional regulation of mammary lipogenesis in ruminants. Future experiments 
examining changes in the mammary transcriptome should provide a more 
comprehensive insight into the role of specific metabolites on milk fat synthesis in 
ruminant species. 
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5.12 Conclusions 
This thesis has studied some aspects of metabolism of FA in dairy cows, particularly 
tFA concentrations in plasma and lipoprotein fractions. Comparison of plasma 
lipoprotein fractions and FA profiles from cows subjected to ruminally pulsed 
treatments was assessed to understand the effects of dietary lipids on transportation of 
tFA among the plasma cholesterol fractions.  LCFA uptake in epithelial mammary 
gland cell cultures on MAC-T cells line was carried out to evaluate the effects of 
lipids on the transportation of FA in epithelial mammary gland cell cultures.  
 
The current study demonstrates that: 
 
I. The LDL fraction is the main transport mechanism of tFA and is more 
responsive to supply of tFA and PUFA and hence, tFA concentrations of 
plasma and lipoprotein fractions can be changed by dietary lipids.  
 
II. Dietary lipids rich in either PUFA or tFA can alter ruminal VFA and NH3-N.  
 
III. SO (induced high VA production in plasma lipoproteins), PHVO (induced 
high concentrations of tFA in plasma lipoprotein fractions) and FO 
(interrupted biohydrogenation of C18 PUFA, resulting in increased production 
of VA) can increase plasma and lipoprotein-fraction concentrations of tFA.  
 
IV. Cytosolic TAG accumulation is stimulated by the addition of palmitate and 
elaidate at different concentrations affecting FA profile of cytosolic FFA. 
Cytosolic TAG accumulation depends on individual chemistry of FA (chain 
length of the FA, degree of saturation and configuration, and number and 
orientation of FA double bonds).  
 
Overall, the information from this thesis, strengths understanding of some aspects of 
milk fat synthesis (Chapter 4) and metabolism of FA in dairy cows and also, data from 
this thesis can be used to predict milk FA profiles from cows fed with different 
sources of tFA (SO and FO). Findings from this thesis are important because tFA in 
milk fat have caused concern among human health researchers and more recently milk 
fat has gained appreciation as a functional food due to the health-promoting potential 
of some FA (VA and CLA) found specifically in ruminant-derived products 
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A p p e n d i x  1 
Methods associated with in vivo 
experiments 
 
x Plasma and lipoprotein fatty acid 
analysis 
x Plasma lipoprotein fractions 
x Dialysis of lipoproteins 
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A.1.1 Fatty acid analysis of plasma and lipoprotein fractions 
Preparation: 
Make reagents up just before experiment is carried out and keep cool. 
1. Rinse clean tubes with hexane and leave to dry. 
2. Adequately label tubes. 
Extraction: 
3. Pipette 1ml of plasma directly into a labelled tube with screw cap. 
4. Add known amount of pentadecanoic acid to tube (200µl). 
5. Add 3.75ml of cold, freshly made chloroform: methanol (1:2) mix and vortex 
for 1 min, 18ml chroloform + 36ml methanol (for 12 samples). 
6. Add 1.25ml cold chloroform. 
7. Add 1.25ml of HPLC water and mix (giving final extraction ratio of 
chloroform: methanol: water as 10:9:9 v/v. Vortex for 1 min. 
8. Centrifuge at 3400rpm at 15ºC for 15min. 
9. Aspirate water above protein layer in test tube. 
10. Collect lower organic chloroform phase, containing lipids into labelled tube 
using a long form Pasteur pipette. 
11. Dry down under a steady stream of nitrogen gas at 40ºC. 
12. *Rinse walls of test tube with 1ml chloroform (extracted lipids at this time can 
be stored in -20ºC). 
 
Methylation: 
13. Take tubes out of -20ºC and bring to room temperature, evaporate chloroform 
to dryness. 
14. Heat oxalic acid at 95ºC (in dessicator) for 30mins in oven. 
15. Weigh out 0.2g of oxalic acid and add 6ml diethyl ether, this is the termination 
reagent.  
16. 7RPDNHXSPOPHWK\ODWLRQUHDJHQW8VHȝO1D20HDQGPO
HPLC methanol. 450µl of NaOMe + 2.05ml Methanol (for 12 samples) 
17. Add 2ml hexane to dried sample. 
18. $GGȝOPHWK\ODFHWDWHWRHDFKWXEH 
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19. $GGȝOPHWK\ODWLRQUHDJHQWWRHDFKWXEH 
20. Close tube and vortex for 1min, let stand and leave to react for 10mins. 
21. $GGȝOWHUPLQDWLRQUHDJHQW. 
22. Add ~200mg Calcium Chloride and vortex for 1 min, let stand for 1 h. 
23. Centrifuge samples at 3400rpm (2400 x g) for 5mins at 15ºC. 
24. Transfer top layer to GC vial and store at -20ºC (if injecting within 24hrs) or -
80ºC (longer-term storage) for injection into GC or analyse immediately. 
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A.1.2 Extraction of lipid from plasma and lipoprotein samples for thin layer 
chromatography 
1. Prepare 15ml Falcon tubes containing 5.4ml of hexane:isopronaponol (3:2, v/v) 
and 3.6 of sodium sulphate (1g/15ml water). 
2. Add 1ml of sample to appropriate labelled 15ml falcon tube. 
3. Vortex for 30 sec to 1 min. 
4. Centrifuge at 2000 rpm for 5 min at room temperature. 
5. Transfer the top layer into a solvent-resistant LP tube. 
6. Dry under nitrogen on a heating block until all the solvent has evaporated. 
7. Pipette 1ml of hexane around the sides of the tube to wash them and then store 
at -20°C until needed. 
Thin layer chromatography (TLC) 
1. Prepare TLC plate by lightly drawing a line across the plate, 2cm up from the 
bottom. On this line, also mark 2cm in from each side of the plate. The 
samples should not be loaded in these parts as the samples can run off the sides 
if the plate does not run straight. Divide the line up into as many sections as 
you need, leaving at least 1cm between each sample. 
2. Prepare TLC tank by adding a solvent mix consisting of petroleum ether bp40-
60:diethyl ether:acetic acid (90:30:1) to a TLC tank and place lid on with a 
weight on top. Let the solvent mix to react for 30 min before placing TLC 
plates. 
3. Load 50 µl of standard along a sample section using a positive displacement 
pipette. Let sample dry between applications. 
4. Load 50 µl to 100 µl of sample (depending on the amount of lipid in the 
sample) onto the TLC plate and put into tank to run. 
5. When the solvent had run to within 2cm of the top of the plate, remove and 
allow drying before placing in a tank, containing iodine vapour, for staining. 
The iodine vapour reacts with the unsaturated bonds in the fatty acids staining 
them brown. Once stained, the bands have to be marked in the plate and left to 
distain until all colours had disappeared. Only stain the standard and some of 
the samples to localize the needed bands. For bovine plasma and lipoprotein 
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fractions iodine vapour has a negative effect and fatty acids are lost in the 
staining process. 
Extraction of lipids from TLC plates 
Types of lipid and solvents to use; 
Cholesterol ester: 2ml hexane:isopropanol (3:2, v/v) twice 
Triacylglycerol: 2ml chloroform:methanol (2:1, v/v) twice 
Phospholipid: 2ml chloroform:methanol (1:2, v/v) and, 
 then 2ml chloroform:methanol (1:5, v/v) 
1. Scrape TLC plates into labelled vials fro extraction 
2. Add required solvent mix and leave for 30 min agitating frequently but gently 
3. Remove solvent to a labelled solvent resistant LP4 tube 
4. Add another 2ml of solvent mix and leave for another 30 min as before 
5. Remove solvent to tube containing previous solvent 
6. Cap tube and centrifuge at 2000 rpm for 10 min at 4°C 
7. Carefully remove solvent to another labelled methylation tube without 
disturbing the silica in the bottom of the tube 
8. Dry under nitrogen on a heating block until all the solvent has evaporated 
 
Combine base-acid methylation of bovine plasma and lipoprotein fractions 
 
1. Add 1ml toluene to dissolve lipid, and then add 2ml 0.5 M sodium 
methoxide/methanol. 
Place a Teflon-screw cap on the tube and thoroughly mix 
 
0.5M = 2.7g sodium methoxide in 100ml methanol 
 
2. Incubate at 60°C for 20 min with gentle shaking. 
 
3. After 10 min, add 2ml 14% boron-tri-fluoride (BF3) in methanol and 
recommence incubation for a further 20 min with gentle shaking. 
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4. After 10 min, allow samples to cool to room temperature before adding 5ml 
distilled water. 
 
5. Mix the samples well and add 2ml hexane. Leave samples until two well-
defined phases are seen (to aid separation centrifuge at 2000 rpm for 5 min at 
room temperature). 
 
6. Transfer the top fatty acid methyl ester (FAME) containing hexane layer into a 
second methylation tube using a Pasteur pipette. 
 
7. Dry combined hexane samples under nitrogen and re-dissolve in an 
appropriate volume of hexane. Pipette into a gas chromatography vial and 
store at -20°C until analysis. 
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A.1.3 Volatile fatty acid analysis 
Preparation of metaphosphoric acid 25%: 
x Mix 100ml Distilled water with 54.3g metaphosphoric acid. 
 
Preparation of ruminal fluid for GC analysis: 
 
x Centrifuge 10ml of ruminal fluid in15ml conical tubes @ 4000 rpm for 15mins. 
x Mix 1ml of supernatant with 200Pl 25% Metaphosphoric acid in an epindorf 
tube (5:1 ratio). 
x Incubate at room temperature for 30 minutes. 
x Centrifuge epindorfs @ 12000 rpm for 10 minutes. 
x Add to tightly capped GC vials for analysis (1Pl). 
x GC should have an oven temp of 200 ºC and a detector temperature of 250ºC. 
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A.1.4 Separation of lipoproteins from bovine plasma by Preparative Sequential 
Ultracentrifugation 
 
1- Invert each tube of bovine plasma samples to maximise homogeneity 
2- Work out how much KBr needs to be added to serum sample to obtain 
required density: 
Volume of sample x (required density – initial density) 
______________________________________________________ 
1 – (0.312 x required density) 
 
50mls (volume of serum that we had) x (1.06 – 1.006) 
= _________________________________________________ 
1 – (0.312 x 1.06) 
 
2.7   2.7 
= _______________ = _______________ = 4.03g KBr 
1-0.3307  0.6993 
   
Calculations are based on the Radding-Steinberg Formula (1960) 
3- Add KBr to plasma and gently mix (prevent bubbles where possible) to 
dissolve salt. 
4- Add solution to Beckman Quick-Seal
®
 Tubes up to neck of tube: 
5- Seal with the bench top tube sealer (ensure that you put metal caps on top of 
tubes first) 
6- Spin the tubes at 39000 rpm for 20 h (or 45000 rpm for 15 h but it will take 
longer to slow down) under vacuum, at 12ºC using 70.1 Ti Rotor (Beckman 
Optima Ultracentrifuge XL-70 – No brake). 
7- After ultracentrifugation, carefully remove from centrifuge and carry upstairs. 
8- Using the Kontron bench top tube slicer carefully cut each tube.  Top layer is 
mostly the LDL, VLDL and CM layer.  Place tube into slicer with indentation 
pointing towards the blade (make sure that the blade is fully back).  Ensure the 
tube is just sticking up a little and place your left thumb lightly over the top.  
With your right hand turn the handle towards you and the blade will move 
towards the tube.  Once you have started cutting the tube, continue until you 
have cut the tube completely.   
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9- Using forceps and the side of the tube holder lever the lid off.  The fraction of 
interest will be trapped in the chamber above the blade.  Add contents of 
chamber to collection tube.  Rinse the top of the tube and the surface of the 
tube slicer blade with a small amount of KBr solution (1.063g/ ml) and re-
pipette into collection tube, labelled LDL #.   
10- Dry the blade with clean tissue paper and draw it back to expose the bottom 
section of the tube.  Using a different plastic Pasteur pipette, pipette some of 
the lower tube into other collection tube.  Very gently tease tube out of holder 
and agitate serum proteins etc.  *Very sticky so be careful not to block end of 
pipette*.  Rinse tube with KBr solution.  Once all tubes are done, make 
solution up to 40 ml with 1.24g/ ml KBr solution. 
Adjust the density to 1.24 using calculation below: 
40 x (1.21 – 1.06)  40 x 0.15  6 
_______________ = _________ = _____ = 9.6g 
1 – (0.312 x 1.21)  1 – (0.377)  0.623 
11- Add salt to tubes and gently mix to minimise bubbles but making sure that 
KBr dissolves. 
12- Syringe each sample into labelled (HDL#) Beckman Quick-Seal
®
 
ultracentrifuge tubes (polyallomer), using 5ml syringe and 19G x 1½”.  Use 
one syringe for each group.  Top the tubes up with 1.24 KBr and heat seal as 
before. 
13- Spin the tubes in ultracentrifuge as before (39000rpm) but for double time (40 
h or 45000rpm for 30 h). Ultracentrifuge takes about 4 hours to stop spinning 
as no brake is used because it will disturb fractions. 
14- Carefully cut the tubes as in stage 8. 
15- Using a plastic Pasteur pipette (one for each group), pipette the top HDL 
fraction into a labelled tube; rinse the top of the tube and the surface of the 
tube slicer with a small amount of 1.24 KBr solution and re-pipette into 
collection tube.   
16- Dry the blade with clean tissue paper and draw it back to expose the bottom 
section of the tube.  Pipette some of the contents into another labelled 
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(lipoprotein free#) and carefully take tube out of holder, agitate and pipette 
into collection tube.   
17- All samples will require dialysis against 0.15M NaCl 3 x 2L using a magnetic 
stirrer (change solution after one hour of dialysis, again after the 2
nd
 hour and 
then leave overnight in the cold room). 
A.1.5 Salt solutions for ultracentrifugation of lipoproteins 
Potassium bromide (KBr) solutions (pH 7.4*) for lipoprotein separation 
For 100ml solution: 
Density of KBr solution 
(g/ml) 
KBr 
(g/100ml) 
EDTA 
(mg/100ml) 
1.006 0.874 37.2 
1.019 2.786 37.2 
1.063 9.426 37.2 
1.24 39.144 37.2 
 
For 250ml solution: 
Density of KBr solution 
(g/ml) 
KBr 
(g/100ml) 
EDTA 
(mg/100ml) 
1.006 2.186 93 
1.019 6.964 93 
1.063 23.566 93 
1.24 97.860 93 
 
For 500ml solution: 
Density of KBr solution 
(g/ml) 
KBr 
(g/100ml) 
EDTA 
(mg/100ml) 
1.006 4.372 186 
1.019 13.928 186 
1.063 47.131 186 
1.24 195.720 186 
* All KBr solutions should be adjusted to pH 7.4 by using 0.5M NaOH or 0.5M HCl 
(it is normally too acidic). Check the density of the prepared solutions by weighing 
1ml of each solution and calculate the density: d = wt (g)/ vol (ml). 
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A p p e n d i x  2 
Methods associated with cell 
cultures 
 
x In vitro treatments preparation 
x Cytosolic fatty acid analysis 
x Cytosolic protein, DNA and TAG 
quantification 
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A.2.1 MAC-T cell preparation for treatments 
Growth medium 
It is the media used for growth and maintenance of MAC-T cells 
To prepare approximately 100 ml: 
x 90 ml RPMI 1640 (comprised of amino acids and vitamins; medium was 
developed by Moore et al., at Roswell Park Memorial Institute; RPMI) 
(GIBCO/invitrogen 61870-044) 
x 10 ml Foetal bovine serum (FBS) 
x 1 ml ABAM (antibiotic-antimycotic solution; 10,000 units of penicillin, 10 
mg streptomycin and 25 µg amphotericin B per ml) 
 
Basal medium 
Prepared approximately 48 h prior to the last subculture before initializing the 
experiment 
To prepare approximately 25 ml: 
 22.5 ml Minimum essential medium (MEM) (HYCLONE) 
 62.5 µl Insulin (Sigma I6634-100 mg) 
 2.5 µl Hydrocortisone (Sigma H0888-1 g) 
 25 µl Transferrin (Sigma T1428-50 mg) 
 25 µl Ascorbic acid (Sigma A4544-25 g) 
25 µl Sodium acetate (Sigma S5636-500 mg) 
250 µl ABAM (Sigma A5955) 
2.5 ml FBS (Sigma F7524) 
2.5 µl Progesterone (Sigma P8783-1g) 
12.5 mg Lactoalbumin (Sigma L5385-25 mg) 
12.5 mg Į-lactose (Sigma 47287-U) 
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Lactogenic medium 
Prepared at approximately 24 h before applying cell treatments (approximately 90% 
confluence) 
To prepare approximately 100 ml: 
 100 ml Dulbecco’s modified Eagle’s medium (DMEM) (Sigma D6429-500 ml) 
 250 µl Insulin 
 10 µl Hydrocortisone 
 100 µl Transferrin 
 100 µl Ascorbic acid 
100 µl Sodium acetate 
1 ml ABAM 
100 mg Bovine serum albumin (BSA) (Sigma A4919-5 g)  
10 µl Progesterone 
50 mg Lactoalbumin 
50 mg Į-lactose 
250 µl Prolactin (Sigma L6520-250 IU) 
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A.2.2 Preparation of LCFA solutions for cell cultures (example) 
1. Prepare a 1 M solution of NaOH (e.g., 4 g in 100 mL PBS or water since 
NaOH MW is 40) 
 
2. Weigh an amount of 16:0 between 20 and 30 mg in a glass tube. Record 
precisely the amount of the FA (eg., 26.1 mg, which divided by the MW 
 ȝ0ROHV 
 
3. $GG WR WKH JODVV WXEH D ȝ0ROHV RI 1D2+  0 VROXWLRQ HJ 
ȝ0ROHV ȝ0ROHVRI1D2+ ȝ/RI01D2+VROXWLRQDnd 
mix by swirling in a water bath at 42
°
C  
 
4. Then add an amount of absolute ethanol to obtain a final solution of 30 mM 
RIVWRFNVROXWLRQHJWKHȝ0ROHVLQ/ ȝ0LQP/ 
101.8 mM, since 30 mM is needed, then 101.8/30 = 3.39 mL – 0.114 mL 
(the NaOH solution) = 3.28 mL) has to be added.  Mix well in the 42
°
C bath 
until all the palmitate is dissolved before storing the stock at -20°C.  
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A.2.3 Fatty acid analysis of MAC-T cells 
Extraction of lipid 
1) From Media 
x Collect media (1ml ) 
x In a solvent resistant tube add 0.8ml of media to 5.4ml of freshly prepared 
hexane isopropanol (3:2 v/v) –mix well 
x Add 3.6ml of 6.6% anhydrous sodium sulphate (w/v in water) – mix well 
x Centrifuge  briefly at room temperature to separate phases 
x Collect top phase and dry down 
x Take up in 1000µl of hexane and carry on with the procedure and preparation 
of samples for GC analysis 
 
2) From Cells 
 
x After removing media wash cells with 3 x 1ml phosphate buffered saline (or 
something similar) 
x Add 1ml of freshly prepared hexane: isopropanol to each well and leave at 
room temperature for 30 minutes 
x Collect hexane: isopropanol into a solvent resistant tube 
x Add a further 1ml of hexane:isopropanol to each well –mix and combine with 
original 1ml 
x Dry down and take up in 1000µl of hexane and carry on with the procedure 
and preparation GC analysis 
x Washed once with ice-cold PBS+albumin (to remove FA traces) and twice 
with PBS  
x Scrapped off into 200 µl of 0.05M trisodium citrate for DNA and protein 
quantification and stored at -20°C until analysis After 10 min scrape the plate 
with to dissolve remaining cell debris in the NaoH 
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A.2.4 Protein assay by method of Lowry et al. (1951) 
BSA standards 
Make BSA stock at 5 mg/ml 
Protein 
 (µg per 50 µl in well) 
Concentration for 
standard (mg/ml) 
Volume BSA 
(5mg/ml) 
Volume H2O 
10 0.2 0.2 4.8 
20 0.4 0.4 4.6 
30 0.6 0.6 4.4 
40 0.8 0.8 4.2 
50 1.0 1.0 4.0 
60 1.2 1.2 3.8 
 
Reagents (make up fresh using stocks) 
1. Prepare reagent 1 using: 
a. 5.0 ml 2% Na2CO3 in 0.1 M NaOH 
b. 0.5 ml 1% CuSO4 
c. 0.5 ml 2% KNa tartrate 
2. Prepare reagent 2 using: 
a. 0.5 ml Folins Ciocaltuae’s phenol reagent 
b. 5.0 ml 0.1M NaOH 
3. Prepare BSA standards into plate (0-50 µg in 50 µl) 
4. Pipette approximate volume of sample (10-50 µl) per well (make up to 50 µl 
by addition of 40 µl distilled H2O 
5. Add 150 µl 0.1M NaOH to all wells to make total volume of 200 µl per well 
6. Add 50 µl of reagent 1 to all wells and pipette up and won to mix. Leave at 
room temperature for 5 min 
7. Add 50 µl of reagent 2 and leave to stand for 20 min at room temperature 
8. Read absorbance at 655 nm 
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A.2.5 DNA quantification – Hoechst fluorimetric method 
Stock solutions 
x 10x TNE buffer stock solution 
12.11 g Tris base [Tris (hydroxymethyl) 
aminomethane], MW = 121.14 
 
3.72 g EDTA, disodium salt, dihydrate, 
MW = 372.20 
116.89 g NaCl, MW = 58.44 
x 1mg/ml Hoechst dye solution (bisBenzimide H33258; SIGMA B2883-25 mg) 
x 20 µg/ml calf thymus DNA (SIGMA D4522 1mg) in distilled water 
Sample preparation 
1. Scrapped off into 200 µl of 0.05M trisodium citrate (Fishers S/3320/60) 
2. Centrifuge 2500 rpm at 4°C form 10 min 
3. Store at -80°C for later analysis 
Working solutions 
x 2x TNE 
x 2 µg/ml dye in 2x TNE 
Add 30 µl of 1 mg/ml stock dye solution to 15 ml of 2x TNE and cover with foil to 
protect from light 
Protocol 
1. Prepare serial dilutions of stock standard to range from 20 to 0.0312 µg/ml 
2. Add 100 µl of distilled water (blank), standard, or sample (10 µl sample 
diluted to 100 µl in distilled water) to each well 
3. Add 100 µl dye solution to each well 
4. Scan on fluorescent plate reader to assay amount of DNA 
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A.2.6 Triacylglyceride (TAG) quantification 
The TAG in the cell lysate was extracted using hexane:isopropanol (3:2 v/v) and 
quantified using a Triglyceride reagent (Infinity Triglyceride, Thermo Scientific, 
TR22421). 
Protocol 
1. After cell lysate is extracted, dry down under nitrogen 
2. Add to each tube 50µl of isopropanol and mix  
3. Load 10 µl of each standard (duplicate) 
4. Load10 µl of each sample (duplicate) 
5. Add 250 µl of TAG reagent 
6. Incubate at 37°C form 15 min 
7. Place it into the platereader 
TAG standard concentrations (TAG standards varies depending on the sensitivity 
needed for each assay) 
Standard mmol/l 
1 0 
2 0.226 
3 0.452 
4 0.904 
5 1.356 
6 1.808 
7 2.26 
 
Standard preparations from trace DMA precipitating kit (Thermo) 200 mg/dl 
Standard mmol/l µl of standard µl of H2O 
1 0 0 1000 
2 0.226 100 900 
3 0.452 200 800 
4 0.904 400 600 
5 1.356 600 400 
6 1.808 800 200 
7 2.26 1000 0 
 
µl standard 
---------------- x mmol/l of standard 
µl total 
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A.2.7 Cryopreservation method for MAC-T cells (example) 
 
1. 4 x 80 cm
2
 flasks confluent with a few floating cells.  
2. Trypsin/EDTA was filtered through 0.2µ syringe filter before use. 
Growth medium 
RPMI-1640 with FCS (10%) and ABAM (1%) filtered as above before use. 
Cryopreservation medium 
RPMI-1640 (70%): FCS (20%): DMSO (10%). RPMI-1640 (35 ml) and FCS (10 ml) 
filtered then 5ml DMSO was added [Method from Wellnitz, O and Kerr, DE. (2004) 
Veterinary Immunology and Immunopathology, 101, 191-202 and Keys, JE, Guidry, 
AJ, and Cifran, E. (1997) In vitro Cellular Developmental Biology – Animal. 33, 201-
205].  
3. 1 flask was trypsinized by pipetting off the medium, washing the cells with 3 ml 
Trypsin/EDTA, pipetting that off and adding a further 3 ml Trypsin/EDTA. The cells 
were transferred to 2 X 175 cm
2
 flasks with 40 ml Growth Medium per flask. 
4. Three flasks were prepared separately for cryopreservation. The cells were trypsinized 
as above and transferred to 15 ml conical centrifuge tubes. The flasks were rinsed 
with 4ml RPMI-1640 and this was added to the relevant tube. A further 2ml RPMI-
1640 was added to each tube to further dilute out the trypsin. 
5. The tubes were centrifuged at 700 rpm for 10 minutes in the MSE Centaur centrifuge. 
6. Supernatants were removed by pipette. The cells were resuspended in 
cryopreservation medium (5 ml per tube). Some clumps persisted after repeated gentle 
pipetting up and down. 
Cell counts: 
&HOOV ZHUH GLOXWHG  LQ  ZLWK FU\RSUHVHUYDWLRQ PHGLXP ȝO FHOO VXVSHQVLRQ LQ ȝO
medium) and counted in a haemocytometer chamber. Five large squares from each of two 
grids were counted for each preparation (a total of 10 squares). 
Flask (1) 212 cells in 10 squares 
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 21.2 cells in 1 square x 10 (dilution factor)   x   10000 = 2 120 000 cells per ml 
X 5 (volume in tube) = 10.6 x 10
6 
cells per flask.         
5 cryovials prepared 
Flask (2)   263 cells in 10 squares 
 26.3 cells in 1 square x 10 (dilution factor)   x   10000 = 2 630 000 cells per ml 
X 5 (volume in tube) = 13.2 x 10
6 
cells per flask. Volume made up to 6.7 ml.  
7 cryovials prepared 
Flask (3) 185 cells in 10 squares 
18.5 cells in 1 square x 10 (dilution factor)   x   10000 = 1 850 000 cells per ml 
X 5 (volume in tube) = 9.25 x 10
6 
cells per flask.         
5 cryovials prepared
 
Cells per flask (mean 
+/-
 SEM) 11.0 +/- 1.2 x 10
6
 cells per flask. 
Vials put into a small plastic bag to keep them upright, wrapped in paper towel and placed in 
a polystyrene box at -80Û&RYHUQLJKW7UDQVIHUWROLTXLGQLWURJHQIRUORQJWHUPVWRUDJH 
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Appendix 3 
 
Cytosolic and media fatty acid 
profiles 
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A.3.1 Cytosolic fatty acid profile 
A.3.1.2 Saturated fatty acids 
 
Cytosolic 16:0 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 26.31 24.20 26.27 28.78 3.526 <0.001 
Palmitate 10.79 19.59 25.62 22.42   
Stearate 26.92 24.32 22.99 25.79   
Oleate 10.81 5.91 4.62 4.91   
Elaidate 12.27 17.48 11.14 9.15   
Vaccenate 17.81 13.32 9.69 9.78   
Linoleate 9.27 6.50 6.23 4.54   
CLA
1 
20.47 16.95 11.18 8.44   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
Cytosolic 18:0 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 30.09 29.20 31.65 38.23 6.081 0.020 
Palmitate 6.67 8.47 8.16 6.59   
Stearate 34.56 35.88 42.21 45.78   
Oleate 8.06 5.01 3.94 4.08   
Elaidate 10.23 17.55 9.14 8.20   
Vaccenate 19.89 13.54 8.47 22.64   
Linoleate 8.37 5.91 5.86 5.13   
CLA
1 
24.31 20.08 11.02 8.58   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
Cytosolic 20:0 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 1.170 1.034 1.300 1.314 1.202 <0.001 
Palmitate 0.843 0.901 0.520 0.287   
Stearate 1.266 1.102 1.239 1.263   
Oleate 0.924 0.704 0.699 0.574   
Elaidate 0.774 1.001 0.702 0.547   
Vaccenate 0.910 0.609 0.439 1.230   
Linoleate 9.662 16.938 19.236 25.327   
CLA
1 
0.773 0.716 0.625 0.629   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
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A.3.1.3 Monounsaturated fatty acids and trans fatty acids 
 
Cytosolic 16:1 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 1.514 0.862 1.472 * 0.3383 0.008 
Palmitate 2.339 3.300 2.545 1.675   
Stearate 1.098 * 0.778 *   
Oleate 0.841 0.601 0.539 1.203   
Elaidate 1.306 1.104 1.176 0.888   
Vaccenate 1.103 0.782 0.856 0.627   
Linoleate 0.778 0.582 0.484 *   
CLA
1 
1.193 0.981 0.879 0.772   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; *not detectable. 
 
Cytosolic 18:1 trans-9 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 3.685 2.205 0.988 1.052 5.694 <0.001 
Palmitate 3.308 4.174 2.645 3.213   
Stearate * 1.944 0.496 1.707   
Oleate 3.805 2.329 2.209 1.975   
Elaidate 15.495 12.867 32.519 39.963   
Vaccenate * * 6.801 *   
Linoleate 3.385 2.733 1.889 1.923   
CLA
1 
1.850 * * *   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; *not detectable. 
 
Cytosolic 18:1 cis-9 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 7.19 5.16 5.78 2.96 3.544 0.002 
Palmitate 11.73 9.95 7.98 5.30   
Stearate 14.66 3.09 8.07 5.13   
Oleate 18.63 28.96 37.45 37.09   
Elaidate 11.34 9.95 15.12 11.62   
Vaccenate 7.37 6.98 7.79 5.19   
Linoleate 7.12 5.26 4.22 3.28   
CLA
1 
7.63 6.35 6.99 6.23   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
  
175 
Cytosolic 24:1 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 0.683 1.045 0.874 0.744 0.9042 0.026 
Palmitate 1.198 2.493 3.483 4.563   
Stearate 0.827 1.091 1.708 1.000   
Oleate 1.935 1.425 0.990 2.004   
Elaidate 0.861 0.812 0.674 0.501   
Vaccenate 0.933 0.755 0.577 1.828   
Linoleate 1.141 2.409 1.605 1.237   
CLA
1 
1.043 1.594 0.808 0.659   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
 
A.3.1.4 Polyunsaturated fatty acids 
 
Cytosolic 18:2n-cis 6 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 2.567 1.538 2.766 1.507 1.213 <0.001 
Palmitate 1.151 1.068 0.855 0.817   
Stearate 3.367 1.075 1.675 1.551   
Oleate 1.463 1.077 0.852 0.837   
Elaidate 1.844 1.598 2.110 1.243   
Vaccenate 1.684 1.380 1.343 1.249   
Linoleate 14.166 22.961 25.234 33.523   
CLA
1 
1.833 1.701 1.525 1.369   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
Cytosolic CLA concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control * * * * 5.383 <0.001 
Palmitate * * * *   
Stearate 2.638 * 0.967 1.135   
Oleate 0.823 1.091 1.195 1.134   
Elaidate 4.835 * 0.761 0.166   
Vaccenate 4.521 3.771 4.774 4.140   
Linoleate * * * 0.648   
CLA
1 
6.709 13.277 28.503 38.538   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; *not detectable. 
  
176 
Cytosolic 20:4n6 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control * * * * 0.2598 0.038 
Palmitate 1.148 1.183 0.944 0.767   
Stearate * 0.540 * *   
Oleate 1.639 1.233 1.047 0.775   
Elaidate 1.125 * * *   
Vaccenate 1.777 1.126 0.957 *   
Linoleate 1.153 0.844 0.644 0.543   
CLA
1 
1.668 1.463 1.661 1.597   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; *not detectable. 
 
A.3.1.5 Major fatty acid classes in cytosol 
 
Cytosolic MUFA concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 14.47 14.32 11.97 7.35 7.199 <0.001 
Palmitate 34.53 30.70 23.30 22.50   
Stearate 17.67 9.75 13.31 9.52   
Oleate 43.22 57.42 70.59 69.59   
Elaidate 36.48 36.28 61.61 65.72   
Vaccenate 20.55 18.93 20.99 20.70   
Linoleate 21.87 16.42 13.73 10.16   
CLA
1 
19.79 15.56 16.98 14.10   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
Cytosolic PUFA concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 13.38 14.31 18.45 13.42 4.021 <0.001 
Palmitate 19.88 16.11 14.41 22.07   
Stearate 14.10 15.69 12.61 10.22   
Oleate 16.88 15.66 10.60 11.71   
Elaidate 10.40 10.37 8.09 6.86   
Vaccenate 17.89 13.98 11.44 12.39   
Linoleate 30.86 39.10 38.88 43.65   
CLA
1 
18.58 27.21 38.37 49.29   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
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Cytosolic SFA concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 61.86 61.61 63.32 72.31 8.952 <0.001 
Palmitate 22.55 32.61 37.56 35.21   
Stearate 65.65 66.81 69.16 76.15   
Oleate 22.47 13.30 9.44 10.65   
Elaidate 24.64 40.08 21.89 19.18   
Vaccenate 43.40 31.79 20.62 32.67   
Linoleate 31.64 33.11 36.60 37.50   
CLA
1 
49.60 42.99 28.83 22.17   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
Cytosolic tFA concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 4.26 5.22 2.27 1.56 4.589 <0.001 
Palmitate 9.47 8.51 5.87 7.50   
Stearate 1.62 4.63 3.13 2.88   
Oleate 7.12 7.00 4.16 4.72   
Elaidate 36.67 20.49 42.75 50.88   
Vaccenate 12.09 28.72 43.01 33.93   
Linoleate 6.86 5.25 5.53 4.56   
CLA
1 
6.26 4.37 3.60 4.34   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
Cytosolic UFA concentration (Mono + PUFA; g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 27.85 28.64 30.43 20.77 7.462 <0.001 
Palmitate 54.42 46.81 37.70 44.57   
Stearate 31.77 25.44 25.92 19.75   
Oleate 60.10 73.08 81.18 81.30   
Elaidate 46.89 46.64 69.71 72.58   
Vaccenate 38.44 32.91 32.44 33.09   
Linoleate 52.73 55.52 52.62 53.81   
CLA
1 
38.37 42.77 55.34 63.39   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
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A.3.2 Media fatty acid profile 
A.3.2.1 Saturated fatty acids 
 
Media 18:0 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 26.17 23.14 23.69 23.26 3.075 0.014 
Palmitate 37.57 33.28 28.84 28.78   
Stearate 24.13 31.51 32.98 30.61   
Oleate 34.66 33.50 34.73 27.76   
Elaidate 35.99 30.52 32.97 28.90   
Vaccenate 33.32 33.39 32.10 29.40   
Linoleate 35.26 35.56 32.77 33.10   
CLA
1 
37.74 39.93 30.29 29.98   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
 
Media 21:0 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 0.668 1.148 1.402 1.448 0.5798 0.012 
Palmitate 0.939 0.742 * 1.511   
Stearate 0.777 1.572 3.409 1.586   
Oleate 1.243 1.583 0.827 1.175   
Elaidate 0.785 1.251 0.843 1.196   
Vaccenate 1.523 1.541 0.534 1.175   
Linoleate 0.987 1.147 0.880 0.956   
CLA
1 
1.231 1.132 0.906 3.116   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; *not detectable. 
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A.3.2.2 Monounsaturated fatty acids 
 
Media 18:1 cis-9 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 1.010 0.966 0.857 1.055 1.448 0.004 
Palmitate 2.715 3.014 3.737 3.559   
Stearate 0.919 1.159 1.447 1.126   
Oleate 5.732 5.291 9.062 14.852   
Elaidate 2.101 2.572 2.886 3.127   
Vaccenate 1.807 2.002 2.152 1.910   
Linoleate 2.719 2.390 2.897 2.450   
CLA
1 
1.896 1.903 1.812 2.632   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
 
A.3.2.3 Polyunsaturated fatty acids 
 
Media 18:2n-cis 6 concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 0.515 0.502 0.473 0.474 0.3145 <0.001 
Palmitate 0.852 0.815 1.061 0.926   
Stearate 0.447 0.497 0.475 0.428   
Oleate 2.060 0.667 0.856 0.914   
Elaidate 0.912 0.934 0.752 0.780   
Vaccenate 0.685 0.883 0.742 0.764   
Linoleate 1.697 4.705 8.092 11.476   
CLA
1 
0.807 0.739 0.760 0.849   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
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Media CLA concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control * * * * 2.608 0.034 
Palmitate * * * *   
Stearate * * * *   
Oleate * * * *   
Elaidate * * * *   
Vaccenate * * 0.637 0.509   
Linoleate * * * *   
CLA
1 
2.613 2.678 2.966 12.772   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction; *not detectable. 
 
 
A.3.2.4 Major fatty acid classes in the media 
 
Media tFA concentration (g/100g) 
 Concentration (µM)   
Fatty acid 100 200 300 400 SED
2 
P-value
3 
       
Control 0.835 1.090 0.854 1.801 1.529 0.006 
Palmitate 1.095 0.652 0.431 1.445   
Stearate 0.673 1.553 2.131 4.127   
Oleate 1.124 2.218 0.247 1.688   
Elaidate 2.767 6.155 6.640 11.483   
Vaccenate 5.487 6.254 7.959 12.825   
Linoleate 1.248 1.283 1.364 2.281   
CLA
1 
2.244 0.181 0.599 0.000   
       
1
Conjugated linoleic acid; 
2
Standard errors of differences between means (calculated on variance scale); 
3
P-value represents the probability of a treatment-concentration interaction. 
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